TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-352230	Amino acid transport across the plasma membrane	0.000120024431050598	-9.02781524381597	31	10	0.0148148148148148	675	8202	6541,6533,6520,6509,23657,81539,8140,54716,124935,117247	SLC7A1,SLC6A6,SLC3A2,SLC1A4,SLC7A11,SLC38A1,SLC7A5,SLC6A20,SLC43A2,SLC16A10
R-HSA-194840	Rho GTPase cycle	0.000165915644049469	-8.70403106714573	124	23	0.0340740740740741	675	8202	64411,58504,7204,1894,4983,84033,9743,10144,115703,9901,29,26230,84144,1123,343578,23263,57522,23221,101928168,9828,90627,57514,50649	ARAP3,ARHGAP22,TRIO,ECT2,OPHN1,OBSCN,ARHGAP32,FAM13A,ARHGAP33,SRGAP3,ABR,TIAM2,SYDE2,CHN1,ARHGAP40,MCF2L,SRGAP1,RHOBTB2,LOC101928168,ARHGEF17,STARD13,ARHGAP31,ARHGEF4
R-HSA-445095	Interaction between L1 and Ankyrins	0.000365364572414745	-7.91461487434554	29	9	0.0133333333333333	675	8202	6712,3786,6324,287,6334,23114,6329,57731,6328	SPTBN2,KCNQ3,SCN1B,ANK2,SCN8A,NFASC,SCN4A,SPTBN4,SCN3A
R-HSA-373760	L1CAM interactions	0.000823738261150804	-7.10165772274888	97	18	0.0266666666666667	675	8202	6712,1759,3786,287,6334,9252,57731,10048,6196,6324,3673,1739,23114,6329,1741,8829,6328,57698	SPTBN2,DNM1,KCNQ3,ANK2,SCN8A,RPS6KA5,SPTBN4,RANBP9,RPS6KA2,SCN1B,ITGA2,DLG1,NFASC,SCN4A,DLG3,NRP1,SCN3A,SHTN1
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.00130040938327627	-6.64507615387595	7	4	0.00592592592592593	675	8202	5096,5091,5095,56922	PCCB,PC,PCCA,MCCC1
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.00130040938327627	-6.64507615387595	7	4	0.00592592592592593	675	8202	5096,5091,5095,56922	PCCB,PC,PCCA,MCCC1
R-HSA-936837	Ion transport by P-type ATPases	0.00173676805192468	-6.35572933436171	49	11	0.0162962962962963	675	8202	23200,10079,10396,27032,9914,286410,23250,481,483,487,79895	ATP11B,ATP9A,ATP8A1,ATP2C1,ATP2C2,ATP11C,ATP11A,ATP1B1,ATP1B3,ATP2A1,ATP8B4
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.00193976809234786	-6.24518685307926	96	17	0.0251851851851852	675	8202	10723,285195,6520,81539,6507,84679,6541,6533,23657,6509,6575,8140,54716,6548,124935,23315,117247	SLC12A7,SLC9A9,SLC3A2,SLC38A1,SLC1A3,SLC9A7,SLC7A1,SLC6A6,SLC7A11,SLC1A4,SLC20A2,SLC7A5,SLC6A20,SLC9A1,SLC43A2,SLC9A8,SLC16A10
R-HSA-382551	Transmembrane transport of small molecules	0.00199016898030209	-6.21953572912612	586	68	0.100740740740741	675	8202	1831,10396,9914,9197,84679,23200,51393,23225,1186,7439,261729,109,7220,55240,121601,57578,81929,10057,6580,4645,285195,115584,6520,10257,81539,64116,9194,5577,481,1181,23516,6541,162514,6575,41,54716,23315,10723,6536,10079,2792,90423,6507,7037,65125,8894,23657,6509,6548,215,57101,79895,53373,84102,27032,286410,23250,487,6533,22841,80036,8140,3099,483,55356,124935,117247,9619	TSC22D3,ATP8A1,ATP2C2,SLC33A1,SLC9A7,ATP11B,TRPV2,NUP210,CLCN7,BEST1,STEAP2,ADCY3,TRPC1,STEAP3,ANO4,UNC79,SEH1L,ABCC5,SLC22A1,MYO5B,SLC9A9,SLC5A11,SLC3A2,ABCC4,SLC38A1,SLC39A8,SLC16A7,PRKAR2B,ATP1B1,CLCN2,SLC39A14,SLC7A1,TRPV3,SLC20A2,ASIC1,SLC6A20,SLC9A8,SLC12A7,SLC6A9,ATP9A,GNGT1,ATP6V1E2,SLC1A3,TFRC,WNK1,EIF2S2,SLC7A11,SLC1A4,SLC9A1,ABCD1,ANO2,ATP8B4,TPCN1,SLC41A2,ATP2C1,ATP11C,ATP11A,ATP2A1,SLC6A6,RAB11FIP2,TRPM3,SLC7A5,HK2,ATP1B3,SLC22A15,SLC43A2,SLC16A10,ABCG1
R-HSA-193648	NRAGE signals death through JNK	0.0030128572208865	-5.80486640764798	45	10	0.0148148148148148	675	8202	5599,23263,9500,7204,1894,84033,9828,29,26230,50649	MAPK8,MCF2L,MAGED1,TRIO,ECT2,OBSCN,ARHGEF17,ABR,TIAM2,ARHGEF4
R-HSA-380994	ATF4 activates genes	0.00319757079639075	-5.74536388358649	25	7	0.0103703703703704	675	8202	22926,467,440,468,5073,9709,1649	ATF6,ATF3,ASNS,ATF4,PARN,HERPUD1,DDIT3
R-HSA-1474290	Collagen formation	0.00406118598873404	-5.50628023257417	86	15	0.0222222222222222	675	8202	9509,4316,7092,1285,9313,5352,1287,26577,1288,1307,1303,1293,85301,7093,3914	ADAMTS2,MMP7,TLL1,COL4A3,MMP20,PLOD2,COL4A5,PCOLCE2,COL4A6,COL16A1,COL12A1,COL6A3,COL27A1,TLL2,LAMB3
R-HSA-425986	Sodium/Proton exchangers	0.0040942362982004	-5.49817507523564	9	4	0.00592592592592593	675	8202	6548,285195,23315,84679	SLC9A1,SLC9A9,SLC9A8,SLC9A7
R-HSA-2990846	SUMOylation	0.00467349620161179	-5.3658478360922	79	14	0.0207407407407407	675	8202	23225,80012,10274,197370,286053,9063,22955,165918,7486,9656,7518,648,205564,81929	NUP210,PHC3,STAG1,NSMCE1,NSMCE2,PIAS2,SCMH1,RNF168,WRN,MDC1,XRCC4,BMI1,SENP5,SEH1L
R-HSA-71032	Propionyl-CoA catabolism	0.00489097285013442	-5.3203640484249	5	3	0.00444444444444444	675	8202	5096,5095,166785	PCCB,PCCA,MMAA
R-HSA-913709	O-linked glycosylation of mucins	0.00536496301141884	-5.22786579734657	64	12	0.0177777777777778	675	8202	2591,4585,4584,6480,9245,256435,146712,79623,374378,84002,10331,9331	GALNT3,MUC4,MUC3A,ST6GAL1,GCNT3,ST6GALNAC3,B3GNTL1,GALNT14,GALNT18,B3GNT5,B3GNT3,B4GALT6
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.00536496301141884	-5.22786579734657	64	12	0.0177777777777778	675	8202	9509,7092,1285,5352,1287,26577,1288,1307,1303,1293,85301,7093	ADAMTS2,TLL1,COL4A3,PLOD2,COL4A5,PCOLCE2,COL4A6,COL16A1,COL12A1,COL6A3,COL27A1,TLL2
R-HSA-381042	PERK regulates gene expression	0.00634341676809491	-5.06033773328709	28	7	0.0103703703703704	675	8202	22926,467,440,468,5073,9709,1649	ATF6,ATF3,ASNS,ATF4,PARN,HERPUD1,DDIT3
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.00679173054897887	-4.99204950258294	74	13	0.0192592592592593	675	8202	23225,80012,10274,197370,286053,9063,22955,165918,7486,9656,7518,648,81929	NUP210,PHC3,STAG1,NSMCE1,NSMCE2,PIAS2,SCMH1,RNF168,WRN,MDC1,XRCC4,BMI1,SEH1L
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.00679173054897887	-4.99204950258294	74	13	0.0192592592592593	675	8202	23225,80012,10274,197370,286053,9063,22955,165918,7486,9656,7518,648,81929	NUP210,PHC3,STAG1,NSMCE1,NSMCE2,PIAS2,SCMH1,RNF168,WRN,MDC1,XRCC4,BMI1,SEH1L
R-HSA-180786	Extension of Telomeres	0.00778156524675439	-4.85599777249869	29	7	0.0103703703703704	675	8202	5984,5983,328,5558,8607,7015,5422	RFC4,RFC3,APEX1,PRIM2,RUVBL1,TERT,POLA1
R-HSA-422475	Axon guidance	0.00823800396702364	-4.79899720141657	516	58	0.0859259259259259	675	8202	6712,200734,6334,5922,2043,1950,7204,9542,1287,5361,2047,9252,785,5217,1847,9965,1293,6196,775,6324,6477,53358,783,5062,1739,57522,7220,776,1741,4233,6328,56896,1759,64283,8831,1285,3786,2247,285704,287,1852,5682,283455,7422,57731,10048,9901,8660,2534,3673,6478,23129,6329,23114,8829,90249,409,57698	SPTBN2,SPRED2,SCN8A,RASA2,EPHA4,EGF,TRIO,NRG2,COL4A5,PLXNA1,EPHB1,RPS6KA5,CACNB4,PFN2,DUSP5,FGF19,COL6A3,RPS6KA2,CACNA1C,SCN1B,SIAH1,SHC3,CACNB2,PAK2,DLG1,SRGAP1,TRPC1,CACNA1D,DLG3,MET,SCN3A,DPYSL5,DNM1,ARHGEF28,SYNGAP1,COL4A3,KCNQ3,FGF2,RGMB,ANK2,DUSP9,PSMA1,KSR2,VEGFA,SPTBN4,RANBP9,SRGAP3,IRS2,FYN,ITGA2,SIAH2,PLXND1,SCN4A,NFASC,NRP1,UNC5A,ARRB2,SHTN1
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.00913703500280052	-4.69541934408752	37	8	0.0118518518518519	675	8202	5984,5983,5932,11073,4361,545,7486,3364	RFC4,RFC3,RBBP8,TOPBP1,MRE11A,ATR,WRN,HUS1
R-HSA-196780	Biotin transport and metabolism	0.00938579930940792	-4.66855744374689	11	4	0.00592592592592593	675	8202	5096,5091,5095,56922	PCCB,PC,PCCA,MCCC1
R-HSA-381119	Unfolded Protein Response (UPR)	0.0100061096299657	-4.60455940955343	86	14	0.0207407407407407	675	8202	58477,440,468,29927,7095,2137,51726,22926,467,11231,5073,27230,9709,1649	SRPRB,ASNS,ATF4,SEC61A1,SEC62,EXTL3,DNAJB11,ATF6,ATF3,SEC63,PARN,SERP1,HERPUD1,DDIT3
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.0101213135974769	-4.59311182142416	61	11	0.0162962962962963	675	8202	5599,23421,23263,9500,7204,1894,84033,9828,29,26230,50649	MAPK8,ITGB3BP,MCF2L,MAGED1,TRIO,ECT2,OBSCN,ARHGEF17,ABR,TIAM2,ARHGEF4
R-HSA-983712	Ion channel transport	0.0113805341757382	-4.47585091151405	198	26	0.0385185185185185	675	8202	10079,1831,10396,27032,9914,90423,286410,23250,481,487,1181,23200,65125,51393,162514,1186,80036,41,7439,7220,483,57101,121601,79895,53373,57578	ATP9A,TSC22D3,ATP8A1,ATP2C1,ATP2C2,ATP6V1E2,ATP11C,ATP11A,ATP1B1,ATP2A1,CLCN2,ATP11B,WNK1,TRPV2,TRPV3,CLCN7,TRPM3,ASIC1,BEST1,TRPC1,ATP1B3,ANO2,ANO4,ATP8B4,TPCN1,UNC79
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.0115687533742541	-4.45944748997279	54	10	0.0148148148148148	675	8202	4316,7092,1285,9313,1287,1288,1293,85301,7093,3914	MMP7,TLL1,COL4A3,MMP20,COL4A5,COL4A6,COL6A3,COL27A1,TLL2,LAMB3
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.0125911990732992	-4.37475719532597	39	8	0.0118518518518519	675	8202	5984,5983,5932,11073,4361,545,7486,3364	RFC4,RFC3,RBBP8,TOPBP1,MRE11A,ATR,WRN,HUS1
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.0129061700614719	-4.35004978262427	18	5	0.00740740740740741	675	8202	5096,5091,166785,5095,56922	PCCB,PC,MMAA,PCCA,MCCC1
R-HSA-210991	Basigin interactions	0.0138687514332646	-4.27811706793847	25	6	0.00888888888888889	675	8202	857,483,6520,481,23657,8140	CAV1,ATP1B3,SLC3A2,ATP1B1,SLC7A11,SLC7A5
R-HSA-199920	CREB phosphorylation	0.0150998691523388	-4.19306920060683	7	3	0.00444444444444444	675	8202	466,6196,9252	ATF1,RPS6KA2,RPS6KA5
R-HSA-2214320	Anchoring fibril formation	0.0150998691523388	-4.19306920060683	7	3	0.00444444444444444	675	8202	7092,3914,7093	TLL1,LAMB3,TLL2
R-HSA-193704	p75 NTR receptor-mediated signalling	0.0158186103114523	-4.14656816427784	82	13	0.0192592592592593	675	8202	5599,23421,23263,9500,7204,1894,5584,84033,9828,29,26230,84894,50649	MAPK8,ITGB3BP,MCF2L,MAGED1,TRIO,ECT2,PRKCI,OBSCN,ARHGEF17,ABR,TIAM2,LINGO1,ARHGEF4
R-HSA-166520	Signalling by NGF	0.0173943965824155	-4.05160716011958	430	48	0.0711111111111111	675	8202	5599,6712,200734,5922,9500,27161,1950,7204,9542,23239,9252,2309,1847,9965,26230,84894,5581,466,6196,53358,23263,5584,109,9828,5046,1759,2889,8831,2247,3164,4914,1894,1852,5682,283455,84033,5577,57731,5291,29,8660,57761,2534,23421,10000,409,4208,50649	MAPK8,SPTBN2,SPRED2,RASA2,MAGED1,AGO2,EGF,TRIO,NRG2,PHLPP1,RPS6KA5,FOXO3,DUSP5,FGF19,TIAM2,LINGO1,PRKCE,ATF1,RPS6KA2,SHC3,MCF2L,PRKCI,ADCY3,ARHGEF17,PCSK6,DNM1,RAPGEF1,SYNGAP1,FGF2,NR4A1,NTRK1,ECT2,DUSP9,PSMA1,KSR2,OBSCN,PRKAR2B,SPTBN4,PIK3CB,ABR,IRS2,TRIB3,FYN,ITGB3BP,AKT3,ARRB2,MEF2C,ARHGEF4
R-HSA-157118	Signaling by NOTCH	0.0175352786518885	-4.04354050433357	110	16	0.0237037037037037	675	8202	79718,7090,27161,4242,55869,3714,487,9734,9148,9759,4609,1869,3516,6907,7029,409	TBL1XR1,TLE3,AGO2,MFNG,HDAC8,JAG2,ATP2A1,HDAC9,NEURL1,HDAC4,MYC,E2F1,RBPJ,TBL1X,TFDP2,ARRB2
R-HSA-977347	Serine biosynthesis	0.0191805434591357	-3.95385887524965	3	2	0.00296296296296296	675	8202	29968,26227	PSAT1,PHGDH
R-HSA-5357572	Lysosomal glycogen catabolism	0.0191805434591357	-3.95385887524965	3	2	0.00296296296296296	675	8202	2548,2992	GAA,GYG1
R-HSA-1474244	Extracellular matrix organization	0.0193260704383475	-3.94630029466637	267	32	0.0474074074074074	675	8202	4052,7092,9313,3339,3684,7148,10319,1287,7042,6382,3383,85301,1293,84467,3914,6696,4316,85007,26577,3687,9509,7077,1285,2247,1303,5352,3673,652,1288,1307,7093,170690	LTBP1,TLL1,MMP20,HSPG2,ITGAM,TNXB,LAMC3,COL4A5,TGFB2,SDC1,ICAM1,COL27A1,COL6A3,FBN3,LAMB3,SPP1,MMP7,PHYKPL,PCOLCE2,ITGAX,ADAMTS2,TIMP2,COL4A3,FGF2,COL12A1,PLOD2,ITGA2,BMP4,COL4A6,COL16A1,TLL2,ADAMTS16
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.0194401421230121	-3.94041516912204	42	8	0.0118518518518519	675	8202	5984,5983,5932,11073,4361,545,7486,3364	RFC4,RFC3,RBBP8,TOPBP1,MRE11A,ATR,WRN,HUS1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0201497035822284	-3.90456570125703	27	6	0.00888888888888889	675	8202	5332,23007,3705,9651,23236,5330	PLCB4,PLCH1,ITPK1,PLCH2,PLCB1,PLCB2
R-HSA-5173105	O-linked glycosylation	0.0208233749452706	-3.87167912781458	103	15	0.0222222222222222	675	8202	23145,2591,9509,4585,4584,6480,9245,256435,146712,79623,374378,9331,170690,84002,10331	SSPO,GALNT3,ADAMTS2,MUC4,MUC3A,ST6GAL1,GCNT3,ST6GALNAC3,B3GNTL1,GALNT14,GALNT18,B4GALT6,ADAMTS16,B3GNT5,B3GNT3
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.0227006014897446	-3.78536385750025	8	3	0.00444444444444444	675	8202	57761,23239,10000	TRIB3,PHLPP1,AKT3
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.0227006014897446	-3.78536385750025	8	3	0.00444444444444444	675	8202	1312,217,6580	COMT,ALDH2,SLC22A1
R-HSA-2046105	Linoleic acid (LA) metabolism	0.0227006014897446	-3.78536385750025	8	3	0.00444444444444444	675	8202	9415,215,2180	FADS2,ABCD1,ACSL1
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.023352403686115	-3.75705535857585	14	4	0.00592592592592593	675	8202	5984,5983,5558,5422	RFC4,RFC3,PRIM2,POLA1
R-HSA-69091	Polymerase switching	0.023352403686115	-3.75705535857585	14	4	0.00592592592592593	675	8202	5984,5983,5558,5422	RFC4,RFC3,PRIM2,POLA1
R-HSA-69109	Leading Strand Synthesis	0.023352403686115	-3.75705535857585	14	4	0.00592592592592593	675	8202	5984,5983,5558,5422	RFC4,RFC3,PRIM2,POLA1
R-HSA-1266738	Developmental Biology	0.0246686154230101	-3.70222347393116	710	73	0.108148148148148	675	8202	6712,200734,2043,1950,9542,203190,5361,785,6196,775,6477,53358,1739,7220,1741,4233,6328,1285,287,9442,283455,4209,7422,57731,8660,2534,23097,3673,23129,23114,8829,90249,409,3172,4208,5922,6334,7204,1287,2047,5217,9252,2309,9965,1847,1293,6324,783,5062,57522,776,5046,56896,1759,64283,8831,3786,57167,285704,79718,2247,5465,1852,5682,10048,9901,4185,10000,6478,3516,6907,6329,57698	SPTBN2,SPRED2,EPHA4,EGF,NRG2,LGI3,PLXNA1,CACNB4,RPS6KA2,CACNA1C,SIAH1,SHC3,DLG1,TRPC1,DLG3,MET,SCN3A,COL4A3,ANK2,MED27,KSR2,MEF2D,VEGFA,SPTBN4,IRS2,FYN,CDK19,ITGA2,PLXND1,NFASC,NRP1,UNC5A,ARRB2,HNF4A,MEF2C,RASA2,SCN8A,TRIO,COL4A5,EPHB1,PFN2,RPS6KA5,FOXO3,FGF19,DUSP5,COL6A3,SCN1B,CACNB2,PAK2,SRGAP1,CACNA1D,PCSK6,DPYSL5,DNM1,ARHGEF28,SYNGAP1,KCNQ3,SALL4,RGMB,TBL1XR1,FGF2,PPARA,DUSP9,PSMA1,RANBP9,SRGAP3,ADAM11,AKT3,SIAH2,RBPJ,TBL1X,SCN4A,SHTN1
R-HSA-69186	Lagging Strand Synthesis	0.0249732552232737	-3.68994981781789	21	5	0.00740740740740741	675	8202	5984,5983,328,5558,5422	RFC4,RFC3,APEX1,PRIM2,POLA1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.0254050449648158	-3.67280750401808	212	26	0.0385185185185185	675	8202	7296,5563,5096,2180,79718,7003,5095,133522,56895,79993,9442,5465,253558,166785,23175,26230,5467,57761,1490,23097,622,406,25937,84649,6907,9575	TXNRD1,PRKAA2,PCCB,ACSL1,TBL1XR1,TEAD1,PCCA,PPARGC1B,AGPAT4,ELOVL7,MED27,PPARA,LCLAT1,MMAA,LPIN1,TIAM2,PPARD,TRIB3,CTGF,CDK19,BDH1,ARNTL,WWTR1,DGAT2,TBL1X,CLOCK
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.0281237908671478	-3.57113941077201	29	6	0.00888888888888889	675	8202	6907,1490,79718,7003,25937,5465	TBL1X,CTGF,TBL1XR1,TEAD1,WWTR1,PPARA
R-HSA-419037	NCAM1 interactions	0.0289993251189816	-3.54048272102571	37	7	0.0103703703703704	675	8202	1287,776,1285,775,785,783,1293	COL4A5,CACNA1D,COL4A3,CACNA1C,CACNB4,CACNB2,COL6A3
R-HSA-2672351	Stimuli-sensing channels	0.0313640688805667	-3.46209234444936	99	14	0.0207407407407407	675	8202	65125,51393,162514,1186,80036,1831,41,7439,7220,57101,121601,1181,53373,57578	WNK1,TRPV2,TRPV3,CLCN7,TRPM3,TSC22D3,ASIC1,BEST1,TRPC1,ANO2,ANO4,CLCN2,TPCN1,UNC79
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.0318289554709811	-3.44737885409272	63	10	0.0148148148148148	675	8202	10382,80321,7846,22981,55835,10806,5577,80254,7840,7277	TUBB4A,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,PRKAR2B,CEP63,ALMS1,TUBA4A
R-HSA-400253	Circadian Clock	0.0318289554709811	-3.44737885409272	63	10	0.0148148148148148	675	8202	56938,79718,79365,406,5465,10743,4209,6907,9575,4208	ARNTL2,TBL1XR1,BHLHE41,ARNTL,PPARA,RAI1,MEF2D,TBL1X,CLOCK,MEF2C
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.0318289554709811	-3.44737885409272	63	10	0.0148148148148148	675	8202	10382,80321,7846,22981,55835,10806,5577,80254,7840,7277	TUBB4A,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,PRKAR2B,CEP63,ALMS1,TUBA4A
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.0320037840856425	-3.44190113049738	9	3	0.00444444444444444	675	8202	3164,2309,10000	NR4A1,FOXO3,AKT3
R-HSA-1980143	Signaling by NOTCH1	0.032311296773037	-3.43233836460489	72	11	0.0162962962962963	675	8202	9759,79718,7090,4609,55869,3714,3516,6907,409,9148,9734	HDAC4,TBL1XR1,TLE3,MYC,HDAC8,JAG2,RBPJ,TBL1X,ARRB2,NEURL1,HDAC9
R-HSA-72086	mRNA Capping	0.0327930696216815	-3.41753807793925	30	6	0.00888888888888889	675	8202	4331,22916,902,8732,728340,8731	MNAT1,NCBP2,CCNH,RNGTT,GTF2H2C,RNMT
R-HSA-380287	Centrosome maturation	0.0353359828642726	-3.34285348962485	73	11	0.0162962962962963	675	8202	10382,80321,7846,22981,55835,10806,5577,80254,7840,10426,7277	TUBB4A,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,PRKAR2B,CEP63,ALMS1,TUBGCP3,TUBA4A
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.0353359828642726	-3.34285348962485	73	11	0.0162962962962963	675	8202	10382,80321,7846,22981,55835,10806,5577,80254,7840,10426,7277	TUBB4A,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,PRKAR2B,CEP63,ALMS1,TUBGCP3,TUBA4A
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.0360555694194949	-3.32269393565825	23	5	0.00740740740740741	675	8202	5984,5983,328,5558,5422	RFC4,RFC3,APEX1,PRIM2,POLA1
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.0361420518134274	-3.3202982214001	47	8	0.0118518518518519	675	8202	9759,79718,7090,4609,55869,3516,6907,9734	HDAC4,TBL1XR1,TLE3,MYC,HDAC8,RBPJ,TBL1X,HDAC9
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.0362771429716109	-3.31656740624043	4	2	0.00296296296296296	675	8202	6507,81539	SLC1A3,SLC38A1
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.0362771429716109	-3.31656740624043	4	2	0.00296296296296296	675	8202	5366,1869	PMAIP1,E2F1
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.0362771429716109	-3.31656740624043	4	2	0.00296296296296296	675	8202	6507,81539	SLC1A3,SLC38A1
R-HSA-198203	PI3K/AKT activation	0.0364300845773278	-3.31236034632484	101	14	0.0207407407407407	675	8202	8660,57761,2534,2247,3164,10000,27161,4914,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,NTRK1,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-399956	CRMPs in Sema3A signaling	0.0372463497994172	-3.29020133092005	16	4	0.00592592592592593	675	8202	56896,2534,5361,8829	DPYSL5,FYN,PLXNA1,NRP1
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.0372463497994172	-3.29020133092005	16	4	0.00592592592592593	675	8202	2534,5361,8829,5062	FYN,PLXNA1,NRP1,PAK2
R-HSA-1989781	PPARA activates gene expression	0.0405460149164874	-3.20531777904572	112	15	0.0222222222222222	675	8202	7296,57761,2180,1490,79718,23097,7003,133522,9442,25937,406,5465,6907,9575,26230	TXNRD1,TRIB3,ACSL1,CTGF,TBL1XR1,CDK19,TEAD1,PPARGC1B,MED27,WWTR1,ARNTL,PPARA,TBL1X,CLOCK,TIAM2
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.0417519800558849	-3.17600840232161	57	9	0.0133333333333333	675	8202	9759,79718,4609,55869,3714,3516,6907,9148,9734	HDAC4,TBL1XR1,MYC,HDAC8,JAG2,RBPJ,TBL1X,NEURL1,HDAC9
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.0417519800558849	-3.17600840232161	57	9	0.0133333333333333	675	8202	9759,79718,4609,55869,3714,3516,6907,9148,9734	HDAC4,TBL1XR1,MYC,HDAC8,JAG2,RBPJ,TBL1X,NEURL1,HDAC9
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.0417519800558849	-3.17600840232161	57	9	0.0133333333333333	675	8202	9759,79718,4609,55869,3714,3516,6907,9148,9734	HDAC4,TBL1XR1,MYC,HDAC8,JAG2,RBPJ,TBL1X,NEURL1,HDAC9
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.0417519800558849	-3.17600840232161	57	9	0.0133333333333333	675	8202	9759,79718,4609,55869,3714,3516,6907,9148,9734	HDAC4,TBL1XR1,MYC,HDAC8,JAG2,RBPJ,TBL1X,NEURL1,HDAC9
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.0417519800558849	-3.17600840232161	57	9	0.0133333333333333	675	8202	9759,79718,4609,55869,3714,3516,6907,9148,9734	HDAC4,TBL1XR1,MYC,HDAC8,JAG2,RBPJ,TBL1X,NEURL1,HDAC9
R-HSA-379716	Cytosolic tRNA aminoacylation	0.042568175034288	-3.15664836982169	24	5	0.00740740740740741	675	8202	833,6301,51520,2617,16	CARS,SARS,LARS,GARS,AARS
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.042568175034288	-3.15664836982169	24	5	0.00740740740740741	675	8202	10335,4842,5140,5152,50940	MRVI1,NOS1,PDE3B,PDE9A,PDE11A
R-HSA-381183	ATF6-alpha activates chaperone genes	0.042983943572181	-3.14692863831981	10	3	0.00444444444444444	675	8202	22926,468,1649	ATF6,ATF4,DDIT3
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0435690525950536	-3.13340818352221	32	6	0.00888888888888889	675	8202	1741,23236,5330,2898,2792,1739	DLG3,PLCB1,PLCB2,GRIK2,GNGT1,DLG1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.0450923889114692	-3.09904180699297	104	14	0.0207407407407407	675	8202	8660,57761,2534,2247,3164,10000,1950,27161,9542,23239,2309,5291,9965,7462	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,EGF,AGO2,NRG2,PHLPP1,FOXO3,PIK3CB,FGF19,LAT2
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.04939954954924	-3.00781397326627	115	15	0.0222222222222222	675	8202	7296,57761,2180,1490,79718,23097,7003,133522,9442,25937,406,5465,6907,9575,26230	TXNRD1,TRIB3,ACSL1,CTGF,TBL1XR1,CDK19,TEAD1,PPARGC1B,MED27,WWTR1,ARNTL,PPARA,TBL1X,CLOCK,TIAM2
R-HSA-69190	DNA strand elongation	0.049696945332399	-3.0018118098932	33	6	0.00888888888888889	675	8202	5984,5983,328,5558,4171,5422	RFC4,RFC3,APEX1,PRIM2,MCM2,POLA1
R-HSA-109582	Hemostasis	0.0501404006981038	-2.99292819469829	515	53	0.0785185185185185	675	8202	7273,2888,3798,3684,2792,1950,2625,8527,4842,139818,7042,1795,5327,140885,5581,10019,3705,23657,2624,30846,3687,11343,1608,285,7277,4602,3048,6520,10257,7035,5577,10335,857,481,7422,80005,487,5140,5291,50940,2534,10000,3673,8140,483,1191,409,91768,5271,5152,7804,57572,3481	TTN,GRB14,KIF5A,ITGAM,GNGT1,EGF,GATA3,DGKD,NOS1,DOCK11,TGFB2,DOCK3,PLAT,SIRPA,PRKCE,SH2B3,ITPK1,SLC7A11,GATA2,EHD2,ITGAX,MGLL,DGKG,ANGPT2,TUBA4A,MYB,HBG2,SLC3A2,ABCC4,TFPI,PRKAR2B,MRVI1,CAV1,ATP1B1,VEGFA,DOCK5,ATP2A1,PDE3B,PIK3CB,PDE11A,FYN,AKT3,ITGA2,SLC7A5,ATP1B3,CLU,ARRB2,CABLES1,SERPINB8,PDE9A,LRP8,DOCK6,IGF2
R-HSA-112316	Neuronal System	0.0507259322794375	-2.98131801434723	289	32	0.0474074074074074	675	8202	2898,84254,2550,2792,6507,785,55799,3749,3770,6196,783,1739,3790,9132,109,1312,56666,1741,2571,6812,5330,8514,6580,217,3786,81539,3784,23236,6857,3755,80852,3782	GRIK2,CAMKK1,GABBR1,GNGT1,SLC1A3,CACNB4,CACNA2D3,KCNC4,KCNJ14,RPS6KA2,CACNB2,DLG1,KCNS3,KCNQ4,ADCY3,COMT,PANX2,DLG3,GAD1,STXBP1,PLCB2,KCNAB2,SLC22A1,ALDH2,KCNQ3,SLC38A1,KCNQ1,PLCB1,SYT1,KCNG1,GRIP2,KCNN3
R-HSA-373752	Netrin-1 signaling	0.0534032392492508	-2.92988387475741	42	7	0.0103703703703704	675	8202	7220,2534,90249,6477,285704,7204,6478	TRPC1,FYN,UNC5A,SIAH1,RGMB,TRIO,SIAH2
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.0534032392492508	-2.92988387475741	42	7	0.0103703703703704	675	8202	56938,6907,9575,79718,79365,406,5465	ARNTL2,TBL1X,CLOCK,TBL1XR1,BHLHE41,ARNTL,PPARA
R-HSA-418457	cGMP effects	0.054985992666098	-2.90067680498404	18	4	0.00592592592592593	675	8202	10335,5140,5152,50940	MRVI1,PDE3B,PDE9A,PDE11A
R-HSA-383280	Nuclear Receptor transcription pathway	0.0549943597114455	-2.90052464970934	51	8	0.0118518518518519	675	8202	7068,5467,9975,3164,5465,2100,3172,7182	THRB,PPARD,NR1D2,NR4A1,PPARA,ESR2,HNF4A,NR2C2
R-HSA-71064	Lysine catabolism	0.0555832476709583	-2.88987342400788	11	3	0.00444444444444444	675	8202	85007,2639,89874	PHYKPL,GCDH,SLC25A21
R-HSA-453274	Mitotic G2-G2/M phases	0.0560030365351817	-2.88234936587452	117	15	0.0222222222222222	675	8202	4331,10382,902,80321,7846,22981,55835,10806,1869,5520,5577,80254,7840,10426,7277	MNAT1,TUBB4A,CCNH,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,E2F1,PPP2R2A,PRKAR2B,CEP63,ALMS1,TUBGCP3,TUBA4A
R-HSA-74713	IRS activation	0.0572012563860795	-2.86117941604601	5	2	0.00296296296296296	675	8202	8660,2887	IRS2,GRB10
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.0572012563860795	-2.86117941604601	5	2	0.00296296296296296	675	8202	115677,857	NOSTRIN,CAV1
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.0572012563860795	-2.86117941604601	5	2	0.00296296296296296	675	8202	403,27031	ARL3,NPHP3
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-5654720	PI-3K cascade:FGFR4	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-5654689	PI-3K cascade:FGFR1	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-5654695	PI-3K cascade:FGFR2	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-5654710	PI-3K cascade:FGFR3	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-1257604	PIP3 activates AKT signaling	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,1950,27161,9542,23239,2309,5291,9965	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,EGF,AGO2,NRG2,PHLPP1,FOXO3,PIK3CB,FGF19
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0575681259145083	-2.85478623398551	98	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-264876	Insulin processing	0.0575846603674317	-2.85449905981334	26	5	0.00740740740740741	675	8202	3800,3798,4644,5873,60412	KIF5C,KIF5A,MYO5A,RAB27A,EXOC4
R-HSA-597592	Post-translational protein modification	0.0586047218139013	-2.83694000861629	411	43	0.0637037037037037	675	8202	23145,23556,6480,55757,9656,84002,23243,6184,23225,4585,149111,4584,79868,89978,146712,374378,205564,4249,81929,9331,54965,9509,83696,412,10274,56648,22955,9245,256435,7486,79623,10195,2591,80012,286053,197370,4253,9063,165918,648,7518,170690,10331	SSPO,PIGN,ST6GAL1,UGGT2,MDC1,B3GNT5,ANKRD28,RPN1,NUP210,MUC4,CNIH3,MUC3A,ALG13,DPH6,B3GNTL1,GALNT18,SENP5,MGAT5,SEH1L,B4GALT6,PIGX,ADAMTS2,TRAPPC9,STS,STAG1,EIF5A2,SCMH1,GCNT3,ST6GALNAC3,WRN,GALNT14,ALG3,GALNT3,PHC3,NSMCE2,NSMCE1,CTAGE5,PIAS2,RNF168,BMI1,XRCC4,ADAMTS16,B3GNT3
R-HSA-1296072	Voltage gated Potassium channels	0.059466558509352	-2.82234116629491	43	7	0.0103703703703704	675	8202	9132,3784,3786,3749,3755,8514,3790	KCNQ4,KCNQ1,KCNQ3,KCNC4,KCNG1,KCNAB2,KCNS3
R-HSA-1474228	Degradation of the extracellular matrix	0.0599574619667932	-2.81411993541626	89	12	0.0177777777777778	675	8202	6696,4316,7077,7092,9313,3339,85007,1307,1303,170690,7093,3914	SPP1,MMP7,TIMP2,TLL1,MMP20,HSPG2,PHYKPL,COL16A1,COL12A1,ADAMTS16,TLL2,LAMB3
R-HSA-202733	Cell surface interactions at the vascular wall	0.0615292043025113	-2.78824335017568	99	13	0.0192592592592593	675	8202	2534,6520,23657,2888,3684,8140,857,481,483,3687,5291,140885,285	FYN,SLC3A2,SLC7A11,GRB14,ITGAM,SLC7A5,CAV1,ATP1B1,ATP1B3,ITGAX,PIK3CB,SIRPA,ANGPT2
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.0652872538986377	-2.72895845472883	19	4	0.00592592592592593	675	8202	10382,6902,7846,7277	TUBB4A,TBCA,TUBA1A,TUBA4A
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.0652872538986377	-2.72895845472883	19	4	0.00592592592592593	675	8202	54716,6533,6536,6580	SLC6A20,SLC6A6,SLC6A9,SLC22A1
R-HSA-425407	SLC-mediated transmembrane transport	0.0658255727161827	-2.72074687304995	264	29	0.042962962962963	675	8202	10723,285195,84102,115584,6520,6536,81539,64116,9194,9197,6507,84679,23516,6541,6533,23225,6509,23657,6575,8140,3099,6548,54716,55356,124935,23315,117247,81929,6580	SLC12A7,SLC9A9,SLC41A2,SLC5A11,SLC3A2,SLC6A9,SLC38A1,SLC39A8,SLC16A7,SLC33A1,SLC1A3,SLC9A7,SLC39A14,SLC7A1,SLC6A6,NUP210,SLC1A4,SLC7A11,SLC20A2,SLC7A5,HK2,SLC9A1,SLC6A20,SLC22A15,SLC43A2,SLC9A8,SLC16A10,SEH1L,SLC22A1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.0660926050908741	-2.71669841295366	27	5	0.00740740740740741	675	8202	10382,5202,7846,5203,7277	TUBB4A,PFDN2,TUBA1A,PFDN4,TUBA4A
R-HSA-1368082	RORA activates gene expression	0.0660926050908741	-2.71669841295366	27	5	0.00740740740740741	675	8202	6907,9575,79718,406,5465	TBL1X,CLOCK,TBL1XR1,ARNTL,PPARA
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.069719031427536	-2.66328195074558	12	3	0.00444444444444444	675	8202	1741,2898,1739	DLG3,GRIK2,DLG1
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.069719031427536	-2.66328195074558	12	3	0.00444444444444444	675	8202	1741,2898,1739	DLG3,GRIK2,DLG1
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.069719031427536	-2.66328195074558	12	3	0.00444444444444444	675	8202	5558,5422,1869	PRIM2,POLA1,E2F1
R-HSA-381033	ATF6-alpha activates chaperones	0.069719031427536	-2.66328195074558	12	3	0.00444444444444444	675	8202	22926,468,1649	ATF6,ATF4,DDIT3
R-HSA-5668914	Diseases of metabolism	0.0728139606118593	-2.61984757551795	45	7	0.0103703703703704	675	8202	5096,2992,5091,166785,5095,7957,56922	PCCB,GYG1,PC,MMAA,PCCA,EPM2A,MCCC1
R-HSA-180292	GAB1 signalosome	0.074488799956344	-2.59710650105469	102	13	0.0192592592592593	675	8202	8660,57761,2534,2247,3164,10000,27161,1950,9542,23239,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,AGO2,EGF,NRG2,PHLPP1,FOXO3,FGF19,PIK3CB
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.0752616378215094	-2.58678473187573	28	5	0.00740740740740741	675	8202	4331,902,8732,728340,8731	MNAT1,CCNH,RNGTT,GTF2H2C,RNMT
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.0752616378215094	-2.58678473187573	28	5	0.00740740740740741	675	8202	10382,5202,7846,5203,7277	TUBB4A,PFDN2,TUBA1A,PFDN4,TUBA4A
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.0752616378215094	-2.58678473187573	28	5	0.00740740740740741	675	8202	4331,902,8732,728340,8731	MNAT1,CCNH,RNGTT,GTF2H2C,RNMT
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.0812089770960167	-2.51072948255563	6	2	0.00296296296296296	675	8202	11343,84649	MGLL,DGAT2
R-HSA-68952	DNA replication initiation	0.0812089770960167	-2.51072948255563	6	2	0.00296296296296296	675	8202	5558,5422	PRIM2,POLA1
R-HSA-1482798	Acyl chain remodeling of CL	0.0812089770960167	-2.51072948255563	6	2	0.00296296296296296	675	8202	253558,8398	LCLAT1,PLA2G6
R-HSA-171319	Telomere Extension By Telomerase	0.0812089770960167	-2.51072948255563	6	2	0.00296296296296296	675	8202	8607,7015	RUVBL1,TERT
R-HSA-174430	Telomere C-strand synthesis initiation	0.0812089770960167	-2.51072948255563	6	2	0.00296296296296296	675	8202	5558,5422	PRIM2,POLA1
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0812089770960167	-2.51072948255563	6	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.0822970007304715	-2.49742061509232	1	1	0.00148148148148148	675	8202	121642	ALKBH2
R-HSA-140180	COX reactions	0.0822970007304715	-2.49742061509232	1	1	0.00148148148148148	675	8202	5742	PTGS1
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.0852901409186971	-2.46169641242248	13	3	0.00444444444444444	675	8202	9415,215,2180	FADS2,ABCD1,ACSL1
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.0852901409186971	-2.46169641242248	13	3	0.00444444444444444	675	8202	9415,215,2180	FADS2,ABCD1,ACSL1
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.0852901409186971	-2.46169641242248	13	3	0.00444444444444444	675	8202	785,55799,783	CACNB4,CACNA2D3,CACNB2
R-HSA-4839726	Chromatin organization	0.0875839826567873	-2.43515714414194	261	28	0.0414814814814815	675	8202	23135,57634,1788,8085,7403,55167,9682,79718,63976,84159,55729,55869,80854,57492,2122,6598,80853,8464,8089,8607,1107,23522,6907,9575,55689,86,64754,23081	KDM6B,EP400,DNMT3A,KMT2D,KDM6A,MSL2,KDM4A,TBL1XR1,PRDM16,ARID5B,ATF7IP,HDAC8,SETD7,ARID1B,MECOM,SMARCB1,KDM7A,SUPT3H,YEATS4,RUVBL1,CHD3,KAT6B,TBL1X,CLOCK,YEATS2,ACTL6A,SMYD3,KDM4C
R-HSA-3247509	Chromatin modifying enzymes	0.0875839826567873	-2.43515714414194	261	28	0.0414814814814815	675	8202	23135,57634,1788,8085,7403,55167,9682,79718,63976,84159,55729,55869,80854,57492,2122,6598,80853,8464,8089,8607,1107,23522,6907,9575,55689,86,64754,23081	KDM6B,EP400,DNMT3A,KMT2D,KDM6A,MSL2,KDM4A,TBL1XR1,PRDM16,ARID5B,ATF7IP,HDAC8,SETD7,ARID1B,MECOM,SMARCB1,KDM7A,SUPT3H,YEATS4,RUVBL1,CHD3,KAT6B,TBL1X,CLOCK,YEATS2,ACTL6A,SMYD3,KDM4C
R-HSA-69236	G1 Phase	0.0879115600693868	-2.43142396906577	38	6	0.00888888888888889	675	8202	5520,4331,902,7029,1021,1869	PPP2R2A,MNAT1,CCNH,TFDP2,CDK6,E2F1
R-HSA-69231	Cyclin D associated events in G1	0.0879115600693868	-2.43142396906577	38	6	0.00888888888888889	675	8202	5520,4331,902,7029,1021,1869	PPP2R2A,MNAT1,CCNH,TFDP2,CDK6,E2F1
R-HSA-69275	G2/M Transition	0.0889168459455667	-2.42005366121287	115	14	0.0207407407407407	675	8202	4331,10382,902,80321,7846,22981,55835,10806,5520,5577,80254,7840,10426,7277	MNAT1,TUBB4A,CCNH,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,PPP2R2A,PRKAR2B,CEP63,ALMS1,TUBGCP3,TUBA4A
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.0955398132005914	-2.34821222621805	30	5	0.00740740740740741	675	8202	5599,466,6196,9252,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,MEF2C
R-HSA-174824	Lipoprotein metabolism	0.0955398132005914	-2.34821222621805	30	5	0.00740740740740741	675	8202	348,949,3339,6382,9619	APOE,SCARB1,HSPG2,SDC1,ABCG1
R-HSA-5693607	Processing of DNA double-strand break ends	0.100056656966047	-2.30201868377357	97	12	0.0177777777777778	675	8202	5984,9577,5983,5932,11073,51720,4361,545,165918,7486,9656,3364	RFC4,BRE,RFC3,RBBP8,TOPBP1,UIMC1,MRE11A,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-203765	eNOS activation and regulation	0.101633579219885	-2.28638129430949	22	4	0.00592592592592593	675	8202	23576,115677,857,2644	DDAH1,NOSTRIN,CAV1,GCHFR
R-HSA-373753	Nephrin interactions	0.101633579219885	-2.28638129430949	22	4	0.00592592592592593	675	8202	2534,4868,84063,5291	FYN,NPHS1,KIRREL2,PIK3CB
R-HSA-202131	Metabolism of nitric oxide	0.101633579219885	-2.28638129430949	22	4	0.00592592592592593	675	8202	23576,115677,857,2644	DDAH1,NOSTRIN,CAV1,GCHFR
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.102182251070833	-2.28099728487751	14	3	0.00444444444444444	675	8202	2534,5361,8829	FYN,PLXNA1,NRP1
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-447038	NrCAM interactions	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	1741,1739	DLG3,DLG1
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	10783,140609	NEK6,NEK7
R-HSA-164843	2-LTR circle formation	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	7518,11168	XRCC4,PSIP1
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.107652620275623	-2.22884571477479	7	2	0.00296296296296296	675	8202	4609,6934	MYC,TCF7L2
R-HSA-109704	PI3K Cascade	0.11237690033898	-2.18589687564163	79	10	0.0148148148148148	675	8202	8660,5563,57761,2247,1978,30849,5140,9965,5291,6009	IRS2,PRKAA2,TRIB3,FGF2,EIF4EBP1,PIK3R4,PDE3B,FGF19,PIK3CB,RHEB
R-HSA-70895	Branched-chain amino acid catabolism	0.115439476019778	-2.15900890351003	23	4	0.00592592592592593	675	8202	594,56922,587,11112	BCKDHB,MCCC1,BCAT2,HIBADH
R-HSA-73980	RNA Polymerase III Transcription Termination	0.115439476019778	-2.15900890351003	23	4	0.00592592592592593	675	8202	4782,4774,10622,4784	NFIC,NFIA,POLR3G,NFIX
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.115439476019778	-2.15900890351003	23	4	0.00592592592592593	675	8202	84706,440,29968,26227	GPT2,ASNS,PSAT1,PHGDH
R-HSA-3000157	Laminin interactions	0.115439476019778	-2.15900890351003	23	4	0.00592592592592593	675	8202	10319,3339,3673,3914	LAMC3,HSPG2,ITGA2,LAMB3
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.119309001736533	-2.12603849810175	90	11	0.0162962962962963	675	8202	10382,80321,7846,9657,22981,55835,10806,5577,80254,7840,7277	TUBB4A,CEP70,TUBA1A,IQCB1,NINL,CENPJ,SDCCAG8,PRKAR2B,CEP63,ALMS1,TUBA4A
R-HSA-194223	HDL-mediated lipid transport	0.120272295433629	-2.11799697817092	15	3	0.00444444444444444	675	8202	348,949,9619	APOE,SCARB1,ABCG1
R-HSA-975577	N-Glycan antennae elongation	0.120272295433629	-2.11799697817092	15	3	0.00444444444444444	675	8202	6480,4249,9331	ST6GAL1,MGAT5,B4GALT6
R-HSA-1592230	Mitochondrial biogenesis	0.122541186646184	-2.09930808798593	51	7	0.0103703703703704	675	8202	5563,6907,4209,79718,133522,5465,4208	PRKAA2,TBL1X,MEF2D,TBL1XR1,PPARGC1B,PPARA,MEF2C
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.12696242547529	-2.06386409869876	81	10	0.0148148148148148	675	8202	10382,80321,7846,22981,55835,10806,5577,80254,7840,7277	TUBB4A,CEP70,TUBA1A,NINL,CENPJ,SDCCAG8,PRKAR2B,CEP63,ALMS1,TUBA4A
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.127359420351874	-2.06074210815369	42	6	0.00888888888888889	675	8202	10319,3339,6382,2247,3673,3914	LAMC3,HSPG2,SDC1,FGF2,ITGA2,LAMB3
R-HSA-379724	tRNA Aminoacylation	0.127359420351874	-2.06074210815369	42	6	0.00888888888888889	675	8202	833,10667,6301,51520,2617,16	CARS,FARS2,SARS,LARS,GARS,AARS
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.127359420351874	-2.06074210815369	42	6	0.00888888888888889	675	8202	6907,4209,79718,133522,5465,4208	TBL1X,MEF2D,TBL1XR1,PPARGC1B,PPARA,MEF2C
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.13001373621683	-2.04011517090213	24	4	0.00592592592592593	675	8202	466,6196,9252,4208	ATF1,RPS6KA2,RPS6KA5,MEF2C
R-HSA-164944	Nef and signal transduction	0.135969959870359	-1.99532130095058	8	2	0.00296296296296296	675	8202	2534,5062	FYN,PAK2
R-HSA-400451	Free fatty acids regulate insulin secretion	0.135969959870359	-1.99532130095058	8	2	0.00296296296296296	675	8202	23236,5330	PLCB1,PLCB2
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.135969959870359	-1.99532130095058	8	2	0.00296296296296296	675	8202	23236,5330	PLCB1,PLCB2
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.135969959870359	-1.99532130095058	8	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-72731	Recycling of eIF2:GDP	0.135969959870359	-1.99532130095058	8	2	0.00296296296296296	675	8202	8893,8894	EIF2B5,EIF2S2
R-HSA-69183	Processive synthesis on the lagging strand	0.139432129040737	-1.97017732628885	16	3	0.00444444444444444	675	8202	328,5558,5422	APEX1,PRIM2,POLA1
R-HSA-381038	XBP1(S) activates chaperone genes	0.142197985084071	-1.95053493130501	53	7	0.0103703703703704	675	8202	58477,51726,11231,29927,27230,7095,2137	SRPRB,DNAJB11,SEC63,SEC61A1,SERP1,SEC62,EXTL3
R-HSA-112315	Transmission across Chemical Synapses	0.142307294147765	-1.94976651625579	210	22	0.0325925925925926	675	8202	217,81539,2898,84254,2550,2792,6507,6857,785,23236,55799,6196,783,80852,1739,109,1312,1741,2571,6812,5330,6580	ALDH2,SLC38A1,GRIK2,CAMKK1,GABBR1,GNGT1,SLC1A3,SYT1,CACNB4,PLCB1,CACNA2D3,RPS6KA2,CACNB2,GRIP2,DLG1,ADCY3,COMT,DLG3,GAD1,STXBP1,PLCB2,SLC22A1
R-HSA-977068	Termination of O-glycan biosynthesis	0.145303394367959	-1.92893134757788	25	4	0.00592592592592593	675	8202	256435,4585,4584,6480	ST6GALNAC3,MUC4,MUC3A,ST6GAL1
R-HSA-114452	Activation of BH3-only proteins	0.145303394367959	-1.92893134757788	25	4	0.00592592592592593	675	8202	5599,5366,10000,1869	MAPK8,PMAIP1,AKT3,E2F1
R-HSA-3295583	TRP channels	0.145303394367959	-1.92893134757788	25	4	0.00592592592592593	675	8202	7220,51393,162514,80036	TRPC1,TRPV2,TRPV3,TRPM3
R-HSA-186797	Signaling by PDGF	0.153333777258355	-1.87513818300812	345	34	0.0503703703703704	675	8202	6712,200734,5922,27161,1950,9542,1287,23239,5327,2309,9965,1847,1293,5581,6696,53358,109,2889,1285,8831,2247,3164,1852,283455,5682,5577,5291,57731,8660,57761,2534,10000,7060,409	SPTBN2,SPRED2,RASA2,AGO2,EGF,NRG2,COL4A5,PHLPP1,PLAT,FOXO3,FGF19,DUSP5,COL6A3,PRKCE,SPP1,SHC3,ADCY3,RAPGEF1,COL4A3,SYNGAP1,FGF2,NR4A1,DUSP9,KSR2,PSMA1,PRKAR2B,PIK3CB,SPTBN4,IRS2,TRIB3,FYN,AKT3,THBS4,ARRB2
R-HSA-5617833	Assembly of the primary cilium	0.155710370192927	-1.85975759868042	180	19	0.0281481481481481	675	8202	80321,7846,9657,5577,8195,27031,403,10382,57539,22981,50807,55835,55764,10806,60412,92482,80254,7840,7277	CEP70,TUBA1A,IQCB1,PRKAR2B,MKKS,NPHP3,ARL3,TUBB4A,WDR35,NINL,ASAP1,CENPJ,IFT122,SDCCAG8,EXOC4,BBIP1,CEP63,ALMS1,TUBA4A
R-HSA-5663202	Diseases of signal transduction	0.157337090080014	-1.84936470472255	268	27	0.04	675	8202	9208,2247,79718,3164,1950,1523,5682,9542,55869,3714,7048,2309,9965,5291,9372,6934,9734,22943,9148,8660,2534,9759,10000,4609,6907,3516,7750	LRRFIP1,FGF2,TBL1XR1,NR4A1,EGF,CUX1,PSMA1,NRG2,HDAC8,JAG2,TGFBR2,FOXO3,FGF19,PIK3CB,ZFYVE9,TCF7L2,HDAC9,DKK1,NEURL1,IRS2,FYN,HDAC4,AKT3,MYC,TBL1X,RBPJ,ZMYM2
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	1312	COMT
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	5062	PAK2
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	2992	GYG1
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-380612	Metabolism of serotonin	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	217	ALDH2
R-HSA-141424	Amplification of signal from the kinetochores	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	8379	MAD1L1
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	7048	TGFBR2
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	8379	MAD1L1
R-HSA-888568	GABA synthesis	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	2571	GAD1
R-HSA-165160	PDE3B signalling	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	5140	PDE3B
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	217	ALDH2
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	166785	MMAA
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	2992	GYG1
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	166785	MMAA
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	5062	PAK2
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	1312	COMT
R-HSA-187042	TRKA activation by NGF	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	4914	NTRK1
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	2992	GYG1
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	4129	MAOB
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	328	APEX1
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	2898	GRIK2
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.157830414273805	-1.84623414976449	2	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.159022679453473	-1.83870844886159	85	10	0.0148148148148148	675	8202	8660,2534,2247,3164,10000,1950,9542,5291,9965,2309	IRS2,FYN,FGF2,NR4A1,AKT3,EGF,NRG2,PIK3CB,FGF19,FOXO3
R-HSA-174800	Chylomicron-mediated lipid transport	0.159531530772692	-1.83551369119911	17	3	0.00444444444444444	675	8202	348,3339,6382	APOE,HSPG2,SDC1
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.159531530772692	-1.83551369119911	17	3	0.00444444444444444	675	8202	5096,5095,166785	PCCB,PCCA,MMAA
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.159531530772692	-1.83551369119911	17	3	0.00444444444444444	675	8202	2548,2992,5255	GAA,GYG1,PHKA1
R-HSA-2029485	Role of phospholipids in phagocytosis	0.161252255095221	-1.82478533831741	26	4	0.00592592592592593	675	8202	5581,5337,8398,5291	PRKCE,PLD1,PLA2G6,PIK3CB
R-HSA-416482	G alpha (12/13) signalling events	0.161346873082449	-1.82419874039027	75	9	0.0133333333333333	675	8202	23263,2792,7204,1894,84033,9828,29,26230,50649	MCF2L,GNGT1,TRIO,ECT2,OBSCN,ARHGEF17,ABR,TIAM2,ARHGEF4
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.161650748647394	-1.82231714353534	45	6	0.00888888888888889	675	8202	3516,7029,487,27161,1869,4242	RBPJ,TFDP2,ATP2A1,AGO2,E2F1,MFNG
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.162908499543727	-1.81456658828514	65	8	0.0118518518518519	675	8202	5984,5983,5932,11073,4361,545,7486,3364	RFC4,RFC3,RBBP8,TOPBP1,MRE11A,ATR,WRN,HUS1
R-HSA-381070	IRE1alpha activates chaperones	0.163263994211606	-1.81238679191699	55	7	0.0103703703703704	675	8202	58477,51726,11231,29927,27230,7095,2137	SRPRB,DNAJB11,SEC63,SEC61A1,SERP1,SEC62,EXTL3
R-HSA-391251	Protein folding	0.163263994211606	-1.81238679191699	55	7	0.0103703703703704	675	8202	10382,6902,5202,7846,3801,5203,7277	TUBB4A,TBCA,PFDN2,TUBA1A,KIFC3,PFDN4,TUBA4A
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	328,8930	APEX1,MBD4
R-HSA-162592	Integration of provirus	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	7518,11168	XRCC4,PSIP1
R-HSA-2243919	Crosslinking of collagen fibrils	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	7092,7093	TLL1,TLL2
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	27161,23405	AGO2,DICER1
R-HSA-428543	Inactivation of Cdc42 and Rac	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	9901,57522	SRGAP3,SRGAP1
R-HSA-447041	CHL1 interactions	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	8829,3673	NRP1,ITGA2
R-HSA-2428933	SHC-related events triggered by IGF1R	0.165674581522042	-1.79772976690787	9	2	0.00296296296296296	675	8202	3480,3481	IGF1R,IGF2
R-HSA-163685	Integration of energy metabolism	0.168265187692106	-1.78221404593034	107	12	0.0177777777777778	675	8202	5563,5207,775,783,2792,3790,109,5577,776,6812,5330,23236	PRKAA2,PFKFB1,CACNA1C,CACNB2,GNGT1,KCNS3,ADCY3,PRKAR2B,CACNA1D,STXBP1,PLCB2,PLCB1
R-HSA-112043	PLC beta mediated events	0.173883368523342	-1.74937050035916	46	6	0.00888888888888889	675	8202	5332,109,5577,2781,23236,5330	PLCB4,ADCY3,PRKAR2B,GNAZ,PLCB1,PLCB2
R-HSA-1483249	Inositol phosphate metabolism	0.173883368523342	-1.74937050035916	46	6	0.00888888888888889	675	8202	5332,23007,3705,9651,23236,5330	PLCB4,PLCH1,ITPK1,PLCH2,PLCB1,PLCB2
R-HSA-114508	Effects of PIP2 hydrolysis	0.17780175944119	-1.72708606033155	27	4	0.00592592592592593	675	8202	5581,8527,11343,1608	PRKCE,DGKD,MGLL,DGKG
R-HSA-437239	Recycling pathway of L1	0.17780175944119	-1.72708606033155	27	4	0.00592592592592593	675	8202	1759,6196,9252,57698	DNM1,RPS6KA2,RPS6KA5,SHTN1
R-HSA-70326	Glucose metabolism	0.180116493472432	-1.71415145146849	77	9	0.0133333333333333	675	8202	2548,5207,5091,5255,10165,3099,2992,5106,7957	GAA,PFKFB1,PC,PHKA1,SLC25A13,HK2,GYG1,PCK2,EPM2A
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.180440638391886	-1.71235342847499	18	3	0.00444444444444444	675	8202	9208,7750,1523	LRRFIP1,ZMYM2,CUX1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.180440638391886	-1.71235342847499	18	3	0.00444444444444444	675	8202	6857,6812,6580	SYT1,STXBP1,SLC22A1
R-HSA-912631	Regulation of signaling by CBL	0.180440638391886	-1.71235342847499	18	3	0.00444444444444444	675	8202	2534,2889,5291	FYN,RAPGEF1,PIK3CB
R-HSA-210993	Tie2 Signaling	0.180440638391886	-1.71235342847499	18	3	0.00444444444444444	675	8202	2888,5291,285	GRB14,PIK3CB,ANGPT2
R-HSA-216083	Integrin cell surface interactions	0.183304486921393	-1.69660664586874	67	8	0.0118518518518519	675	8202	6696,1285,3339,3684,3673,3687,1307,3383	SPP1,COL4A3,HSPG2,ITGAM,ITGA2,ITGAX,COL16A1,ICAM1
R-HSA-176187	Activation of ATR in response to replication stress	0.184694443250285	-1.68905247750139	37	5	0.00740740740740741	675	8202	5984,545,5983,4171,3364	RFC4,ATR,RFC3,MCM2,HUS1
R-HSA-112040	G-protein mediated events	0.186482020272805	-1.67942045058957	47	6	0.00888888888888889	675	8202	5332,109,5577,2781,23236,5330	PLCB4,ADCY3,PRKAR2B,GNAZ,PLCB1,PLCB2
R-HSA-1296071	Potassium Channels	0.189412017708011	-1.66383064877527	99	11	0.0162962962962963	675	8202	3786,2550,2792,3755,3790,3782,9132,3784,3770,3749,8514	KCNQ3,GABBR1,GNGT1,KCNG1,KCNS3,KCNN3,KCNQ4,KCNQ1,KCNJ14,KCNC4,KCNAB2
R-HSA-194315	Signaling by Rho GTPases	0.190226394907903	-1.65954036400963	399	38	0.0562962962962963	675	8202	64411,3798,58504,7204,4983,5585,81624,10144,115703,5217,26230,84144,1123,23263,5062,57522,8379,9828,114793,57514,81929,10152,1894,84033,64105,9743,29,9901,401541,23421,644150,343578,4638,23221,101928168,90627,23081,50649	ARAP3,KIF5A,ARHGAP22,TRIO,OPHN1,PKN1,DIAPH3,FAM13A,ARHGAP33,PFN2,TIAM2,SYDE2,CHN1,MCF2L,PAK2,SRGAP1,MAD1L1,ARHGEF17,FMNL2,ARHGAP31,SEH1L,ABI2,ECT2,OBSCN,CENPK,ARHGAP32,ABR,SRGAP3,CENPP,ITGB3BP,WIPF3,ARHGAP40,MYLK,RHOBTB2,LOC101928168,STARD13,KDM4C,ARHGEF4
R-HSA-392499	Metabolism of proteins	0.191664360867756	-1.65200955718045	943	85	0.125925925925926	675	8202	23145,3339,3798,10165,51726,55757,9656,84002,23243,10382,58477,440,23225,4585,149111,89978,146712,374378,205564,4249,81929,54965,7277,468,7846,2137,467,131118,27230,10195,6165,29927,1978,197370,286053,4253,6747,1803,22926,165918,7518,648,23556,23621,6480,7095,3800,23062,11231,5073,134266,6184,8894,4584,79868,6902,10651,4644,9331,9509,83696,8893,412,10274,56648,1974,22955,9245,256435,7486,3801,79623,9709,6934,5873,2591,80012,5203,60412,9063,5202,1649,3481,170690,10331	SSPO,HSPG2,KIF5A,SLC25A13,DNAJB11,UGGT2,MDC1,B3GNT5,ANKRD28,TUBB4A,SRPRB,ASNS,NUP210,MUC4,CNIH3,DPH6,B3GNTL1,GALNT18,SENP5,MGAT5,SEH1L,PIGX,TUBA4A,ATF4,TUBA1A,EXTL3,ATF3,DNAJC19,SERP1,ALG3,RPL35A,SEC61A1,EIF4EBP1,NSMCE1,NSMCE2,CTAGE5,SSR3,DPP4,ATF6,RNF168,XRCC4,BMI1,PIGN,BACE1,ST6GAL1,SEC62,KIF5C,GGA2,SEC63,PARN,GRPEL2,RPN1,EIF2S2,MUC3A,ALG13,TBCA,MTX2,MYO5A,B4GALT6,ADAMTS2,TRAPPC9,EIF2B5,STS,STAG1,EIF5A2,EIF4A2,SCMH1,GCNT3,ST6GALNAC3,WRN,KIFC3,GALNT14,HERPUD1,TCF7L2,RAB27A,GALNT3,PHC3,PFDN4,EXOC4,PIAS2,PFDN2,DDIT3,IGF2,ADAMTS16,B3GNT3
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.194891779712808	-1.63531085030623	28	4	0.00592592592592593	675	8202	776,775,783,2792	CACNA1D,CACNA1C,CACNB2,GNGT1
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.194891779712808	-1.63531085030623	28	4	0.00592592592592593	675	8202	57761,857,10000,5062	TRIB3,CAV1,AKT3,PAK2
R-HSA-5663084	Diseases of carbohydrate metabolism	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	2992,7957	GYG1,EPM2A
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	4361,5932	MRE11A,RBBP8
R-HSA-3229121	Glycogen storage diseases	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	2992,7957	GYG1,EPM2A
R-HSA-74749	Signal attenuation	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	8660,2887	IRS2,GRB10
R-HSA-418886	Netrin mediated repulsion signals	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	2534,90249	FYN,UNC5A
R-HSA-549127	Organic cation transport	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	55356,6580	SLC22A15,SLC22A1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	23516,64116	SLC39A14,SLC39A8
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	2992,7957	GYG1,EPM2A
R-HSA-399997	Acetylcholine regulates insulin secretion	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	23236,5330	PLCB1,PLCB2
R-HSA-419812	Calcitonin-like ligand receptors	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	797,10267	CALCB,RAMP1
R-HSA-418889	Ligand-independent caspase activation via DCC	0.196347241009704	-1.62787054944618	10	2	0.00296296296296296	675	8202	90249,9500	UNC5A,MAGED1
R-HSA-1852241	Organelle biogenesis and maintenance	0.196576663729262	-1.62670277755517	321	31	0.0459259259259259	675	8202	5563,80321,7846,79718,9657,133522,5465,60488,5577,4209,8195,27031,403,56945,10382,85476,57539,22981,50807,55835,10806,55764,60412,92482,6907,80254,7840,11222,57129,4208,7277	PRKAA2,CEP70,TUBA1A,TBL1XR1,IQCB1,PPARGC1B,PPARA,MRPS35,PRKAR2B,MEF2D,MKKS,NPHP3,ARL3,MRPS22,TUBB4A,GFM1,WDR35,NINL,ASAP1,CENPJ,SDCCAG8,IFT122,EXOC4,BBIP1,TBL1X,CEP63,ALMS1,MRPL3,MRPL47,MEF2C,TUBA4A
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.196686859545381	-1.62614236036679	355	34	0.0503703703703704	675	8202	6712,200734,5922,27161,1950,9542,23239,9252,2309,9965,1847,5581,466,6196,53358,109,1759,2889,8831,2247,3164,4914,283455,5682,1852,5577,5291,57731,8660,57761,2534,10000,409,4208	SPTBN2,SPRED2,RASA2,AGO2,EGF,NRG2,PHLPP1,RPS6KA5,FOXO3,FGF19,DUSP5,PRKCE,ATF1,RPS6KA2,SHC3,ADCY3,DNM1,RAPGEF1,SYNGAP1,FGF2,NR4A1,NTRK1,KSR2,PSMA1,DUSP9,PRKAR2B,PIK3CB,SPTBN4,IRS2,TRIB3,FYN,AKT3,ARRB2,MEF2C
R-HSA-1442490	Collagen degradation	0.199358516461189	-1.61265048491762	38	5	0.00740740740740741	675	8202	85007,4316,9313,1307,1303	PHYKPL,MMP7,MMP20,COL16A1,COL12A1
R-HSA-3214842	HDMs demethylate histones	0.199423933875071	-1.61232239919361	48	6	0.00888888888888889	675	8202	80853,23135,7403,9682,84159,23081	KDM7A,KDM6B,KDM6A,KDM4A,ARID5B,KDM4C
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.202031897982629	-1.59932968324244	19	3	0.00444444444444444	675	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-3928664	Ephrin signaling	0.202031897982629	-1.59932968324244	19	3	0.00444444444444444	675	8202	2534,2047,5062	FYN,EPHB1,PAK2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.202031897982629	-1.59932968324244	19	3	0.00444444444444444	675	8202	6857,2571,6812	SYT1,GAD1,STXBP1
R-HSA-422356	Regulation of insulin secretion	0.209991017263469	-1.5606905241154	80	9	0.0133333333333333	675	8202	775,783,2792,3790,5577,776,6812,5330,23236	CACNA1C,CACNB2,GNGT1,KCNS3,PRKAR2B,CACNA1D,STXBP1,PLCB2,PLCB1
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.212461340853723	-1.54899523256234	29	4	0.00592592592592593	675	8202	3516,7029,27161,1869	RBPJ,TFDP2,AGO2,E2F1
R-HSA-5339562	Uptake and actions of bacterial toxins	0.212461340853723	-1.54899523256234	29	4	0.00592592592592593	675	8202	7296,118429,6857,84168	TXNRD1,ANTXR2,SYT1,ANTXR1
R-HSA-917977	Transferrin endocytosis and recycling	0.212461340853723	-1.54899523256234	29	4	0.00592592592592593	675	8202	90423,55240,7037,261729	ATP6V1E2,STEAP3,TFRC,STEAP2
R-HSA-1839124	FGFR1 mutant receptor activation	0.212461340853723	-1.54899523256234	29	4	0.00592592592592593	675	8202	9208,2247,7750,1523	LRRFIP1,FGF2,ZMYM2,CUX1
R-HSA-390466	Chaperonin-mediated protein folding	0.212685425508786	-1.54794108047396	49	6	0.00888888888888889	675	8202	10382,5202,7846,3801,5203,7277	TUBB4A,PFDN2,TUBA1A,KIFC3,PFDN4,TUBA4A
R-HSA-73923	Lipid digestion, mobilization, and transport	0.22134834317427	-1.50801760492678	60	7	0.0103703703703704	675	8202	348,857,949,3339,6382,11343,9619	APOE,CAV1,SCARB1,HSPG2,SDC1,MGLL,ABCG1
R-HSA-2028269	Signaling by Hippo	0.224181599048458	-1.49529884553722	20	3	0.00444444444444444	675	8202	51421,6788,25937	AMOTL2,STK3,WWTR1
R-HSA-3000170	Syndecan interactions	0.224181599048458	-1.49529884553722	20	3	0.00444444444444444	675	8202	6382,2247,3673	SDC1,FGF2,ITGA2
R-HSA-418217	G beta:gamma signalling through PLC beta	0.224181599048458	-1.49529884553722	20	3	0.00444444444444444	675	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-2980766	Nuclear Envelope Breakdown	0.226242067145917	-1.48614975935529	50	6	0.00888888888888889	675	8202	23225,10783,7443,140609,81929,23175	NUP210,NEK6,VRK1,NEK7,SEH1L,LPIN1
R-HSA-1483152	Hydrolysis of LPE	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	56261	GPCPD1
R-HSA-77108	Utilization of Ketone Bodies	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	622	BDH1
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	10644	IGF2BP2
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	1312	COMT
R-HSA-198745	Signalling to STAT3	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	4914	NTRK1
R-HSA-177539	Autointegration results in viral DNA circles	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	11168	PSIP1
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	5599	MAPK8
R-HSA-3249367	STAT6-mediated induction of chemokines	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	340061	TMEM173
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	6934	TCF7L2
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	11168	PSIP1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	6857	SYT1
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	5599	MAPK8
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	5297	PI4KA
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	2736	GLI2
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	6857	SYT1
R-HSA-1307965	betaKlotho-mediated ligand binding	0.22715534968419	-1.4821211357259	3	1	0.00148148148148148	675	8202	9965	FGF19
R-HSA-2022923	Dermatan sulfate biosynthesis	0.227628128417328	-1.48004199729535	11	2	0.00296296296296296	675	8202	10090,29940	UST,DSE
R-HSA-199983	Golgi to ER Retrograde Transport	0.227628128417328	-1.48004199729535	11	2	0.00296296296296296	675	8202	9276,22820	COPB2,COPG1
R-HSA-199997	COPI Mediated Transport	0.227628128417328	-1.48004199729535	11	2	0.00296296296296296	675	8202	9276,22820	COPB2,COPG1
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.227628128417328	-1.48004199729535	11	2	0.00296296296296296	675	8202	5563,5467	PRKAA2,PPARD
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.22979040422154	-1.47058767152575	40	5	0.00740740740740741	675	8202	4782,10302,4774,10622,4784	NFIC,SNAPC5,NFIA,POLR3G,NFIX
R-HSA-74158	RNA Polymerase III Transcription	0.22979040422154	-1.47058767152575	40	5	0.00740740740740741	675	8202	4782,10302,4774,10622,4784	NFIC,SNAPC5,NFIA,POLR3G,NFIX
R-HSA-4086398	Ca2+ pathway	0.233763391948811	-1.45344582069483	61	7	0.0103703703703704	675	8202	51701,5530,23236,5330,27161,2792,6934	NLK,PPP3CA,PLCB1,PLCB2,AGO2,GNGT1,TCF7L2
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.233763391948811	-1.45344582069483	61	7	0.0103703703703704	675	8202	8660,9542,2534,2247,9965,5291,1950	IRS2,NRG2,FYN,FGF2,FGF19,PIK3CB,EGF
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.235862555732777	-1.44450603457483	137	14	0.0207407407407407	675	8202	10019,3705,3048,2624,3798,30846,2625,5577,1795,139818,80005,91768,57572,4602	SH2B3,ITPK1,HBG2,GATA2,KIF5A,EHD2,GATA3,PRKAR2B,DOCK3,DOCK11,DOCK5,CABLES1,DOCK6,MYB
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.240068851208751	-1.42682951674589	51	6	0.00888888888888889	675	8202	403,92482,8195,27031,50807,60412	ARL3,BBIP1,MKKS,NPHP3,ASAP1,EXOC4
R-HSA-500657	Presynaptic function of Kainate receptors	0.246771057625989	-1.39929426438683	21	3	0.00444444444444444	675	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.246771057625989	-1.39929426438683	21	3	0.00444444444444444	675	8202	57761,2534,10000	TRIB3,FYN,AKT3
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.246771057625989	-1.39929426438683	21	3	0.00444444444444444	675	8202	2534,9252,5062	FYN,RPS6KA5,PAK2
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.246771057625989	-1.39929426438683	21	3	0.00444444444444444	675	8202	10382,7846,7277	TUBB4A,TUBA1A,TUBA4A
R-HSA-198753	ERK/MAPK targets	0.246771057625989	-1.39929426438683	21	3	0.00444444444444444	675	8202	6196,9252,4208	RPS6KA2,RPS6KA5,MEF2C
R-HSA-70263	Gluconeogenesis	0.248794762675648	-1.39112696867771	31	4	0.00592592592592593	675	8202	5207,5106,5091,10165	PFKFB1,PCK2,PC,SLC25A13
R-HSA-73772	RNA Polymerase I Promoter Escape	0.248794762675648	-1.39112696867771	31	4	0.00592592592592593	675	8202	4331,902,9014,728340	MNAT1,CCNH,TAF1B,GTF2H2C
R-HSA-2022928	HS-GAG biosynthesis	0.248794762675648	-1.39112696867771	31	4	0.00592592592592593	675	8202	90161,3339,6382,266722	HS6ST2,HSPG2,SDC1,HS6ST3
R-HSA-111885	Opioid Signalling	0.252619146889956	-1.37587227269071	84	9	0.0133333333333333	675	8202	5530,2781,2792,5332,109,5577,5144,5330,23236	PPP3CA,GNAZ,GNGT1,PLCB4,ADCY3,PRKAR2B,PDE4D,PLCB2,PLCB1
R-HSA-156581	Methylation	0.259209947819872	-1.35011693630578	12	2	0.00296296296296296	675	8202	1312,4144	COMT,MAT2A
R-HSA-203615	eNOS activation	0.259209947819872	-1.35011693630578	12	2	0.00296296296296296	675	8202	23576,857	DDAH1,CAV1
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.259209947819872	-1.35011693630578	12	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.259209947819872	-1.35011693630578	12	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-389359	CD28 dependent Vav1 pathway	0.259209947819872	-1.35011693630578	12	2	0.00296296296296296	675	8202	2534,5062	FYN,PAK2
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.261447137812676	-1.34152316576812	42	5	0.00740740740740741	675	8202	26108,8085,6659,7090,6934	PYGO1,KMT2D,SOX4,TLE3,TCF7L2
R-HSA-73863	RNA Polymerase I Transcription Termination	0.2674379059791	-1.31886786677269	32	4	0.00592592592592593	675	8202	4331,902,9014,728340	MNAT1,CCNH,TAF1B,GTF2H2C
R-HSA-389356	CD28 co-stimulation	0.2674379059791	-1.31886786677269	32	4	0.00592592592592593	675	8202	57761,2534,10000,5062	TRIB3,FYN,AKT3,PAK2
R-HSA-376176	Signaling by Robo receptor	0.2674379059791	-1.31886786677269	32	4	0.00592592592592593	675	8202	5217,5062,9901,57522	PFN2,PAK2,SRGAP3,SRGAP1
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.269687501576098	-1.31049139186023	22	3	0.00444444444444444	675	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.269687501576098	-1.31049139186023	22	3	0.00444444444444444	675	8202	5520,4331,902	PPP2R2A,MNAT1,CCNH
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.269687501576098	-1.31049139186023	22	3	0.00444444444444444	675	8202	6480,4249,9331	ST6GAL1,MGAT5,B4GALT6
R-HSA-375165	NCAM signaling for neurite out-growth	0.270634869393921	-1.30698471199827	266	25	0.037037037037037	675	8202	6712,200734,8831,1285,2247,5922,1950,1852,5682,9542,283455,1287,9252,785,57731,9965,1847,1293,8660,2534,775,53358,783,776,409	SPTBN2,SPRED2,SYNGAP1,COL4A3,FGF2,RASA2,EGF,DUSP9,PSMA1,NRG2,KSR2,COL4A5,RPS6KA5,CACNB4,SPTBN4,FGF19,DUSP5,COL6A3,IRS2,FYN,CACNA1C,SHC3,CACNB2,CACNA1D,ARRB2
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.277641619943931	-1.28142413383562	43	5	0.00740740740740741	675	8202	4645,109,5577,22841,2792	MYO5B,ADCY3,PRKAR2B,RAB11FIP2,GNGT1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.286320098238131	-1.25064486941835	33	4	0.00592592592592593	675	8202	23225,10783,140609,81929	NUP210,NEK6,NEK7,SEH1L
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	200424	TET3
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	7048	TGFBR2
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	7048	TGFBR2
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	56648	EIF5A2
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	7048	TGFBR2
R-HSA-1296053	Classical Kir channels	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	3770	KCNJ14
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	8829	NRP1
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	10000	AKT3
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	328	APEX1
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	2992	GYG1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	9194	SLC16A7
R-HSA-140179	Amine Oxidase reactions	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	4129	MAOB
R-HSA-165158	Activation of AKT2	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	57761	TRIB3
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	1869	E2F1
R-HSA-390650	Histamine receptors	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	3269	HRH1
R-HSA-167060	NGF processing	0.290781418592273	-1.23518343291495	4	1	0.00148148148148148	675	8202	5046	PCSK6
R-HSA-75205	Dissolution of Fibrin Clot	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	5327,5271	PLAT,SERPINB8
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	4361,340061	MRE11A,TMEM173
R-HSA-5210891	Uptake and function of anthrax toxins	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	118429,84168	ANTXR2,ANTXR1
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	5520,7443	PPP2R2A,VRK1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	4919,4920	ROR1,ROR2
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	9542,10000	NRG2,AKT3
R-HSA-2995410	Nuclear Envelope Reassembly	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	5520,7443	PPP2R2A,VRK1
R-HSA-4641265	Repression of WNT target genes	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	7090,6934	TLE3,TCF7L2
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	2185,140885	PTK2B,SIRPA
R-HSA-75892	Platelet Adhesion to exposed collagen	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	2534,3673	FYN,ITGA2
R-HSA-177504	Retrograde neurotrophin signalling	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	1759,4914	DNM1,NTRK1
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.290831730891857	-1.23501042341627	13	2	0.00296296296296296	675	8202	4773,5530	NFATC2,PPP3CA
R-HSA-429947	Deadenylation of mRNA	0.29282470541365	-1.22818112404173	23	3	0.00444444444444444	675	8202	57472,5073,1974	CNOT6,PARN,EIF4A2
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.29282470541365	-1.22818112404173	23	3	0.00444444444444444	675	8202	29102,27161,23405	DROSHA,AGO2,DICER1
R-HSA-2428924	IGF1R signaling cascade	0.292825620165019	-1.22817800015934	281	26	0.0385185185185185	675	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,57731,5291,9965,1847,6009,8660,57761,2534,3480,53358,1978,409,3481	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,SPTBN4,PIK3CB,FGF19,DUSP5,RHEB,IRS2,TRIB3,FYN,IGF1R,SHC3,EIF4EBP1,ARRB2,IGF2
R-HSA-2428928	IRS-related events triggered by IGF1R	0.292825620165019	-1.22817800015934	281	26	0.0385185185185185	675	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,57731,5291,9965,1847,6009,8660,57761,2534,3480,53358,1978,409,3481	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,SPTBN4,PIK3CB,FGF19,DUSP5,RHEB,IRS2,TRIB3,FYN,IGF1R,SHC3,EIF4EBP1,ARRB2,IGF2
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.292825620165019	-1.22817800015934	281	26	0.0385185185185185	675	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,57731,5291,9965,1847,6009,8660,57761,2534,3480,53358,1978,409,3481	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,SPTBN4,PIK3CB,FGF19,DUSP5,RHEB,IRS2,TRIB3,FYN,IGF1R,SHC3,EIF4EBP1,ARRB2,IGF2
R-HSA-382556	ABC-family proteins mediated transport	0.294030822039708	-1.2240706802687	44	5	0.00740740740740741	675	8202	215,8894,10257,10057,9619	ABCD1,EIF2S2,ABCC4,ABCC5,ABCG1
R-HSA-113418	Formation of the Early Elongation Complex	0.305384432346948	-1.18618386213029	34	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.305384432346948	-1.18618386213029	34	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.309395048750226	-1.17313634371774	89	9	0.0133333333333333	675	8202	5599,466,6196,51295,30849,9252,8411,170506,4208	MAPK8,ATF1,RPS6KA2,ECSIT,PIK3R4,RPS6KA5,EEA1,DHX36,MEF2C
R-HSA-418346	Platelet homeostasis	0.311183626237809	-1.16737210297918	78	8	0.0118518518518519	675	8202	2792,4842,10335,5140,487,5152,7804,50940	GNGT1,NOS1,MRVI1,PDE3B,ATP2A1,PDE9A,LRP8,PDE11A
R-HSA-1630316	Glycosaminoglycan metabolism	0.311871040914583	-1.16516550701919	123	12	0.0177777777777778	675	8202	10090,90161,3339,6548,29940,6382,9435,55454,10331,266722,9331,10057	UST,HS6ST2,HSPG2,SLC9A1,DSE,SDC1,CHST2,CSGALNACT2,B3GNT3,HS6ST3,B4GALT6,ABCC5
R-HSA-373755	Semaphorin interactions	0.312307397214798	-1.16376732872707	67	7	0.0103703703703704	675	8202	56896,23129,2534,5361,8829,4233,5062	DPYSL5,PLXND1,FYN,PLXNA1,NRP1,MET,PAK2
R-HSA-167172	Transcription of the HIV genome	0.312307397214798	-1.16376732872707	67	7	0.0103703703703704	675	8202	4331,22916,902,8732,6875,728340,8731	MNAT1,NCBP2,CCNH,RNGTT,TAF4B,GTF2H2C,RNMT
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.316083415295093	-1.151749127777	24	3	0.00444444444444444	675	8202	3164,2309,10000	NR4A1,FOXO3,AKT3
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.316083415295093	-1.151749127777	24	3	0.00444444444444444	675	8202	6507,6857,6812	SLC1A3,SYT1,STXBP1
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.318173901446418	-1.14515718578094	101	10	0.0148148148148148	675	8202	23516,84102,115584,6533,6536,64116,9194,54716,55356,6580	SLC39A14,SLC41A2,SLC5A11,SLC6A6,SLC6A9,SLC39A8,SLC16A7,SLC6A20,SLC22A15,SLC22A1
R-HSA-196854	Metabolism of vitamins and cofactors	0.321096978927493	-1.13601208644076	90	9	0.0133333333333333	675	8202	5096,349565,5091,10243,5095,5646,60490,56922,166785	PCCB,NMNAT3,PC,GPHN,PCCA,PRSS3,PPCDC,MCCC1,MMAA
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.321096978927493	-1.13601208644076	90	9	0.0133333333333333	675	8202	5096,349565,5091,10243,5095,5646,60490,56922,166785	PCCB,NMNAT3,PC,GPHN,PCCA,PRSS3,PPCDC,MCCC1,MMAA
R-HSA-162594	Early Phase of HIV Life Cycle	0.322273310857319	-1.13235530197516	14	2	0.00296296296296296	675	8202	7518,11168	XRCC4,PSIP1
R-HSA-69166	Removal of the Flap Intermediate	0.322273310857319	-1.13235530197516	14	2	0.00296296296296296	675	8202	5558,5422	PRIM2,POLA1
R-HSA-190322	FGFR4 ligand binding and activation	0.322273310857319	-1.13235530197516	14	2	0.00296296296296296	675	8202	2247,9965	FGF2,FGF19
R-HSA-418885	DCC mediated attractive signaling	0.322273310857319	-1.13235530197516	14	2	0.00296296296296296	675	8202	2534,7204	FYN,TRIO
R-HSA-5682910	LGI-ADAM interactions	0.322273310857319	-1.13235530197516	14	2	0.00296296296296296	675	8202	203190,4185	LGI3,ADAM11
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.324576008581134	-1.12523553735057	35	4	0.00592592592592593	675	8202	5984,5983,328,8930	RFC4,RFC3,APEX1,MBD4
R-HSA-73884	Base Excision Repair	0.324576008581134	-1.12523553735057	35	4	0.00592592592592593	675	8202	5984,5983,328,8930	RFC4,RFC3,APEX1,MBD4
R-HSA-425410	Metal ion SLC transporters	0.339371599974211	-1.08065960683632	25	3	0.00444444444444444	675	8202	23516,84102,64116	SLC39A14,SLC41A2,SLC39A8
R-HSA-167021	PLC-gamma1 signalling	0.343842193913004	-1.06757246548648	36	4	0.00592592592592593	675	8202	5581,109,5577,4914	PRKCE,ADCY3,PRKAR2B,NTRK1
R-HSA-5655302	Signaling by FGFR1 in disease	0.343842193913004	-1.06757246548648	36	4	0.00592592592592593	675	8202	9208,2247,7750,1523	LRRFIP1,FGF2,ZMYM2,CUX1
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.343842193913004	-1.06757246548648	36	4	0.00592592592592593	675	8202	253782,8613,224,259230	CERS6,PLPP3,ALDH3A2,SGMS1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.343842193913004	-1.06757246548648	36	4	0.00592592592592593	675	8202	5581,109,5577,1950	PRKCE,ADCY3,PRKAR2B,EGF
R-HSA-1640170	Cell Cycle	0.34504426970214	-1.06408255220561	572	50	0.0740740740740741	675	8202	80321,5520,9656,27030,23175,10382,9577,23225,10783,55835,4609,8379,4361,545,80254,1021,10426,81929,10051,7277,5984,5983,902,7846,328,5558,10274,140609,5422,5682,64105,55869,5577,4171,3364,401541,4331,5932,8607,23421,22981,7015,10806,1869,51720,165918,23345,7029,7840,7443	CEP70,PPP2R2A,MDC1,MLH3,LPIN1,TUBB4A,BRE,NUP210,NEK6,CENPJ,MYC,MAD1L1,MRE11A,ATR,CEP63,CDK6,TUBGCP3,SEH1L,SMC4,TUBA4A,RFC4,RFC3,CCNH,TUBA1A,APEX1,PRIM2,STAG1,NEK7,POLA1,PSMA1,CENPK,HDAC8,PRKAR2B,MCM2,HUS1,CENPP,MNAT1,RBBP8,RUVBL1,ITGB3BP,NINL,TERT,SDCCAG8,E2F1,UIMC1,RNF168,SYNE1,TFDP2,ALMS1,VRK1
R-HSA-177929	Signaling by EGFR	0.345767863069731	-1.06198764507269	336	30	0.0444444444444444	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,30011,8660,5581,57761,2534,53358,10000,26018,109,409,5796	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,SH3KBP1,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,LRIG1,ADCY3,ARRB2,PTPRK
R-HSA-114608	Platelet degranulation	0.349082367462289	-1.05244737470507	81	8	0.0118518518518519	675	8202	7273,10257,1950,1191,7422,7042,3481,7277	TTN,ABCC4,EGF,CLU,VEGFA,TGFB2,IGF2,TUBA4A
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	9208	LRRFIP1
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	121642	ALKBH2
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	7035	TFPI
R-HSA-3000471	Scavenging by Class B Receptors	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	949	SCARB1
R-HSA-2161517	Abacavir transmembrane transport	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	6580	SLC22A1
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	5207	PFKFB1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	10057	ABCC5
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	6575	SLC20A2
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	9542	NRG2
R-HSA-187024	NGF-independant TRKA activation	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	4914	NTRK1
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	11168	PSIP1
R-HSA-112303	Electric Transmission Across Gap Junctions	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	56666	PANX2
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	5563	PRKAA2
R-HSA-68911	G2 Phase	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	1869	E2F1
R-HSA-426048	Arachidonate production from DAG	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	11343	MGLL
R-HSA-112307	Transmission across Electrical Synapses	0.349176459144603	-1.05217787096434	5	1	0.00148148148148148	675	8202	56666	PANX2
R-HSA-3322077	Glycogen synthesis	0.3533503901538	-1.0402951076891	15	2	0.00296296296296296	675	8202	2992,7957	GYG1,EPM2A
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.3533503901538	-1.0402951076891	15	2	0.00296296296296296	675	8202	3714,9148	JAG2,NEURL1
R-HSA-549132	Organic cation/anion/zwitterion transport	0.3533503901538	-1.0402951076891	15	2	0.00296296296296296	675	8202	55356,6580	SLC22A15,SLC22A1
R-HSA-205043	NRIF signals cell death from the nucleus	0.3533503901538	-1.0402951076891	15	2	0.00296296296296296	675	8202	5599,23421	MAPK8,ITGB3BP
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.3533503901538	-1.0402951076891	15	2	0.00296296296296296	675	8202	3714,9148	JAG2,NEURL1
R-HSA-5693532	DNA Double-Strand Break Repair	0.355218082838973	-1.03502336026643	162	15	0.0222222222222222	675	8202	5599,5984,9577,5983,5932,11073,9682,51720,4361,545,165918,7486,9656,7518,3364	MAPK8,RFC4,BRE,RFC3,RBBP8,TOPBP1,KDM4A,UIMC1,MRE11A,ATR,RNF168,WRN,MDC1,XRCC4,HUS1
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.360818266390153	-1.01938086460803	48	5	0.00740740740740741	675	8202	5581,109,5577,2247,9965	PRKCE,ADCY3,PRKAR2B,FGF2,FGF19
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.360818266390153	-1.01938086460803	48	5	0.00740740740740741	675	8202	4331,902,9014,1107,728340	MNAT1,CCNH,TAF1B,CHD3,GTF2H2C
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.362604557999261	-1.014442410417	26	3	0.00444444444444444	675	8202	4361,7486,5932	MRE11A,WRN,RBBP8
R-HSA-69481	G2/M Checkpoints	0.362897904814263	-1.01363373823179	105	10	0.0148148148148148	675	8202	5984,9577,5983,51720,4361,545,165918,4171,9656,3364	RFC4,BRE,RFC3,UIMC1,MRE11A,ATR,RNF168,MCM2,MDC1,HUS1
R-HSA-73886	Chromosome Maintenance	0.362897904814263	-1.01363373823179	105	10	0.0148148148148148	675	8202	5984,5983,328,23421,5558,8607,7015,5422,64105,401541	RFC4,RFC3,APEX1,ITGB3BP,PRIM2,RUVBL1,TERT,POLA1,CENPK,CENPP
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.363132830365649	-1.01298658777879	37	4	0.00592592592592593	675	8202	5581,109,5577,1950	PRKCE,ADCY3,PRKAR2B,EGF
R-HSA-74751	Insulin receptor signalling cascade	0.363947413621305	-1.01074588985525	280	25	0.037037037037037	675	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,57731,5291,9965,1847,6009,8660,57761,2534,53358,1978,2887,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,SPTBN4,PIK3CB,FGF19,DUSP5,RHEB,IRS2,TRIB3,FYN,SHC3,EIF4EBP1,GRB10,ARRB2
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.372501622203818	-0.987513886262427	129	12	0.0177777777777778	675	8202	5984,9577,5983,5932,11073,51720,4361,545,165918,7486,9656,3364	RFC4,BRE,RFC3,RBBP8,TOPBP1,UIMC1,MRE11A,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-73894	DNA Repair	0.380447427465918	-0.966407278201582	306	27	0.04	675	8202	5599,5984,5983,902,328,11073,9682,728340,7486,9656,2178,3364,8930,55120,4331,9577,5932,56852,8607,121642,4437,51720,4361,545,165918,7518,86	MAPK8,RFC4,RFC3,CCNH,APEX1,TOPBP1,KDM4A,GTF2H2C,WRN,MDC1,FANCE,HUS1,MBD4,FANCL,MNAT1,BRE,RBBP8,RAD18,RUVBL1,ALKBH2,MSH3,UIMC1,MRE11A,ATR,RNF168,XRCC4,ACTL6A
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.3809713780296	-0.965031029959222	72	7	0.0103703703703704	675	8202	6498,7029,7048,4609,9372,25937,56288	SKIL,TFDP2,TGFBR2,MYC,ZFYVE9,WWTR1,PARD3
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.382400396705939	-0.961287060394501	38	4	0.00592592592592593	675	8202	5599,5366,10000,1869	MAPK8,PMAIP1,AKT3,E2F1
R-HSA-110312	Translesion synthesis by REV1	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-1433559	Regulation of KIT signaling	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	10019,2534	SH2B3,FYN
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	23556,54965	PIGN,PIGX
R-HSA-163615	PKA activation	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	7048,56288	TGFBR2,PARD3
R-HSA-1834941	STING mediated induction of host immune responses	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	4361,340061	MRE11A,TMEM173
R-HSA-1369062	ABC transporters in lipid homeostasis	0.383910141740901	-0.95734675966113	16	2	0.00296296296296296	675	8202	215,9619	ABCD1,ABCG1
R-HSA-180024	DARPP-32 events	0.385704907814292	-0.952682689414654	27	3	0.00444444444444444	675	8202	5577,5530,5144	PRKAR2B,PPP3CA,PDE4D
R-HSA-182971	EGFR downregulation	0.385704907814292	-0.952682689414654	27	3	0.00444444444444444	675	8202	30011,1950,5796	SH3KBP1,EGF,PTPRK
R-HSA-1433557	Signaling by SCF-KIT	0.387180086546042	-0.948865354277141	307	27	0.04	675	8202	6712,200734,8831,2247,10076,3164,5922,27161,1950,1852,5682,283455,9542,23239,2309,57731,5291,9965,1847,8660,10019,57761,2534,53358,10000,2887,409	SPTBN2,SPRED2,SYNGAP1,FGF2,PTPRU,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,SH2B3,TRIB3,FYN,SHC3,AKT3,GRB10,ARRB2
R-HSA-1500931	Cell-Cell communication	0.393072866578332	-0.933760273158602	131	12	0.0177777777777778	675	8202	5599,2534,55679,84063,5584,2185,4868,5291,1366,56288,140885,3914	MAPK8,FYN,LIMS2,KIRREL2,PRKCI,PTK2B,NPHS1,PIK3CB,CLDN7,PARD3,SIRPA,LAMB3
R-HSA-112310	Neurotransmitter Release Cycle	0.394474818950587	-0.930199971023468	50	5	0.00740740740740741	675	8202	6507,6857,2571,6812,6580	SLC1A3,SYT1,GAD1,STXBP1,SLC22A1
R-HSA-5336415	Uptake and function of diphtheria toxin	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	7296	TXNRD1
R-HSA-190370	FGFR1b ligand binding and activation	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	215	ABCD1
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	4361	MRE11A
R-HSA-947581	Molybdenum cofactor biosynthesis	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	10243	GPHN
R-HSA-5626978	TNFR1-mediated ceramide production	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	55512	SMPD3
R-HSA-77111	Synthesis of Ketone Bodies	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	622	BDH1
R-HSA-173623	Classical antibody-mediated complement activation	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	716	C1S
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	340061	TMEM173
R-HSA-187015	Activation of TRKA receptors	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	4914	NTRK1
R-HSA-3065679	SUMO is proteolytically processed	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	205564	SENP5
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	84254	CAMKK1
R-HSA-73942	DNA Damage Reversal	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	121642	ALKBH2
R-HSA-444257	RSK activation	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	6196	RPS6KA2
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.402769955554984	-0.90938970990924	6	1	0.00148148148148148	675	8202	22943	DKK1
R-HSA-5654716	Downstream signaling of activated FGFR4	0.40748517436839	-0.897750728881119	310	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-5654687	Downstream signaling of activated FGFR1	0.40748517436839	-0.897750728881119	310	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-5654708	Downstream signaling of activated FGFR3	0.40748517436839	-0.897750728881119	310	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-5654696	Downstream signaling of activated FGFR2	0.40748517436839	-0.897750728881119	310	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-186763	Downstream signal transduction	0.40815376546317	-0.896111299442727	322	28	0.0414814814814815	675	8202	6712,200734,2889,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,RAPGEF1,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-2022854	Keratan sulfate biosynthesis	0.40860248319433	-0.895012519293711	28	3	0.00444444444444444	675	8202	9435,10331,9331	CHST2,B3GNT3,B4GALT6
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.40860248319433	-0.895012519293711	28	3	0.00444444444444444	675	8202	5984,5983,56852	RFC4,RFC3,RAD18
R-HSA-1483166	Synthesis of PA	0.40860248319433	-0.895012519293711	28	3	0.00444444444444444	675	8202	5337,253558,56895	PLD1,LCLAT1,AGPAT4
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.408687915273812	-0.894803457545392	74	7	0.0103703703703704	675	8202	51720,5599,4361,165918,9577,9656,9682	UIMC1,MAPK8,MRE11A,RNF168,BRE,MDC1,KDM4A
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.411258076307549	-0.888534338657578	51	5	0.00740740740740741	675	8202	10090,29940,3339,6382,55454	UST,DSE,HSPG2,SDC1,CSGALNACT2
R-HSA-445717	Aquaporin-mediated transport	0.411258076307549	-0.888534338657578	51	5	0.00740740740740741	675	8202	4645,109,5577,22841,2792	MYO5B,ADCY3,PRKAR2B,RAB11FIP2,GNGT1
R-HSA-397795	G-protein beta:gamma signalling	0.411258076307549	-0.888534338657578	51	5	0.00740740740740741	675	8202	23236,5330,5291,10000,2792	PLCB1,PLCB2,PIK3CB,AKT3,GNGT1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.413249573810759	-0.883703573592464	86	8	0.0118518518518519	675	8202	5581,10152,2534,644150,5337,5291,8398,4644	PRKCE,ABI2,FYN,WIPF3,PLD1,PIK3CB,PLA2G6,MYO5A
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.413249573810759	-0.883703573592464	86	8	0.0118518518518519	675	8202	7273,10257,1950,1191,7422,7042,3481,7277	TTN,ABCC4,EGF,CLU,VEGFA,TGFB2,IGF2,TUBA4A
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-5656121	Translesion synthesis by POLI	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-5655862	Translesion synthesis by POLK	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-435354	Zinc transporters	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	23516,64116	SLC39A14,SLC39A8
R-HSA-2142845	Hyaluronan metabolism	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	6548,10057	SLC9A1,ABCC5
R-HSA-69205	G1/S-Specific Transcription	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	5422,1869	POLA1,E2F1
R-HSA-164378	PKA activation in glucagon signalling	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.413827289880531	-0.882306566399804	17	2	0.00296296296296296	675	8202	6857,6812	SYT1,STXBP1
R-HSA-109703	PKB-mediated events	0.420690097363382	-0.865858827138136	40	4	0.00592592592592593	675	8202	5563,5140,1978,6009	PRKAA2,PDE3B,EIF4EBP1,RHEB
R-HSA-5693606	DNA Double Strand Break Response	0.422529662113779	-0.861495628462789	75	7	0.0103703703703704	675	8202	51720,5599,4361,165918,9577,9656,9682	UIMC1,MAPK8,MRE11A,RNF168,BRE,MDC1,KDM4A
R-HSA-112399	IRS-mediated signalling	0.426742128924964	-0.85157536170741	277	24	0.0355555555555556	675	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,57731,5291,9965,1847,6009,8660,57761,2534,53358,1978,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,SPTBN4,PIK3CB,FGF19,DUSP5,RHEB,IRS2,TRIB3,FYN,SHC3,EIF4EBP1,ARRB2
R-HSA-5654741	Signaling by FGFR3	0.427907737373901	-0.84884767352163	313	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-5654743	Signaling by FGFR4	0.427907737373901	-0.84884767352163	313	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-3214841	PKMTs methylate histone lysines	0.432852364961382	-0.837358567637968	64	6	0.00888888888888889	675	8202	55729,8085,80854,63976,64754,2122	ATF7IP,KMT2D,SETD7,PRDM16,SMYD3,MECOM
R-HSA-5693538	Homology Directed Repair	0.434403971844396	-0.833780367116006	135	12	0.0177777777777778	675	8202	5984,9577,5983,5932,11073,51720,4361,545,165918,7486,9656,3364	RFC4,BRE,RFC3,RBBP8,TOPBP1,UIMC1,MRE11A,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-5654736	Signaling by FGFR1	0.434731780340397	-0.833026034986139	314	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.443000621308545	-0.814184106435626	18	2	0.00296296296296296	675	8202	6857,6812	SYT1,STXBP1
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.443000621308545	-0.814184106435626	18	2	0.00296296296296296	675	8202	5297,30849	PI4KA,PIK3R4
R-HSA-156584	Cytosolic sulfonation of small molecules	0.443000621308545	-0.814184106435626	18	2	0.00296296296296296	675	8202	6820,25830	SULT2B1,SULT4A1
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.443000621308545	-0.814184106435626	18	2	0.00296296296296296	675	8202	487,4242	ATP2A1,MFNG
R-HSA-556833	Metabolism of lipids and lipoproteins	0.443914131214467	-0.812124133419364	628	53	0.0785185185185185	675	8202	5563,2180,3339,133522,79993,259230,30849,5297,6382,253558,5305,26230,23175,55512,1490,57834,622,348,215,5742,8309,11343,8398,224,7296,9415,5096,412,79718,7003,56895,5095,56261,9442,5465,857,5291,166785,80270,5467,57761,253782,23097,8613,406,25937,84649,1800,5337,949,6907,9575,9619	PRKAA2,ACSL1,HSPG2,PPARGC1B,ELOVL7,SGMS1,PIK3R4,PI4KA,SDC1,LCLAT1,PIP4K2A,TIAM2,LPIN1,SMPD3,CTGF,CYP4F11,BDH1,APOE,ABCD1,PTGS1,ACOX2,MGLL,PLA2G6,ALDH3A2,TXNRD1,FADS2,PCCB,STS,TBL1XR1,TEAD1,AGPAT4,PCCA,GPCPD1,MED27,PPARA,CAV1,PIK3CB,MMAA,HSD3B7,PPARD,TRIB3,CERS6,CDK19,PLPP3,ARNTL,WWTR1,DGAT2,DPEP1,PLD1,SCARB1,TBL1X,CLOCK,ABCG1
R-HSA-5654738	Signaling by FGFR2	0.448392397041503	-0.802086543678323	316	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-74752	Signaling by Insulin receptor	0.448438344572901	-0.801984077227729	304	26	0.0385185185185185	675	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,90423,283455,9542,5140,57731,5291,9965,1847,6009,8660,57761,2534,53358,1978,2887,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,ATP6V1E2,KSR2,NRG2,PDE3B,SPTBN4,PIK3CB,FGF19,DUSP5,RHEB,IRS2,TRIB3,FYN,SHC3,EIF4EBP1,GRB10,ARRB2
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	109	ADCY3
R-HSA-174577	Activation of C3 and C5	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	717	C2
R-HSA-447043	Neurofascin interactions	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	23114	NFASC
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	7443	VRK1
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	328	APEX1
R-HSA-426117	Cation-coupled Chloride cotransporters	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	10723	SLC12A7
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	3516	RBPJ
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	3714	JAG2
R-HSA-429593	Inositol transporters	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	115584	SLC5A11
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	5207	PFKFB1
R-HSA-74182	Ketone body metabolism	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	622	BDH1
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	3714	JAG2
R-HSA-448706	Interleukin-1 processing	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	3606	IL18
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	27161	AGO2
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.451956178110626	-0.794170054932651	7	1	0.00148148148148148	675	8202	131870	NUDT16
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.453543585161425	-0.790663905640597	30	3	0.00444444444444444	675	8202	3714,409,9148	JAG2,ARRB2,NEURL1
R-HSA-68962	Activation of the pre-replicative complex	0.453543585161425	-0.790663905640597	30	3	0.00444444444444444	675	8202	5558,4171,5422	PRIM2,MCM2,POLA1
R-HSA-2559585	Oncogene Induced Senescence	0.453543585161425	-0.790663905640597	30	3	0.00444444444444444	675	8202	2113,1021,1869	ETS1,CDK6,E2F1
R-HSA-420029	Tight junction interactions	0.453543585161425	-0.790663905640597	30	3	0.00444444444444444	675	8202	1366,56288,5584	CLDN7,PARD3,PRKCI
R-HSA-69242	S Phase	0.454532129153763	-0.78848667665571	125	11	0.0162962962962963	675	8202	4331,5984,5983,902,328,10274,5558,5422,4609,5682,4171	MNAT1,RFC4,RFC3,CCNH,APEX1,STAG1,PRIM2,POLA1,MYC,PSMA1,MCM2
R-HSA-190236	Signaling by FGFR	0.455224917092025	-0.786963658889514	317	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-975634	Retinoid metabolism and transport	0.458387486813245	-0.780040411482016	42	4	0.00592592592592593	675	8202	348,3339,6382,7804	APOE,HSPG2,SDC1,LRP8
R-HSA-1566948	Elastic fibre formation	0.458387486813245	-0.780040411482016	42	4	0.00592592592592593	675	8202	4052,652,7042,84467	LTBP1,BMP4,TGFB2,FBN3
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.461438874289467	-0.773405683888511	342	29	0.042962962962963	675	8202	5599,6712,5530,200734,8831,2247,3164,5922,1950,27161,1852,5682,9542,283455,4773,23239,2309,5291,57731,9965,1847,7462,8660,57761,2534,53358,10000,5062,409	MAPK8,SPTBN2,PPP3CA,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,AGO2,DUSP9,PSMA1,NRG2,KSR2,NFATC2,PHLPP1,FOXO3,PIK3CB,SPTBN4,FGF19,DUSP5,LAT2,IRS2,TRIB3,FYN,SHC3,AKT3,PAK2,ARRB2
R-HSA-157579	Telomere Maintenance	0.463794067348168	-0.76831464564362	78	7	0.0103703703703704	675	8202	5984,5983,328,5558,8607,7015,5422	RFC4,RFC3,APEX1,PRIM2,RUVBL1,TERT,POLA1
R-HSA-416700	Other semaphorin interactions	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	23129,5361	PLXND1,PLXNA1
R-HSA-3000480	Scavenging by Class A Receptors	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	348,117156	APOE,SCGB3A2
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-110320	Translesion Synthesis by POLH	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-1181150	Signaling by NODAL	0.471349882869997	-0.752154609639007	19	2	0.00296296296296296	675	8202	2309,5046	FOXO3,PCSK6
R-HSA-1296065	Inwardly rectifying K+ channels	0.475480958996014	-0.743428441970903	31	3	0.00444444444444444	675	8202	3770,2550,2792	KCNJ14,GABBR1,GNGT1
R-HSA-2129379	Molecules associated with elastic fibres	0.475480958996014	-0.743428441970903	31	3	0.00444444444444444	675	8202	4052,652,7042	LTBP1,BMP4,TGFB2
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.475480958996014	-0.743428441970903	31	3	0.00444444444444444	675	8202	7029,4609,25937	TFDP2,MYC,WWTR1
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.475480958996014	-0.743428441970903	31	3	0.00444444444444444	675	8202	23225,11168,81929	NUP210,PSIP1,SEH1L
R-HSA-1227986	Signaling by ERBB2	0.475707255540004	-0.742952623316295	320	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,5577,23239,2309,57731,5291,9965,1847,8660,5581,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,PRKCE,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-418555	G alpha (s) signalling events	0.47604051040555	-0.742252322478005	127	11	0.0162962962962963	675	8202	3363,2781,2792,109,5151,797,5144,10267,5140,8622,50940	HTR7,GNAZ,GNGT1,ADCY3,PDE8A,CALCB,PDE4D,RAMP1,PDE3B,PDE8B,PDE11A
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.476925524446177	-0.740394933520386	43	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.476925524446177	-0.740394933520386	43	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-917937	Iron uptake and transport	0.476925524446177	-0.740394933520386	43	4	0.00592592592592593	675	8202	90423,55240,7037,261729	ATP6V1E2,STEAP3,TFRC,STEAP2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.476925524446177	-0.740394933520386	43	4	0.00592592592592593	675	8202	6498,7029,4609,25937	SKIL,TFDP2,MYC,WWTR1
R-HSA-167169	HIV Transcription Elongation	0.476925524446177	-0.740394933520386	43	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-1632852	Macroautophagy	0.477536957311531	-0.739113724545326	67	6	0.00888888888888889	675	8202	5563,9140,9821,6009,10533,30849	PRKAA2,ATG12,RB1CC1,RHEB,ATG7,PIK3R4
R-HSA-168898	Toll-Like Receptors Cascades	0.485842195676395	-0.721871408062517	140	12	0.0177777777777778	675	8202	5599,466,1759,6196,3684,51295,30849,9252,170506,329,8411,4208	MAPK8,ATF1,DNM1,RPS6KA2,ITGAM,ECSIT,PIK3R4,RPS6KA5,DHX36,BIRC2,EEA1,MEF2C
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.492211944664474	-0.708845873411326	68	6	0.00888888888888889	675	8202	51720,4361,165918,9577,9656,7518	UIMC1,MRE11A,RNF168,BRE,MDC1,XRCC4
R-HSA-75109	Triglyceride Biosynthesis	0.492211944664474	-0.708845873411326	68	6	0.00888888888888889	675	8202	2180,253558,56895,79993,23175,84649	ACSL1,LCLAT1,AGPAT4,ELOVL7,LPIN1,DGAT2
R-HSA-71387	Metabolism of carbohydrates	0.492744212145928	-0.707765079043807	274	23	0.0340740740740741	675	8202	10090,2548,5207,3339,10165,2992,29940,6382,9435,7957,23225,5091,90161,5255,3099,6548,5106,81929,55454,10331,266722,9331,10057	UST,GAA,PFKFB1,HSPG2,SLC25A13,GYG1,DSE,SDC1,CHST2,EPM2A,NUP210,PC,HS6ST2,PHKA1,HK2,SLC9A1,PCK2,SEH1L,CSGALNACT2,B3GNT3,HS6ST3,B4GALT6,ABCC5
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.495214994682427	-0.702763278016816	44	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.495214994682427	-0.702763278016816	44	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-112382	Formation of RNA Pol II elongation complex	0.495214994682427	-0.702763278016816	44	4	0.00592592592592593	675	8202	4331,22916,902,728340	MNAT1,NCBP2,CCNH,GTF2H2C
R-HSA-1980145	Signaling by NOTCH2	0.4970026541368	-0.699159912584274	32	3	0.00444444444444444	675	8202	3714,3516,9148	JAG2,RBPJ,NEURL1
R-HSA-186712	Regulation of beta-cell development	0.4970026541368	-0.699159912584274	32	3	0.00444444444444444	675	8202	3516,3172,10000	RBPJ,HNF4A,AKT3
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.4970026541368	-0.699159912584274	32	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-1253288	Downregulation of ERBB4 signaling	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	4734	NEDD4
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	4233	MET
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	5366	PMAIP1
R-HSA-1483115	Hydrolysis of LPC	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	56261	GPCPD1
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	7422	VEGFA
R-HSA-73928	Depyrimidination	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	8930	MBD4
R-HSA-110329	Cleavage of the damaged pyrimidine	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	8930	MBD4
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	8309	ACOX2
R-HSA-196783	Coenzyme A biosynthesis	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	60490	PPCDC
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	89978	DPH6
R-HSA-194313	VEGF ligand-receptor interactions	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	7422	VEGFA
R-HSA-1483148	Synthesis of PG	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	5337	PLD1
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	84894	LINGO1
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.49709706642442	-0.698969967278083	8	1	0.00148148148148148	675	8202	8930	MBD4
R-HSA-166663	Initial triggering of complement	0.498813025520773	-0.695523951802753	20	2	0.00296296296296296	675	8202	716,717	C1S,C2
R-HSA-210745	Regulation of gene expression in beta cells	0.498813025520773	-0.695523951802753	20	2	0.00296296296296296	675	8202	3172,10000	HNF4A,AKT3
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.498813025520773	-0.695523951802753	20	2	0.00296296296296296	675	8202	857,11343	CAV1,MGLL
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.498813025520773	-0.695523951802753	20	2	0.00296296296296296	675	8202	1803,6934	DPP4,TCF7L2
R-HSA-1236394	Signaling by ERBB4	0.503967781176761	-0.685242939190722	312	26	0.0385185185185185	675	8202	6712,200734,8831,2247,3164,5922,27161,1950,1852,5682,283455,9542,23239,2309,57731,5291,9965,1847,4734,8660,57761,2534,53358,51741,10000,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,PHLPP1,FOXO3,SPTBN4,PIK3CB,FGF19,DUSP5,NEDD4,IRS2,TRIB3,FYN,SHC3,WWOX,AKT3,ARRB2
R-HSA-2424491	DAP12 signaling	0.509676033044209	-0.673979984432475	325	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,1950,27161,1852,5682,9542,283455,5577,23239,2309,5291,57731,9965,1847,5581,8660,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,AGO2,DUSP9,PSMA1,NRG2,KSR2,PRKAR2B,PHLPP1,FOXO3,PIK3CB,SPTBN4,FGF19,DUSP5,PRKCE,IRS2,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-1226099	Signaling by FGFR in disease	0.513228327708416	-0.667034449579265	45	4	0.00592592592592593	675	8202	9208,2247,7750,1523	LRRFIP1,FGF2,ZMYM2,CUX1
R-HSA-113510	E2F mediated regulation of DNA replication	0.518070909723496	-0.657643154733321	33	3	0.00444444444444444	675	8202	5558,5422,1869	PRIM2,POLA1,E2F1
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.518070909723496	-0.657643154733321	33	3	0.00444444444444444	675	8202	9435,10331,9331	CHST2,B3GNT3,B4GALT6
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.518070909723496	-0.657643154733321	33	3	0.00444444444444444	675	8202	4361,7486,5932	MRE11A,WRN,RBBP8
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.518070909723496	-0.657643154733321	33	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.521132247961537	-0.651751434580392	70	6	0.00888888888888889	675	8202	8672,3840,23225,4734,81929,1974	EIF4G3,KPNA4,NUP210,NEDD4,SEH1L,EIF4A2
R-HSA-1169408	ISG15 antiviral mechanism	0.521132247961537	-0.651751434580392	70	6	0.00888888888888889	675	8202	8672,3840,23225,4734,81929,1974	EIF4G3,KPNA4,NUP210,NEDD4,SEH1L,EIF4A2
R-HSA-69473	G2/M DNA damage checkpoint	0.521132247961537	-0.651751434580392	70	6	0.00888888888888889	675	8202	51720,4361,165918,545,9577,9656	UIMC1,MRE11A,RNF168,ATR,BRE,MDC1
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.521670029959889	-0.650720017489322	168	14	0.0207407407407407	675	8202	8660,57761,2534,2247,3164,10000,1950,27161,5682,9542,23239,2309,5291,9965	IRS2,TRIB3,FYN,FGF2,NR4A1,AKT3,EGF,AGO2,PSMA1,NRG2,PHLPP1,FOXO3,PIK3CB,FGF19
R-HSA-2024096	HS-GAG degradation	0.525343758995269	-0.64370245162617	21	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.525343758995269	-0.64370245162617	21	2	0.00296296296296296	675	8202	3714,9148	JAG2,NEURL1
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.525343758995269	-0.64370245162617	21	2	0.00296296296296296	675	8202	10667,2617	FARS2,GARS
R-HSA-390918	Peroxisomal lipid metabolism	0.525343758995269	-0.64370245162617	21	2	0.00296296296296296	675	8202	215,8309	ABCD1,ACOX2
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.525343758995269	-0.64370245162617	21	2	0.00296296296296296	675	8202	166785,5646	MMAA,PRSS3
R-HSA-5620916	VxPx cargo-targeting to cilium	0.525343758995269	-0.64370245162617	21	2	0.00296296296296296	675	8202	50807,60412	ASAP1,EXOC4
R-HSA-3858494	Beta-catenin independent WNT signaling	0.52630193768509	-0.641880204917059	144	12	0.0177777777777778	675	8202	5530,4920,27161,2792,6259,5682,51701,4919,409,5330,23236,6934	PPP3CA,ROR2,AGO2,GNGT1,RYK,PSMA1,NLK,ROR1,ARRB2,PLCB2,PLCB1,TCF7L2
R-HSA-1643685	Disease	0.5266969783209	-0.641129889511528	657	54	0.08	675	8202	9208,3339,728340,1950,56922,9542,2992,3714,7048,6382,2309,9965,11168,7957,9372,9734,23225,4609,5062,8732,7750,81929,7296,118429,5096,902,2247,79718,8731,3164,5095,1523,5682,55869,6875,6857,84168,166785,5291,6934,9148,22943,4331,8660,6165,2534,3840,9759,5091,10000,22916,6907,3516,7518	LRRFIP1,HSPG2,GTF2H2C,EGF,MCCC1,NRG2,GYG1,JAG2,TGFBR2,SDC1,FOXO3,FGF19,PSIP1,EPM2A,ZFYVE9,HDAC9,NUP210,MYC,PAK2,RNGTT,ZMYM2,SEH1L,TXNRD1,ANTXR2,PCCB,CCNH,FGF2,TBL1XR1,RNMT,NR4A1,PCCA,CUX1,PSMA1,HDAC8,TAF4B,SYT1,ANTXR1,MMAA,PIK3CB,TCF7L2,NEURL1,DKK1,MNAT1,IRS2,RPL35A,FYN,KPNA4,HDAC4,PC,AKT3,NCBP2,TBL1X,RBPJ,XRCC4
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.530823719823244	-0.633325290591008	83	7	0.0103703703703704	675	8202	4331,5984,5983,902,8607,728340,86	MNAT1,RFC4,RFC3,CCNH,RUVBL1,GTF2H2C,ACTL6A
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	4331,902,6875,728340	MNAT1,CCNH,TAF4B,GTF2H2C
R-HSA-73776	RNA Polymerase II Promoter Escape	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	4331,902,6875,728340	MNAT1,CCNH,TAF4B,GTF2H2C
R-HSA-167161	HIV Transcription Initiation	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	4331,902,6875,728340	MNAT1,CCNH,TAF4B,GTF2H2C
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	5581,109,5577,2247	PRKCE,ADCY3,PRKAR2B,FGF2
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	4331,902,6875,728340	MNAT1,CCNH,TAF4B,GTF2H2C
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	4331,902,6875,728340	MNAT1,CCNH,TAF4B,GTF2H2C
R-HSA-418597	G alpha (z) signalling events	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	5581,109,2781,2792	PRKCE,ADCY3,GNAZ,GNGT1
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.530940697144316	-0.633104945437836	46	4	0.00592592592592593	675	8202	4331,902,6875,728340	MNAT1,CCNH,TAF4B,GTF2H2C
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	57128	LYRM4
R-HSA-1300642	Sperm Motility And Taxes	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	79820	CATSPERB
R-HSA-70635	Urea cycle	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	384	ARG2
R-HSA-73614	Pyrimidine salvage reactions	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	7378	UPP1
R-HSA-446107	Type I hemidesmosome assembly	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	3914	LAMB3
R-HSA-419408	Lysosphingolipid and LPA receptors	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	23566	LPAR3
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	7422	VEGFA
R-HSA-193697	p75NTR regulates axonogenesis	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	84894	LINGO1
R-HSA-196025	Formation of annular gap junctions	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	1759	DNM1
R-HSA-1296052	Ca2+ activated K+ channels	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	3782	KCNN3
R-HSA-3215018	Processing and activation of SUMO	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	205564	SENP5
R-HSA-1462054	Alpha-defensins	0.538524877037393	-0.618921586540216	9	1	0.00148148148148148	675	8202	5646	PRSS3
R-HSA-1489509	DAG and IP3 signaling	0.538653472054026	-0.618682823818421	34	3	0.00444444444444444	675	8202	5581,109,5577	PRKCE,ADCY3,PRKAR2B
R-HSA-3928663	EPHA-mediated growth cone collapse	0.538653472054026	-0.618682823818421	34	3	0.00444444444444444	675	8202	2534,7422,2043	FYN,VEGFA,EPHA4
R-HSA-5693537	Resolution of D-Loop Structures	0.538653472054026	-0.618682823818421	34	3	0.00444444444444444	675	8202	4361,7486,5932	MRE11A,WRN,RBBP8
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.538653472054026	-0.618682823818421	34	3	0.00444444444444444	675	8202	23225,11168,81929	NUP210,PSIP1,SEH1L
R-HSA-1483206	Glycerophospholipid biosynthesis	0.539266363456001	-0.617545649331356	96	8	0.0118518518518519	675	8202	56895,56261,84649,5337,253558,11343,8398,23175	AGPAT4,GPCPD1,DGAT2,PLD1,LCLAT1,MGLL,PLA2G6,LPIN1
R-HSA-1483257	Phospholipid metabolism	0.546170767261289	-0.604823591584806	146	12	0.0177777777777778	675	8202	56895,56261,84649,30849,5297,5337,253558,11343,8398,5291,5305,23175	AGPAT4,GPCPD1,DGAT2,PIK3R4,PI4KA,PLD1,LCLAT1,MGLL,PLA2G6,PIK3CB,PIP4K2A,LPIN1
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.550909384726426	-0.596184939385493	22	2	0.00296296296296296	675	8202	8630,8608	HSD17B6,RDH16
R-HSA-166208	mTORC1-mediated signalling	0.550909384726426	-0.596184939385493	22	2	0.00296296296296296	675	8202	1978,6009	EIF4EBP1,RHEB
R-HSA-389513	CTLA4 inhibitory signaling	0.550909384726426	-0.596184939385493	22	2	0.00296296296296296	675	8202	2534,10000	FYN,AKT3
R-HSA-170968	Frs2-mediated activation	0.552480767255083	-0.593336656594165	233	19	0.0281481481481481	675	8202	6712,200734,2889,8831,2247,5922,4914,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,RAPGEF1,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-450294	MAP kinase activation in TLR cascade	0.556293869367228	-0.586458582333306	60	5	0.00740740740740741	675	8202	5599,466,6196,9252,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,MEF2C
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.556726785386201	-0.585680670371015	85	7	0.0103703703703704	675	8202	5599,466,6196,9252,170506,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,DHX36,ECSIT,MEF2C
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.556726785386201	-0.585680670371015	85	7	0.0103703703703704	675	8202	5599,466,6196,9252,170506,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,DHX36,ECSIT,MEF2C
R-HSA-194138	Signaling by VEGF	0.558483706358673	-0.582529834830996	320	26	0.0385185185185185	675	8202	6712,10152,200734,8831,2247,5922,1950,1852,5682,283455,9542,857,7422,57731,5291,9965,1847,8660,57761,2534,53358,10000,5062,2185,8829,409	SPTBN2,ABI2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,CAV1,VEGFA,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,TRIB3,FYN,SHC3,AKT3,PAK2,PTK2B,NRP1,ARRB2
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.55872323425745	-0.582101037096684	35	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-453279	Mitotic G1-G1/S phases	0.5599097469539	-0.579979674395352	135	11	0.0162962962962963	675	8202	4331,902,5558,5422,4609,1869,5682,5520,4171,7029,1021	MNAT1,CCNH,PRIM2,POLA1,MYC,E2F1,PSMA1,PPP2R2A,MCM2,TFDP2,CDK6
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.56322249375683	-0.574080535736937	73	6	0.00888888888888889	675	8202	7296,5563,83667,10000,6009,54541	TXNRD1,PRKAA2,SESN2,AKT3,RHEB,DDIT4
R-HSA-3700989	Transcriptional Regulation by TP53	0.56322249375683	-0.574080535736937	73	6	0.00888888888888889	675	8202	7296,5563,83667,10000,6009,54541	TXNRD1,PRKAA2,SESN2,AKT3,RHEB,DDIT4
R-HSA-2187338	Visual phototransduction	0.563312803218073	-0.573920204388812	98	8	0.0118518518518519	675	8202	8787,3339,8608,2792,8630,348,6382,7804	RGS9,HSPG2,RDH16,GNGT1,HSD17B6,APOE,SDC1,LRP8
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.565376453720216	-0.570263479937883	48	4	0.00592592592592593	675	8202	1759,2534,2047,2043	DNM1,FYN,EPHB1,EPHA4
R-HSA-169893	Prolonged ERK activation events	0.568064154321367	-0.565520918890216	235	19	0.0281481481481481	675	8202	6712,200734,2889,8831,2247,5922,4914,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,RAPGEF1,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.56916743689368	-0.563580622952315	198	16	0.0237037037037037	675	8202	2247,3164,1950,27161,5682,9542,23239,2309,5291,9965,30011,8660,57761,2534,10000,7220	FGF2,NR4A1,EGF,AGO2,PSMA1,NRG2,PHLPP1,FOXO3,PIK3CB,FGF19,SH3KBP1,IRS2,TRIB3,FYN,AKT3,TRPC1
R-HSA-2980736	Peptide hormone metabolism	0.569439956035629	-0.563101934426585	86	7	0.0103703703703704	675	8202	3800,1803,3798,4644,6934,5873,60412	KIF5C,DPP4,KIF5A,MYO5A,TCF7L2,RAB27A,EXOC4
R-HSA-5683057	MAPK family signaling cascades	0.574737233188297	-0.553842328394085	273	22	0.0325925925925926	675	8202	10602,6712,200734,8831,2247,5922,27161,1950,1852,5682,283455,9542,2309,57731,9965,1847,8660,2534,53358,4609,5062,409	CDC42EP3,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,AGO2,EGF,DUSP9,PSMA1,KSR2,NRG2,FOXO3,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,MYC,PAK2,ARRB2
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	1803,6934	DPP4,TCF7L2
R-HSA-5627123	RHO GTPases activate PAKs	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	5062,4638	PAK2,MYLK
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	2247,9965	FGF2,FGF19
R-HSA-112409	RAF-independent MAPK1/3 activation	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	1852,1847	DUSP9,DUSP5
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	6857,6812	SYT1,STXBP1
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	1800,57834	DPEP1,CYP4F11
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.575488877997057	-0.552535376815709	23	2	0.00296296296296296	675	8202	92482,8195	BBIP1,MKKS
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	5563	PRKAA2
R-HSA-168799	Neurotoxicity of clostridium toxins	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	6857	SYT1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	30849	PIK3R4
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	8930	MBD4
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	55757	UGGT2
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	487	ATP2A1
R-HSA-2470946	Cohesin Loading onto Chromatin	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	10274	STAG1
R-HSA-1300644	Interaction With The Zona Pellucida	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	7784	ZP3
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	5599	MAPK8
R-HSA-5621480	Dectin-2 family	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	2534	FYN
R-HSA-170660	Adenylate cyclase activating pathway	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	109	ADCY3
R-HSA-190377	FGFR2b ligand binding and activation	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-190873	Gap junction degradation	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	1759	DNM1
R-HSA-2161522	Abacavir transport and metabolism	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	6580	SLC22A1
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	7220	TRPC1
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.576544614370683	-0.550702553940055	10	1	0.00148148148148148	675	8202	3705	ITPK1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.57825787427866	-0.547735360533716	36	3	0.00444444444444444	675	8202	89978,412,56648	DPH6,STS,EIF5A2
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.57825787427866	-0.547735360533716	36	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.57825787427866	-0.547735360533716	36	3	0.00444444444444444	675	8202	7220,2534,30011	TRPC1,FYN,SH3KBP1
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.581981758910705	-0.541316173819698	87	7	0.0103703703703704	675	8202	26108,8085,8607,7015,7090,4609,6934	PYGO1,KMT2D,RUVBL1,TERT,TLE3,MYC,TCF7L2
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.582063112382515	-0.541176396610163	49	4	0.00592592592592593	675	8202	5581,109,5577,2247	PRKCE,ADCY3,PRKAR2B,FGF2
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.587607327603858	-0.531696364365585	312	25	0.037037037037037	675	8202	6712,10152,200734,8831,2247,5922,1950,1852,5682,283455,9542,857,7422,57731,5291,9965,1847,8660,57761,2534,53358,10000,5062,2185,409	SPTBN2,ABI2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,CAV1,VEGFA,SPTBN4,PIK3CB,FGF19,DUSP5,IRS2,TRIB3,FYN,SHC3,AKT3,PAK2,PTK2B,ARRB2
R-HSA-438064	Post NMDA receptor activation events	0.59723949580876	-0.515437080526094	37	3	0.00444444444444444	675	8202	109,6196,84254	ADCY3,RPS6KA2,CAMKK1
R-HSA-429914	Deadenylation-dependent mRNA decay	0.598375137910209	-0.51353740079494	50	4	0.00592592592592593	675	8202	57472,54464,5073,1974	CNOT6,XRN1,PARN,EIF4A2
R-HSA-977606	Regulation of Complement cascade	0.599071192783101	-0.512374835202735	24	2	0.00296296296296296	675	8202	1604,717	CD55,C2
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.599071192783101	-0.512374835202735	24	2	0.00296296296296296	675	8202	8309,80270	ACOX2,HSD3B7
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.600666177147915	-0.509715944441371	63	5	0.00740740740740741	675	8202	4331,5984,5983,902,728340	MNAT1,RFC4,RFC3,CCNH,GTF2H2C
R-HSA-428157	Sphingolipid metabolism	0.603472546805606	-0.505054729445106	76	6	0.00888888888888889	675	8202	55512,412,253782,8613,224,259230	SMPD3,STS,CERS6,PLPP3,ALDH3A2,SGMS1
R-HSA-416476	G alpha (q) signalling events	0.606639268613046	-0.499820950226069	190	15	0.0222222222222222	675	8202	5581,2869,2792,7204,5332,8527,10911,1608,11343,5330,23236,23566,257313,3269,84634	PRKCE,GRK5,GNGT1,TRIO,PLCB4,DGKD,UTS2,DGKG,MGLL,PLCB2,PLCB1,LPAR3,UTS2B,HRH1,KISS1R
R-HSA-2172127	DAP12 interactions	0.608223489199241	-0.497212883637481	340	27	0.04	675	8202	6712,200734,8831,2247,3164,5922,1950,27161,1852,5682,9542,283455,5577,23239,2309,5291,57731,9965,1847,5581,8660,57761,2534,53358,10000,109,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,AGO2,DUSP9,PSMA1,NRG2,KSR2,PRKAR2B,PHLPP1,FOXO3,PIK3CB,SPTBN4,FGF19,DUSP5,PRKCE,IRS2,TRIB3,FYN,SHC3,AKT3,ADCY3,ARRB2
R-HSA-162587	HIV Life Cycle	0.609576837413126	-0.494990271701125	140	11	0.0162962962962963	675	8202	4331,23225,902,728340,8731,22916,6875,8732,7518,11168,81929	MNAT1,NUP210,CCNH,GTF2H2C,RNMT,NCBP2,TAF4B,RNGTT,XRCC4,PSIP1,SEH1L
R-HSA-69278	Cell Cycle, Mitotic	0.611009210835169	-0.492643244907525	477	38	0.0562962962962963	675	8202	80321,5520,23175,10382,23225,10783,55835,4609,8379,80254,1021,10426,81929,10051,7277,5984,5983,902,5558,10274,328,7846,140609,5422,5682,64105,55869,5577,4171,401541,4331,23421,22981,10806,1869,7029,7840,7443	CEP70,PPP2R2A,LPIN1,TUBB4A,NUP210,NEK6,CENPJ,MYC,MAD1L1,CEP63,CDK6,TUBGCP3,SEH1L,SMC4,TUBA4A,RFC4,RFC3,CCNH,PRIM2,STAG1,APEX1,TUBA1A,NEK7,POLA1,PSMA1,CENPK,HDAC8,PRKAR2B,MCM2,CENPP,MNAT1,ITGB3BP,NINL,SDCCAG8,E2F1,TFDP2,ALMS1,VRK1
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	8833	GMPS
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	10426	TUBGCP3
R-HSA-5625970	RHO GTPases activate KTN1	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	3798	KIF5A
R-HSA-2485179	Activation of the phototransduction cascade	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-68689	CDC6 association with the ORC:origin complex	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	1869	E2F1
R-HSA-376172	DSCAM interactions	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	5599	MAPK8
R-HSA-1980148	Signaling by NOTCH3	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	3714	JAG2
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	10274	STAG1
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	170506	DHX36
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	166785	MMAA
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	10051	SMC4
R-HSA-189451	Heme biosynthesis	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	1352	COX10
R-HSA-196807	Nicotinate metabolism	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	349565	NMNAT3
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-1980150	Signaling by NOTCH4	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	3714	JAG2
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.611436262966277	-0.491944559922988	11	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-1483255	PI Metabolism	0.614299994203906	-0.487271880247538	51	4	0.00592592592592593	675	8202	5297,5291,5305,30849	PI4KA,PIK3CB,PIP4K2A,PIK3R4
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.614299994203906	-0.487271880247538	51	4	0.00592592592592593	675	8202	5581,109,5577,2247	PRKCE,ADCY3,PRKAR2B,FGF2
R-HSA-6782135	Dual incision in TC-NER	0.614887686658348	-0.486315651173048	64	5	0.00740740740740741	675	8202	4331,5984,5983,902,728340	MNAT1,RFC4,RFC3,CCNH,GTF2H2C
R-HSA-166658	Complement cascade	0.61565427573515	-0.485069713692819	38	3	0.00444444444444444	675	8202	716,1604,717	C1S,CD55,C2
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.61565427573515	-0.485069713692819	38	3	0.00444444444444444	675	8202	3840,23225,81929	KPNA4,NUP210,SEH1L
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	2550,2792	GABBR1,GNGT1
R-HSA-1296059	G protein gated Potassium channels	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	2550,2792	GABBR1,GNGT1
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	23556,54965	PIGN,PIGX
R-HSA-1538133	G0 and Early G1	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	7029,1869	TFDP2,E2F1
R-HSA-982772	Growth hormone receptor signaling	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	8660,8835	IRS2,SOCS2
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	2180,79993	ACSL1,ELOVL7
R-HSA-1296041	Activation of G protein gated Potassium channels	0.621653766080666	-0.475371987400518	25	2	0.00296296296296296	675	8202	2550,2792	GABBR1,GNGT1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.628673513073622	-0.464143214155132	142	11	0.0162962962962963	675	8202	6196,2898,84254,80852,2550,2792,1739,109,1741,5330,23236	RPS6KA2,GRIK2,CAMKK1,GRIP2,GABBR1,GNGT1,DLG1,ADCY3,DLG3,PLCB2,PLCB1
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.628808385670593	-0.463928701965935	65	5	0.00740740740740741	675	8202	4331,22916,902,6875,728340	MNAT1,NCBP2,CCNH,TAF4B,GTF2H2C
R-HSA-1268020	Mitochondrial protein import	0.629827266372001	-0.462309677552768	52	4	0.00592592592592593	675	8202	131118,10651,10165,134266	DNAJC19,MTX2,SLC25A13,GRPEL2
R-HSA-6783310	Fanconi Anemia Pathway	0.63349212137785	-0.456507715955186	39	3	0.00444444444444444	675	8202	55120,545,2178	FANCL,ATR,FANCE
R-HSA-977444	GABA B receptor activation	0.63349212137785	-0.456507715955186	39	3	0.00444444444444444	675	8202	109,2550,2792	ADCY3,GABBR1,GNGT1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.63349212137785	-0.456507715955186	39	3	0.00444444444444444	675	8202	85007,2639,89874	PHYKPL,GCDH,SLC25A21
R-HSA-991365	Activation of GABAB receptors	0.63349212137785	-0.456507715955186	39	3	0.00444444444444444	675	8202	109,2550,2792	ADCY3,GABBR1,GNGT1
R-HSA-165159	mTOR signalling	0.63349212137785	-0.456507715955186	39	3	0.00444444444444444	675	8202	5563,1978,6009	PRKAA2,EIF4EBP1,RHEB
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.63349212137785	-0.456507715955186	39	3	0.00444444444444444	675	8202	23145,9509,170690	SSPO,ADAMTS2,ADAMTS16
R-HSA-170984	ARMS-mediated activation	0.639944197029654	-0.44637429857104	232	18	0.0266666666666667	675	8202	6712,200734,8831,2247,5922,4914,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-187706	Signalling to p38 via RIT and RIN	0.639944197029654	-0.44637429857104	232	18	0.0266666666666667	675	8202	6712,200734,8831,2247,5922,4914,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.642420525449344	-0.442512165662405	66	5	0.00740740740740741	675	8202	9208,4361,170506,340061,10622	LRRFIP1,MRE11A,DHX36,TMEM173,POLR3G
R-HSA-451927	Interleukin-2 signaling	0.642710713039425	-0.442060557941229	245	19	0.0281481481481481	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,9542,283455,5291,57731,9965,1847,8660,2534,53358,2185,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,NRG2,KSR2,PIK3CB,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,PTK2B,ARRB2
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-3781865	Diseases of glycosylation	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-1474165	Reproduction	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	79820,7784	CATSPERB,ZP3
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	3339,6382	HSPG2,SDC1
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	10616,329	RBCK1,BIRC2
R-HSA-1187000	Fertilization	0.643241200083817	-0.441235508312125	26	2	0.00296296296296296	675	8202	79820,7784	CATSPERB,ZP3
R-HSA-2160916	Hyaluronan uptake and degradation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	6548	SLC9A1
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-190373	FGFR1c ligand binding and activation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-390666	Serotonin receptors	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	3363	HTR7
R-HSA-210990	PECAM1 interactions	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2534	FYN
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	3516	RBPJ
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	60490	PPCDC
R-HSA-73621	Pyrimidine catabolism	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	7378	UPP1
R-HSA-71384	Ethanol oxidation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	217	ALDH2
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	328	APEX1
R-HSA-211958	Miscellaneous substrates	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	57834	CYP4F11
R-HSA-176974	Unwinding of DNA	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	4171	MCM2
R-HSA-190239	FGFR3 ligand binding and activation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-166786	Creation of C4 and C2 activators	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	716	C1S
R-HSA-844456	The NLRP3 inflammasome	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	5027	P2RX7
R-HSA-211979	Eicosanoids	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	57834	CYP4F11
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2644	GCHFR
R-HSA-190372	FGFR3c ligand binding and activation	0.643456837080345	-0.44090032943982	12	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-187687	Signalling to ERKs	0.649824449594817	-0.431053030116398	246	19	0.0281481481481481	675	8202	6712,200734,2889,8831,2247,5922,4914,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,RAPGEF1,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-168253	Host Interactions with Influenza Factors	0.650746339533544	-0.429635360119758	40	3	0.00444444444444444	675	8202	3840,23225,81929	KPNA4,NUP210,SEH1L
R-HSA-5696400	Dual Incision in GG-NER	0.650746339533544	-0.429635360119758	40	3	0.00444444444444444	675	8202	5984,5983,728340	RFC4,RFC3,GTF2H2C
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.650746339533544	-0.429635360119758	40	3	0.00444444444444444	675	8202	348,117156,949	APOE,SCGB3A2,SCARB1
R-HSA-69306	DNA Replication	0.653357718261094	-0.425630492253181	106	8	0.0118518518518519	675	8202	5984,5983,328,5558,5422,1869,5682,4171	RFC4,RFC3,APEX1,PRIM2,POLA1,E2F1,PSMA1,MCM2
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.659657275670464	-0.416034858121023	54	4	0.00592592592592593	675	8202	90161,3339,6382,266722	HS6ST2,HSPG2,SDC1,HS6ST3
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.661196164857169	-0.413704713328603	424	33	0.0488888888888889	675	8202	6712,200734,2869,5922,2792,1950,7204,9542,8527,1847,9965,23566,5581,6196,53358,10911,1608,11343,5330,8831,2247,1852,283455,5682,23236,57731,257313,84634,8660,2534,5332,409,3269	SPTBN2,SPRED2,GRK5,RASA2,GNGT1,EGF,TRIO,NRG2,DGKD,DUSP5,FGF19,LPAR3,PRKCE,RPS6KA2,SHC3,UTS2,DGKG,MGLL,PLCB2,SYNGAP1,FGF2,DUSP9,KSR2,PSMA1,PLCB1,SPTBN4,UTS2B,KISS1R,IRS2,FYN,PLCB4,ARRB2,HRH1
R-HSA-2871796	FCERI mediated MAPK activation	0.663836584601063	-0.409719267323651	248	19	0.0281481481481481	675	8202	5599,6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,5062,409	MAPK8,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,PAK2,ARRB2
R-HSA-192105	Synthesis of bile acids and bile salts	0.663844103463056	-0.409707941012948	27	2	0.00296296296296296	675	8202	8309,80270	ACOX2,HSD3B7
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.663844103463056	-0.409707941012948	27	2	0.00296296296296296	675	8202	90249,9500	UNC5A,MAGED1
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.667413319244319	-0.404345755950127	41	3	0.00444444444444444	675	8202	6907,79718,5465	TBL1X,TBL1XR1,PPARA
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.667413319244319	-0.404345755950127	41	3	0.00444444444444444	675	8202	109,6196,84254	ADCY3,RPS6KA2,CAMKK1
R-HSA-75893	TNF signaling	0.667413319244319	-0.404345755950127	41	3	0.00444444444444444	675	8202	55512,10616,329	SMPD3,RBCK1,BIRC2
R-HSA-70153	Glucose transport	0.667413319244319	-0.404345755950127	41	3	0.00444444444444444	675	8202	23225,81929,3099	NUP210,SEH1L,HK2
R-HSA-2029481	FCGR activation	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	2534	FYN
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	1803	DPP4
R-HSA-350054	Notch-HLH transcription pathway	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	3516	RBPJ
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	10000	AKT3
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	170506	DHX36
R-HSA-74217	Purine salvage	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	132	ADK
R-HSA-209543	p75NTR recruits signalling complexes	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	5584	PRKCI
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	30849	PIK3R4
R-HSA-1483213	Synthesis of PE	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	23175	LPIN1
R-HSA-190375	FGFR2c ligand binding and activation	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-1663150	The activation of arylsulfatases	0.672842262598052	-0.396244356306271	13	1	0.00148148148148148	675	8202	412	STS
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.673666394961555	-0.395020253569486	121	9	0.0133333333333333	675	8202	5599,466,1759,6196,3684,51295,9252,329,4208	MAPK8,ATF1,DNM1,RPS6KA2,ITGAM,ECSIT,RPS6KA5,BIRC2,MEF2C
R-HSA-6784531	tRNA processing in the nucleus	0.673948693156909	-0.394601293879925	55	4	0.00592592592592593	675	8202	10556,23225,116461,81929	RPP30,NUP210,TSEN15,SEH1L
R-HSA-68877	Mitotic Prometaphase	0.674101634595177	-0.394374386270059	108	8	0.0118518518518519	675	8202	10274,23421,8379,64105,55869,81929,401541,10051	STAG1,ITGB3BP,MAD1L1,CENPK,HDAC8,SEH1L,CENPP,SMC4
R-HSA-948021	Transport to the Golgi and subsequent modification	0.675268887366895	-0.392644315775904	95	7	0.0103703703703704	675	8202	23243,83696,149111,6480,4249,4253,9331	ANKRD28,TRAPPC9,CNIH3,ST6GAL1,MGAT5,CTAGE5,B4GALT6
R-HSA-2682334	EPH-Ephrin signaling	0.675268887366895	-0.392644315775904	95	7	0.0103703703703704	675	8202	1759,2534,64283,2047,7422,5062,2043	DNM1,FYN,ARHGEF28,EPHB1,VEGFA,PAK2,EPHA4
R-HSA-168249	Innate Immune System	0.676935545005093	-0.390179217389475	752	59	0.0874074074074074	675	8202	5599,9208,6712,200734,3684,5922,1950,27161,5646,30849,9542,5027,23239,9252,2309,329,8411,1847,9965,5581,466,6196,53358,5062,109,4361,717,8398,4644,10152,5530,1759,1604,8831,2247,3164,51295,1852,5682,9140,283455,4773,5577,5291,57731,7462,10622,8660,57761,2534,644150,10000,84166,716,5337,409,170506,340061,4208	MAPK8,LRRFIP1,SPTBN2,SPRED2,ITGAM,RASA2,EGF,AGO2,PRSS3,PIK3R4,NRG2,P2RX7,PHLPP1,RPS6KA5,FOXO3,BIRC2,EEA1,DUSP5,FGF19,PRKCE,ATF1,RPS6KA2,SHC3,PAK2,ADCY3,MRE11A,C2,PLA2G6,MYO5A,ABI2,PPP3CA,DNM1,CD55,SYNGAP1,FGF2,NR4A1,ECSIT,DUSP9,PSMA1,ATG12,KSR2,NFATC2,PRKAR2B,PIK3CB,SPTBN4,LAT2,POLR3G,IRS2,TRIB3,FYN,WIPF3,AKT3,NLRC5,C1S,PLD1,ARRB2,DHX36,TMEM173,MEF2C
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.677498944135603	-0.38934728470093	82	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.677498944135603	-0.38934728470093	82	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.677498944135603	-0.38934728470093	82	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-912526	Interleukin receptor SHC signaling	0.682722586465935	-0.381666671077139	238	18	0.0266666666666667	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,5291,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PIK3CB,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.683478074259918	-0.380560701957509	28	2	0.00296296296296296	675	8202	10302,10622	SNAPC5,POLR3G
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.683478074259918	-0.380560701957509	28	2	0.00296296296296296	675	8202	2534,5062	FYN,PAK2
R-HSA-111933	Calmodulin induced events	0.683478074259918	-0.380560701957509	28	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-111997	CaM pathway	0.683478074259918	-0.380560701957509	28	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.683478074259918	-0.380560701957509	28	2	0.00296296296296296	675	8202	5563,6009	PRKAA2,RHEB
R-HSA-202040	G-protein activation	0.683478074259918	-0.380560701957509	28	2	0.00296296296296296	675	8202	2781,2792	GNAZ,GNGT1
R-HSA-3928662	EPHB-mediated forward signaling	0.683492229437352	-0.380539991664979	42	3	0.00444444444444444	675	8202	2534,64283,2047	FYN,ARHGEF28,EPHB1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.683492229437352	-0.380539991664979	42	3	0.00444444444444444	675	8202	5577,2792,3790	PRKAR2B,GNGT1,KCNS3
R-HSA-69206	G1/S Transition	0.684185209532096	-0.379526623842565	109	8	0.0118518518518519	675	8202	4331,902,5558,5422,4609,1869,5682,4171	MNAT1,CCNH,PRIM2,POLA1,MYC,E2F1,PSMA1,MCM2
R-HSA-3000178	ECM proteoglycans	0.687819643865195	-0.374228620959718	56	4	0.00592592592592593	675	8202	7042,3687,3673,7148	TGFB2,ITGAX,ITGA2,TNXB
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.688928182384513	-0.372618247966572	83	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-167044	Signalling to RAS	0.689571616901622	-0.371684719265051	239	18	0.0266666666666667	675	8202	6712,200734,8831,2247,5922,4914,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	5742	PTGS1
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	10274	STAG1
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-428540	Activation of Rac	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	5062	PAK2
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	4437	MSH3
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	109	ADCY3
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	80270	HSD3B7
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	109	ADCY3
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	5467	PPARD
R-HSA-5675482	Regulation of necroptotic cell death	0.699809105027286	-0.356947688233954	14	1	0.00148148148148148	675	8202	329	BIRC2
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-180336	SHC1 events in EGFR signaling	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-5673001	RAF/MAP kinase cascade	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-179812	GRB2 events in EGFR signaling	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-112412	SOS-mediated signalling	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.702080436557258	-0.353707299529944	228	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.702162809139826	-0.353589979994437	29	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-375170	CDO in myogenesis	0.702162809139826	-0.353589979994437	29	2	0.00296296296296296	675	8202	4209,4208	MEF2D,MEF2C
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.702162809139826	-0.353589979994437	29	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-445355	Smooth Muscle Contraction	0.702162809139826	-0.353589979994437	29	2	0.00296296296296296	675	8202	10580,4638	SORBS1,MYLK
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.702162809139826	-0.353589979994437	29	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-525793	Myogenesis	0.702162809139826	-0.353589979994437	29	2	0.00296296296296296	675	8202	4209,4208	MEF2D,MEF2C
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.703016835762873	-0.352374439004644	241	18	0.0266666666666667	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,7422,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,VEGFA,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.704046005950964	-0.350911575597107	254	19	0.0281481481481481	675	8202	6712,200734,2889,8831,2247,5922,1950,1852,5682,9542,283455,5291,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,RAPGEF1,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,NRG2,KSR2,PIK3CB,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-69239	Synthesis of DNA	0.706675591665247	-0.347183570348971	98	7	0.0103703703703704	675	8202	5682,5984,5983,328,5558,4171,5422	PSMA1,RFC4,RFC3,APEX1,PRIM2,MCM2,POLA1
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.708859152812152	-0.344098428303012	229	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.708859152812152	-0.344098428303012	229	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.708859152812152	-0.344098428303012	229	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.708859152812152	-0.344098428303012	229	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.713894713116202	-0.337019788137505	44	3	0.00444444444444444	675	8202	4331,902,728340	MNAT1,CCNH,GTF2H2C
R-HSA-76002	Platelet activation, signaling and aggregation	0.71554560741393	-0.334709939998997	230	17	0.0251851851851852	675	8202	7273,10257,2792,1950,8527,7042,7422,5291,5581,2534,10000,1191,11343,1608,409,3481,7277	TTN,ABCC4,GNGT1,EGF,DGKD,TGFB2,VEGFA,PIK3CB,PRKCE,FYN,AKT3,CLU,MGLL,DGKG,ARRB2,IGF2,TUBA4A
R-HSA-399719	Trafficking of AMPA receptors	0.719921325131778	-0.328613343592817	30	2	0.00296296296296296	675	8202	80852,1739	GRIP2,DLG1
R-HSA-111996	Ca-dependent events	0.719921325131778	-0.328613343592817	30	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-5656169	Termination of translesion DNA synthesis	0.719921325131778	-0.328613343592817	30	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.719921325131778	-0.328613343592817	30	2	0.00296296296296296	675	8202	4773,5530	NFATC2,PPP3CA
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.719921325131778	-0.328613343592817	30	2	0.00296296296296296	675	8202	80852,1739	GRIP2,DLG1
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	54464	XRN1
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	23175	LPIN1
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	80270	HSD3B7
R-HSA-211935	Fatty acids	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	57834	CYP4F11
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	340061	TMEM173
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	10000	AKT3
R-HSA-901042	Calnexin/calreticulin cycle	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	55757	UGGT2
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	1869	E2F1
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	22943	DKK1
R-HSA-5358508	Mismatch Repair	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	4437	MSH3
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.724556156093586	-0.322196010089081	15	1	0.00148148148148148	675	8202	409	ARRB2
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.726460785302595	-0.31957077498873	100	7	0.0103703703703704	675	8202	55869,64105,10274,23421,81929,401541,8379	HDAC8,CENPK,STAG1,ITGB3BP,SEH1L,CENPP,MAD1L1
R-HSA-162599	Late Phase of HIV Life Cycle	0.728402958984546	-0.31690086882976	127	9	0.0133333333333333	675	8202	4331,23225,902,728340,8731,22916,6875,8732,81929	MNAT1,NUP210,CCNH,GTF2H2C,RNMT,NCBP2,TAF4B,RNGTT,SEH1L
R-HSA-5663220	RHO GTPases Activate Formins	0.731621096395155	-0.312492526911855	114	8	0.0118518518518519	675	8202	23421,8379,64105,81624,5217,114793,81929,401541	ITGB3BP,MAD1L1,CENPK,DIAPH3,PFN2,FMNL2,SEH1L,CENPP
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.736779281412067	-0.305466914126868	31	2	0.00296296296296296	675	8202	2247,9965	FGF2,FGF19
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.736779281412067	-0.305466914126868	31	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.736779281412067	-0.305466914126868	31	2	0.00296296296296296	675	8202	4316,7077	MMP7,TIMP2
R-HSA-70171	Glycolysis	0.736779281412067	-0.305466914126868	31	2	0.00296296296296296	675	8202	5207,3099	PFKFB1,HK2
R-HSA-5357905	Regulation of TNFR1 signaling	0.736779281412067	-0.305466914126868	31	2	0.00296296296296296	675	8202	10616,329	RBCK1,BIRC2
R-HSA-180746	Nuclear import of Rev protein	0.736779281412067	-0.305466914126868	31	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-5684996	MAPK1/MAPK3 signaling	0.741350786653959	-0.299281369408584	234	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-73893	DNA Damage Bypass	0.741992258635141	-0.298416468975461	46	3	0.00444444444444444	675	8202	5984,5983,56852	RFC4,RFC3,RAD18
R-HSA-5687128	MAPK6/MAPK4 signaling	0.74200027761096	-0.298405661676067	88	6	0.00888888888888889	675	8202	5682,10602,2309,4609,5062,27161	PSMA1,CDC42EP3,FOXO3,MYC,PAK2,AGO2
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	57634	EP400
R-HSA-193639	p75NTR signals via NF-kB	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	5584	PRKCI
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	5599	MAPK8
R-HSA-5218859	Regulated Necrosis	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	329	BIRC2
R-HSA-446353	Cell-extracellular matrix interactions	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	55679	LIMS2
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	80852	GRIP2
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	329	BIRC2
R-HSA-190242	FGFR1 ligand binding and activation	0.747265890384003	-0.2913342128933	16	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.752764389896852	-0.284002995367471	32	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.752764389896852	-0.284002995367471	32	2	0.00296296296296296	675	8202	409,2792	ARRB2,GNGT1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.752764389896852	-0.284002995367471	32	2	0.00296296296296296	675	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-2586552	Signaling by Leptin	0.753678978103773	-0.282788760118117	236	17	0.0251851851851852	675	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,57731,9965,1847,8660,2534,53358,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,SPTBN4,FGF19,DUSP5,IRS2,FYN,SHC3,ARRB2
R-HSA-189200	Hexose transport	0.755196507763384	-0.280777288415532	47	3	0.00444444444444444	675	8202	23225,81929,3099	NUP210,SEH1L,HK2
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.762215702538067	-0.271525689156493	62	4	0.00592592592592593	675	8202	5563,8773,4644,60412	PRKAA2,SNAP23,MYO5A,EXOC4
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.765209652342219	-0.267605427352603	145	10	0.0148148148148148	675	8202	4331,902,9014,1107,728340,4774,4782,10302,4784,10622	MNAT1,CCNH,TAF1B,CHD3,GTF2H2C,NFIA,NFIC,SNAPC5,NFIX,POLR3G
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.767851178030217	-0.264159343218454	48	3	0.00444444444444444	675	8202	5291,10000,2792	PIK3CB,AKT3,GNGT1
R-HSA-73887	Death Receptor Signalling	0.767851178030217	-0.264159343218454	48	3	0.00444444444444444	675	8202	55512,10616,329	SMPD3,RBCK1,BIRC2
R-HSA-73847	Purine metabolism	0.767905904742188	-0.26408807320758	33	2	0.00296296296296296	675	8202	8833,132	GMPS,ADK
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.767905904742188	-0.26408807320758	33	2	0.00296296296296296	675	8202	2247,57167	FGF2,SALL4
R-HSA-4085001	Sialic acid metabolism	0.767905904742188	-0.26408807320758	33	2	0.00296296296296296	675	8202	256435,6480	ST6GALNAC3,ST6GAL1
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.767905904742188	-0.26408807320758	33	2	0.00296296296296296	675	8202	5291,5305	PIK3CB,PIP4K2A
R-HSA-5694530	Cargo concentration in the ER	0.767905904742188	-0.26408807320758	33	2	0.00296296296296296	675	8202	149111,4253	CNIH3,CTAGE5
R-HSA-163359	Glucagon signaling in metabolic regulation	0.767905904742188	-0.26408807320758	33	2	0.00296296296296296	675	8202	109,5577	ADCY3,PRKAR2B
R-HSA-2033519	Activated point mutants of FGFR2	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-1839126	FGFR2 mutant receptor activation	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	55757	UGGT2
R-HSA-622312	Inflammasomes	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	5027	P2RX7
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	54464	XRN1
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	5073	PARN
R-HSA-189445	Metabolism of porphyrins	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	1352	COX10
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	329	BIRC2
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	54464	XRN1
R-HSA-432142	Platelet sensitization by LDL	0.768105802931309	-0.26382779108961	17	1	0.00148148148148148	675	8202	7804	LRP8
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.770687169198072	-0.260472734581133	77	5	0.00740740740740741	675	8202	4331,5984,5983,902,728340	MNAT1,RFC4,RFC3,CCNH,GTF2H2C
R-HSA-2559580	Oxidative Stress Induced Senescence	0.773977744902813	-0.256212159161334	119	8	0.0118518518518519	675	8202	23135,5599,80012,9448,1869,22955,648,1021	KDM6B,MAPK8,PHC3,MAP4K4,E2F1,SCMH1,BMI1,CDK6
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.779545567694958	-0.249044134598326	92	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.779545567694958	-0.249044134598326	92	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.779545567694958	-0.249044134598326	92	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.779545567694958	-0.249044134598326	92	6	0.00888888888888889	675	8202	5599,466,6196,9252,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,ECSIT,MEF2C
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.780381240508239	-0.247972708825233	78	5	0.00740740740740741	675	8202	6907,79718,23097,9442,5465	TBL1X,TBL1XR1,CDK19,MED27,PPARA
R-HSA-4791275	Signaling by WNT in cancer	0.782234181794345	-0.245601118057422	34	2	0.00296296296296296	675	8202	6934,22943	TCF7L2,DKK1
R-HSA-1222556	ROS production in response to bacteria	0.782234181794345	-0.245601118057422	34	2	0.00296296296296296	675	8202	90423,4842	ATP6V1E2,NOS1
R-HSA-177243	Interactions of Rev with host cellular proteins	0.782234181794345	-0.245601118057422	34	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.782234181794345	-0.245601118057422	34	2	0.00296296296296296	675	8202	8787,2792	RGS9,GNGT1
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.782234181794345	-0.245601118057422	34	2	0.00296296296296296	675	8202	9140,84166	ATG12,NLRC5
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.787229637127555	-0.239235285162706	18	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-5635838	Activation of SMO	0.787229637127555	-0.239235285162706	18	1	0.00148148148148148	675	8202	409	ARRB2
R-HSA-73780	RNA Polymerase III Chain Elongation	0.787229637127555	-0.239235285162706	18	1	0.00148148148148148	675	8202	10622	POLR3G
R-HSA-73857	RNA Polymerase II Transcription	0.788362862227688	-0.237796810054449	107	7	0.0103703703703704	675	8202	4331,22916,902,8732,6875,728340,8731	MNAT1,NCBP2,CCNH,RNGTT,TAF4B,GTF2H2C,RNMT
R-HSA-5358351	Signaling by Hedgehog	0.791312673259243	-0.234062100749957	135	9	0.0133333333333333	675	8202	2736,57539,55764,55733,5682,109,5577,339745,409	GLI2,WDR35,IFT122,HHAT,PSMA1,ADCY3,PRKAR2B,SPOPL,ARRB2
R-HSA-191859	snRNP Assembly	0.79155881142935	-0.233751098657276	50	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-194441	Metabolism of non-coding RNA	0.79155881142935	-0.233751098657276	50	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.79155881142935	-0.233751098657276	50	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-69202	Cyclin E associated events during G1/S transition	0.793878402711058	-0.230824974663103	65	4	0.00592592592592593	675	8202	5682,4331,902,4609	PSMA1,MNAT1,CCNH,MYC
R-HSA-2514856	The phototransduction cascade	0.795780299831761	-0.22843213647069	35	2	0.00296296296296296	675	8202	8787,2792	RGS9,GNGT1
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.795780299831761	-0.22843213647069	35	2	0.00296296296296296	675	8202	10302,10622	SNAPC5,POLR3G
R-HSA-194068	Bile acid and bile salt metabolism	0.795780299831761	-0.22843213647069	35	2	0.00296296296296296	675	8202	8309,80270	ACOX2,HSD3B7
R-HSA-72306	tRNA processing	0.796707125589465	-0.227268138755476	94	6	0.00888888888888889	675	8202	10556,54901,60487,23225,116461,81929	RPP30,CDKAL1,TRMT11,NUP210,TSEN15,SEH1L
R-HSA-162582	Signal Transduction	0.799436503425292	-0.2238481702182	2357	185	0.274074074074074	675	8202	6712,2736,3339,3798,1950,51701,9542,81624,10144,6382,115703,5327,329,23566,30011,84894,6196,53358,8379,109,81929,5796,1604,10616,1285,4914,8608,283455,728,5577,55869,64105,857,4919,6659,7422,6009,29,6498,644150,4638,26018,2185,7029,8829,409,90627,4208,5563,30817,2869,64411,5922,7204,2792,2550,4983,30849,90423,23239,7048,5217,1847,1293,10019,1123,5581,55512,6696,3480,6788,4609,5062,57522,5584,348,339745,1608,4543,5330,114793,10152,1759,2889,8831,7090,4242,5682,1852,84033,8630,5151,487,23236,6934,50940,23421,7060,55733,5332,23221,6907,5599,10602,51083,200734,9500,58504,8527,9372,26230,2781,9628,5144,9828,11343,57514,8085,10076,1894,26108,57731,8622,9148,3363,8660,2534,8607,9759,1978,343578,55764,25937,2887,797,7804,56288,59352,27161,1287,3714,5585,10267,9252,2309,9965,4734,84144,9734,466,58191,23263,10911,5046,51421,5530,4920,79718,2247,3164,9743,5140,5291,9901,257313,22943,84634,401541,5467,57761,8787,57539,7015,51741,10000,6259,1869,2914,101928168,2863,3516,23081,3481,3269,50649	SPTBN2,GLI2,HSPG2,KIF5A,EGF,NLK,NRG2,DIAPH3,FAM13A,SDC1,ARHGAP33,PLAT,BIRC2,LPAR3,SH3KBP1,LINGO1,RPS6KA2,SHC3,MAD1L1,ADCY3,SEH1L,PTPRK,CD55,RBCK1,COL4A3,NTRK1,RDH16,KSR2,C5AR1,PRKAR2B,HDAC8,CENPK,CAV1,ROR1,SOX4,VEGFA,RHEB,ABR,SKIL,WIPF3,MYLK,LRIG1,PTK2B,TFDP2,NRP1,ARRB2,STARD13,MEF2C,PRKAA2,ADGRE2,GRK5,ARAP3,RASA2,TRIO,GNGT1,GABBR1,OPHN1,PIK3R4,ATP6V1E2,PHLPP1,TGFBR2,PFN2,DUSP5,COL6A3,SH2B3,CHN1,PRKCE,SMPD3,SPP1,IGF1R,STK3,MYC,PAK2,SRGAP1,PRKCI,APOE,SPOPL,DGKG,MTNR1A,PLCB2,FMNL2,ABI2,DNM1,RAPGEF1,SYNGAP1,TLE3,MFNG,PSMA1,DUSP9,OBSCN,HSD17B6,PDE8A,ATP2A1,PLCB1,TCF7L2,PDE11A,ITGB3BP,THBS4,HHAT,PLCB4,RHOBTB2,TBL1X,MAPK8,CDC42EP3,GAL,SPRED2,MAGED1,ARHGAP22,DGKD,ZFYVE9,TIAM2,GNAZ,RGS6,PDE4D,ARHGEF17,MGLL,ARHGAP31,KMT2D,PTPRU,ECT2,PYGO1,SPTBN4,PDE8B,NEURL1,HTR7,IRS2,FYN,RUVBL1,HDAC4,EIF4EBP1,ARHGAP40,IFT122,WWTR1,GRB10,CALCB,LRP8,PARD3,LGR6,AGO2,COL4A5,JAG2,PKN1,RAMP1,RPS6KA5,FOXO3,FGF19,NEDD4,SYDE2,HDAC9,ATF1,CXCL16,MCF2L,UTS2,PCSK6,AMOTL2,PPP3CA,ROR2,TBL1XR1,FGF2,NR4A1,ARHGAP32,PDE3B,PIK3CB,SRGAP3,UTS2B,DKK1,KISS1R,CENPP,PPARD,TRIB3,RGS9,WDR35,TERT,WWOX,AKT3,RYK,E2F1,GRM4,LOC101928168,GPR39,RBPJ,KDM4C,IGF2,HRH1,ARHGEF4
R-HSA-449147	Signaling by Interleukins	0.803635005461395	-0.218610086186972	311	22	0.0325925925925926	675	8202	6712,200734,2889,8831,2247,5922,1950,1852,5682,9542,283455,3606,5291,57731,1847,9965,8660,2534,53358,2185,409,3556	SPTBN2,SPRED2,RAPGEF1,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,NRG2,KSR2,IL18,PIK3CB,SPTBN4,DUSP5,FGF19,IRS2,FYN,SHC3,PTK2B,ARRB2,IL1RAP
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.803649878655689	-0.218591578958489	66	4	0.00592592592592593	675	8202	5682,4331,902,4609	PSMA1,MNAT1,CCNH,MYC
R-HSA-5696398	Nucleotide Excision Repair	0.80397487126396	-0.218187264938423	109	7	0.0103703703703704	675	8202	4331,5984,5983,902,8607,728340,86	MNAT1,RFC4,RFC3,CCNH,RUVBL1,GTF2H2C,ACTL6A
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.80477851236178	-0.217188179344762	19	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-69618	Mitotic Spindle Checkpoint	0.80477851236178	-0.217188179344762	19	1	0.00148148148148148	675	8202	8379	MAD1L1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.80477851236178	-0.217188179344762	19	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-418360	Platelet calcium homeostasis	0.80477851236178	-0.217188179344762	19	1	0.00148148148148148	675	8202	487	ATP2A1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.80477851236178	-0.217188179344762	19	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-1643713	Signaling by EGFR in Cancer	0.80477851236178	-0.217188179344762	19	1	0.00148148148148148	675	8202	1950	EGF
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.80857573660949	-0.212480928892148	36	2	0.00296296296296296	675	8202	10152,644150	ABI2,WIPF3
R-HSA-69620	Cell Cycle Checkpoints	0.811022828809375	-0.209459076299428	179	12	0.0177777777777778	675	8202	5984,9577,5983,8379,5682,51720,4361,545,165918,9656,4171,3364	RFC4,BRE,RFC3,MAD1L1,PSMA1,UIMC1,MRE11A,ATR,RNF168,MDC1,MCM2,HUS1
R-HSA-5658442	Regulation of RAS by GAPs	0.813042405097376	-0.206972012003188	67	4	0.00592592592592593	675	8202	5682,200734,8831,5922	PSMA1,SPRED2,SYNGAP1,RASA2
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.813042405097376	-0.206972012003188	67	4	0.00592592592592593	675	8202	10195,256435,6480,79868	ALG3,ST6GALNAC3,ST6GAL1,ALG13
R-HSA-75153	Apoptotic execution  phase	0.813217705104142	-0.206756425325085	52	3	0.00444444444444444	675	8202	329,8428,5062	BIRC2,STK24,PAK2
R-HSA-15869	Metabolism of nucleotides	0.816014488391588	-0.203323168793807	82	5	0.00740740740740741	675	8202	7296,8833,131870,132,7378	TXNRD1,GMPS,NUDT16,ADK,UPP1
R-HSA-68874	M/G1 Transition	0.816014488391588	-0.203323168793807	82	5	0.00740740740740741	675	8202	5682,5558,4171,5422,1869	PSMA1,PRIM2,MCM2,POLA1,E2F1
R-HSA-69002	DNA Replication Pre-Initiation	0.816014488391588	-0.203323168793807	82	5	0.00740740740740741	675	8202	5682,5558,4171,5422,1869	PSMA1,PRIM2,MCM2,POLA1,E2F1
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.820496400423053	-0.197845755514566	97	6	0.00888888888888889	675	8202	5599,466,6196,9252,329,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,BIRC2,MEF2C
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.820496400423053	-0.197845755514566	97	6	0.00888888888888889	675	8202	5599,466,6196,9252,329,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,BIRC2,MEF2C
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.820496400423053	-0.197845755514566	97	6	0.00888888888888889	675	8202	5599,466,6196,9252,329,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,BIRC2,MEF2C
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.820652093242921	-0.197656019094082	37	2	0.00296296296296296	675	8202	5984,5983	RFC4,RFC3
R-HSA-1483191	Synthesis of PC	0.820881959037952	-0.19737595692149	20	1	0.00148148148148148	675	8202	23175	LPIN1
R-HSA-190241	FGFR2 ligand binding and activation	0.820881959037952	-0.19737595692149	20	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-388841	Costimulation by the CD28 family	0.822064166300217	-0.195936825780096	68	4	0.00592592592592593	675	8202	57761,2534,10000,5062	TRIB3,FYN,AKT3,PAK2
R-HSA-199977	ER to Golgi Anterograde Transport	0.822064166300217	-0.195936825780096	68	4	0.00592592592592593	675	8202	23243,83696,149111,4253	ANKRD28,TRAPPC9,CNIH3,CTAGE5
R-HSA-446203	Asparagine N-linked glycosylation	0.822499878590471	-0.195406943952991	181	12	0.0177777777777778	675	8202	23243,10195,6184,83696,149111,6480,79868,4253,55757,256435,4249,9331	ANKRD28,ALG3,RPN1,TRAPPC9,CNIH3,ST6GAL1,ALG13,CTAGE5,UGGT2,ST6GALNAC3,MGAT5,B4GALT6
R-HSA-166054	Activated TLR4 signalling	0.825721208302988	-0.191498082648227	112	7	0.0103703703703704	675	8202	5599,466,6196,9252,329,51295,4208	MAPK8,ATF1,RPS6KA2,RPS6KA5,BIRC2,ECSIT,MEF2C
R-HSA-5389840	Mitochondrial translation elongation	0.832013775132394	-0.183906281648476	84	5	0.00740740740740741	675	8202	56945,60488,85476,11222,57129	MRPS22,MRPS35,GFM1,MRPL3,MRPL47
R-HSA-5674135	MAP2K and MAPK activation	0.832040860885135	-0.183873727726079	38	2	0.00296296296296296	675	8202	283455,409	KSR2,ARRB2
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.832040860885135	-0.183873727726079	38	2	0.00296296296296296	675	8202	8607,86	RUVBL1,ACTL6A
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.832040860885135	-0.183873727726079	38	2	0.00296296296296296	675	8202	329,8428	BIRC2,STK24
R-HSA-114604	GPVI-mediated activation cascade	0.832940712670376	-0.182792812613086	54	3	0.00444444444444444	675	8202	2534,5291,10000	FYN,PIK3CB,AKT3
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.832940712670376	-0.182792812613086	54	3	0.00444444444444444	675	8202	6907,79718,5465	TBL1X,TBL1XR1,PPARA
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.832940712670376	-0.182792812613086	54	3	0.00444444444444444	675	8202	4331,902,728340	MNAT1,CCNH,GTF2H2C
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.832940712670376	-0.182792812613086	54	3	0.00444444444444444	675	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-5610787	Hedgehog 'off' state	0.835095948202513	-0.180208652705742	99	6	0.00888888888888889	675	8202	5682,109,5577,2736,57539,55764	PSMA1,ADCY3,PRKAR2B,GLI2,WDR35,IFT122
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.835658869066262	-0.179534800529191	21	1	0.00148148148148148	675	8202	55454	CSGALNACT2
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.835658869066262	-0.179534800529191	21	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.835658869066262	-0.179534800529191	21	1	0.00148148148148148	675	8202	59352	LGR6
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.835658869066262	-0.179534800529191	21	1	0.00148148148148148	675	8202	3481	IGF2
R-HSA-445144	Signal transduction by L1	0.835658869066262	-0.179534800529191	21	1	0.00148148148148148	675	8202	8829	NRP1
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.835658869066262	-0.179534800529191	21	1	0.00148148148148148	675	8202	7296	TXNRD1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.839029997973884	-0.175508818715627	70	4	0.00592592592592593	675	8202	64105,23421,8607,401541	CENPK,ITGB3BP,RUVBL1,CENPP
R-HSA-421837	Clathrin derived vesicle budding	0.839029997973884	-0.175508818715627	70	4	0.00592592592592593	675	8202	1777,152503,8773,7037	DNASE2,SH3D19,SNAP23,TFRC
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.839029997973884	-0.175508818715627	70	4	0.00592592592592593	675	8202	1777,152503,8773,7037	DNASE2,SH3D19,SNAP23,TFRC
R-HSA-774815	Nucleosome assembly	0.839029997973884	-0.175508818715627	70	4	0.00592592592592593	675	8202	64105,23421,8607,401541	CENPK,ITGB3BP,RUVBL1,CENPP
R-HSA-2142753	Arachidonic acid metabolism	0.842113329183662	-0.171840678566933	55	3	0.00444444444444444	675	8202	1800,5742,57834	DPEP1,PTGS1,CYP4F11
R-HSA-977443	GABA receptor activation	0.842113329183662	-0.171840678566933	55	3	0.00444444444444444	675	8202	109,2550,2792	ADCY3,GABBR1,GNGT1
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.842773225187633	-0.171057366437104	39	2	0.00296296296296296	675	8202	2914,2550	GRM4,GABBR1
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.842773225187633	-0.171057366437104	39	2	0.00296296296296296	675	8202	54901,60487	CDKAL1,TRMT11
R-HSA-3214847	HATs acetylate histones	0.842827590272703	-0.170992861146657	143	9	0.0133333333333333	675	8202	8464,57634,8089,55167,8607,23522,9575,55689,86	SUPT3H,EP400,YEATS4,MSL2,RUVBL1,KAT6B,CLOCK,YEATS2,ACTL6A
R-HSA-446728	Cell junction organization	0.846861794756308	-0.166217767943323	86	5	0.00740740740740741	675	8202	55679,1366,56288,5584,3914	LIMS2,CLDN7,PARD3,PRKCI,LAMB3
R-HSA-5423646	Aflatoxin activation and detoxification	0.849218368299647	-0.163438919264911	22	1	0.00148148148148148	675	8202	1800	DPEP1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.849218368299647	-0.163438919264911	22	1	0.00148148148148148	675	8202	9140	ATG12
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.849218368299647	-0.163438919264911	22	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-5655332	Signaling by FGFR3 in disease	0.849218368299647	-0.163438919264911	22	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-5205647	Mitophagy	0.849218368299647	-0.163438919264911	22	1	0.00148148148148148	675	8202	9140	ATG12
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.849218368299647	-0.163438919264911	22	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.85084693401332	-0.161523032610897	56	3	0.00444444444444444	675	8202	8894,1978,1974	EIF2S2,EIF4EBP1,EIF4A2
R-HSA-1251985	Nuclear signaling by ERBB4	0.852879903366592	-0.159136534642391	40	2	0.00296296296296296	675	8202	9542,51741	NRG2,WWOX
R-HSA-5675221	Negative regulation of MAPK pathway	0.852879903366592	-0.159136534642391	40	2	0.00296296296296296	675	8202	1852,1847	DUSP9,DUSP5
R-HSA-1660662	Glycosphingolipid metabolism	0.852879903366592	-0.159136534642391	40	2	0.00296296296296296	675	8202	55512,412	SMPD3,STS
R-HSA-2559583	Cellular Senescence	0.853797588161813	-0.158061129490313	187	12	0.0177777777777778	675	8202	23135,5599,57634,6196,80012,9448,1869,4361,22955,648,2113,1021	KDM6B,MAPK8,EP400,RPS6KA2,PHC3,MAP4K4,E2F1,MRE11A,SCMH1,BMI1,ETS1,CDK6
R-HSA-373080	Class B/2 (Secretin family receptors)	0.853869661247368	-0.157976718331614	87	5	0.00740740740740741	675	8202	30817,797,1604,10267,2792	ADGRE2,CALCB,CD55,RAMP1,GNGT1
R-HSA-2132295	MHC class II antigen presentation	0.855189893027697	-0.156431737596871	102	6	0.00888888888888889	675	8202	3108,6712,1759,1780,3798,7879	HLA-DMA,SPTBN2,DNM1,DYNC1I1,KIF5A,RAB7A
R-HSA-109581	Apoptosis	0.858565769030845	-0.152491992340919	160	10	0.0148148148148148	675	8202	5599,5366,10000,9500,5062,1869,5682,90249,329,8428	MAPK8,PMAIP1,AKT3,MAGED1,PAK2,E2F1,PSMA1,UNC5A,BIRC2,STK24
R-HSA-72766	Translation	0.859366093640772	-0.15156026194437	146	9	0.0133333333333333	675	8202	58477,6184,6165,8893,8894,29927,1978,1974,6747	SRPRB,RPN1,RPL35A,EIF2B5,EIF2S2,SEC61A1,EIF4EBP1,EIF4A2,SSR3
R-HSA-1482839	Acyl chain remodelling of PE	0.861660617865057	-0.148893800618171	23	1	0.00148148148148148	675	8202	8398	PLA2G6
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.861660617865057	-0.148893800618171	23	1	0.00148148148148148	675	8202	6498	SKIL
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.861660617865057	-0.148893800618171	23	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-428930	Thromboxane signalling through TP receptor	0.861660617865057	-0.148893800618171	23	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.861660617865057	-0.148893800618171	23	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-168325	Viral Messenger RNA Synthesis	0.862391010236984	-0.148046503003972	41	2	0.00296296296296296	675	8202	23225,81929	NUP210,SEH1L
R-HSA-5620924	Intraflagellar transport	0.862391010236984	-0.148046503003972	41	2	0.00296296296296296	675	8202	57539,55764	WDR35,IFT122
R-HSA-195721	Signaling by Wnt	0.864965488448051	-0.145065670594112	326	22	0.0325925925925926	675	8202	5530,8085,4920,7090,27161,2792,5682,51701,857,4919,26108,6659,23236,6934,22943,8607,7015,4609,6259,409,5330,59352	PPP3CA,KMT2D,ROR2,TLE3,AGO2,GNGT1,PSMA1,NLK,CAV1,ROR1,PYGO1,SOX4,PLCB1,TCF7L2,DKK1,RUVBL1,TERT,MYC,RYK,ARRB2,PLCB2,LGR6
R-HSA-211945	Phase 1 - Functionalization of compounds	0.867085840512775	-0.142617298437376	89	5	0.00740740740740741	675	8202	8639,5742,217,4129,57834	AOC3,PTGS1,ALDH2,MAOB,CYP4F11
R-HSA-375280	Amine ligand-binding receptors	0.871335949285125	-0.13772767123058	42	2	0.00296296296296296	675	8202	3363,3269	HTR7,HRH1
R-HSA-70268	Pyruvate metabolism	0.873077549380389	-0.135730896182395	24	1	0.00148148148148148	675	8202	5467	PPARD
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.873077549380389	-0.135730896182395	24	1	0.00148148148148148	675	8202	329	BIRC2
R-HSA-73848	Pyrimidine metabolism	0.873077549380389	-0.135730896182395	24	1	0.00148148148148148	675	8202	7378	UPP1
R-HSA-5365859	RA biosynthesis pathway	0.873077549380389	-0.135730896182395	24	1	0.00148148148148148	675	8202	8608	RDH16
R-HSA-5357801	Programmed Cell Death	0.87315170680497	-0.135645961831006	163	10	0.0148148148148148	675	8202	5599,5366,10000,9500,5062,1869,5682,90249,329,8428	MAPK8,PMAIP1,AKT3,MAGED1,PAK2,E2F1,PSMA1,UNC5A,BIRC2,STK24
R-HSA-5368287	Mitochondrial translation	0.8733076330787	-0.13546739910059	90	5	0.00740740740740741	675	8202	56945,60488,85476,11222,57129	MRPS22,MRPS35,GFM1,MRPL3,MRPL47
R-HSA-3214858	RMTs methylate histone arginines	0.875588504527021	-0.132859042100492	75	4	0.00592592592592593	675	8202	1788,57492,86,6598	DNMT3A,ARID1B,ACTL6A,SMARCB1
R-HSA-4086400	PCP/CE pathway	0.879281029135016	-0.128650717792944	91	5	0.00740740740740741	675	8202	5682,4919,4920,409,6259	PSMA1,ROR1,ROR2,ARRB2,RYK
R-HSA-162906	HIV Infection	0.880629439592841	-0.127118354930583	221	14	0.0207407407407407	675	8202	4331,2534,23225,902,728340,8731,5062,5682,22916,6875,8732,7518,11168,81929	MNAT1,FYN,NUP210,CCNH,GTF2H2C,RNMT,PAK2,PSMA1,NCBP2,TAF4B,RNGTT,XRCC4,PSIP1,SEH1L
R-HSA-1482788	Acyl chain remodelling of PC	0.883553540365958	-0.123803388757482	25	1	0.00148148148148148	675	8202	8398	PLA2G6
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.883553540365958	-0.123803388757482	25	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-2262749	Cellular response to hypoxia	0.883553540365958	-0.123803388757482	25	1	0.00148148148148148	675	8202	7422	VEGFA
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.883553540365958	-0.123803388757482	25	1	0.00148148148148148	675	8202	7422	VEGFA
R-HSA-5362517	Signaling by Retinoic Acid	0.887640878703667	-0.11918803366237	44	2	0.00296296296296296	675	8202	5467,8608	PPARD,RDH16
R-HSA-421270	Cell-cell junction organization	0.888465043626237	-0.118259975294496	61	3	0.00444444444444444	675	8202	1366,56288,5584	CLDN7,PARD3,PRKCI
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.888465043626237	-0.118259975294496	61	3	0.00444444444444444	675	8202	10152,644150,4644	ABI2,WIPF3,MYO5A
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.893166033977763	-0.112982787081598	26	1	0.00148148148148148	675	8202	340061	TMEM173
R-HSA-983189	Kinesins	0.893166033977763	-0.112982787081598	26	1	0.00148148148148148	675	8202	3798	KIF5A
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.893166033977763	-0.112982787081598	26	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-77387	Insulin receptor recycling	0.893166033977763	-0.112982787081598	26	1	0.00148148148148148	675	8202	90423	ATP6V1E2
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.893166033977763	-0.112982787081598	26	1	0.00148148148148148	675	8202	10622	POLR3G
R-HSA-212165	Epigenetic regulation of gene expression	0.894295685031982	-0.111718814608675	124	7	0.0103703703703704	675	8202	200424,4331,1788,902,9014,728340,3720	TET3,MNAT1,DNMT3A,CCNH,TAF1B,GTF2H2C,JARID2
R-HSA-71291	Metabolism of amino acids and derivatives	0.89913296527573	-0.106324351914652	212	13	0.0192592592592593	675	8202	384,84706,440,29968,594,56922,89874,5682,85007,2639,26227,11112,587	ARG2,GPT2,ASNS,PSAT1,BCKDHB,MCCC1,SLC25A21,PSMA1,PHYKPL,GCDH,PHGDH,HIBADH,BCAT2
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.901986108220809	-0.103156160123689	27	1	0.00148148148148148	675	8202	10622	POLR3G
R-HSA-5655253	Signaling by FGFR2 in disease	0.901986108220809	-0.103156160123689	27	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-400685	Sema4D in semaphorin signaling	0.901986108220809	-0.103156160123689	27	1	0.00148148148148148	675	8202	4233	MET
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.90201284686298	-0.103126516379055	46	2	0.00296296296296296	675	8202	2180,79993	ACSL1,ELOVL7
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.908538017491186	-0.095918545580958	47	2	0.00296296296296296	675	8202	5027,329	P2RX7,BIRC2
R-HSA-68882	Mitotic Anaphase	0.909751396327775	-0.0945839076432583	172	10	0.0148148148148148	675	8202	10274,23421,8379,5682,5520,64105,55869,7443,81929,401541	STAG1,ITGB3BP,MAD1L1,PSMA1,PPP2R2A,CENPK,HDAC8,VRK1,SEH1L,CENPP
R-HSA-190828	Gap junction trafficking	0.910078998379247	-0.094223871833368	28	1	0.00148148148148148	675	8202	1759	DNM1
R-HSA-397014	Muscle contraction	0.912197598873251	-0.0918986469451744	65	3	0.00444444444444444	675	8202	7273,10580,4638	TTN,SORBS1,MYLK
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.913209175522767	-0.0907903167173514	173	10	0.0148148148148148	675	8202	10274,23421,8379,5682,5520,64105,55869,7443,81929,401541	STAG1,ITGB3BP,MAD1L1,PSMA1,PPP2R2A,CENPK,HDAC8,VRK1,SEH1L,CENPP
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.91736653792323	-0.0862481723881174	66	3	0.00444444444444444	675	8202	23243,83696,149111	ANKRD28,TRAPPC9,CNIH3
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.917504576573638	-0.0860977109746939	29	1	0.00148148148148148	675	8202	3801	KIFC3
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.917504576573638	-0.0860977109746939	29	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.917504576573638	-0.0860977109746939	29	1	0.00148148148148148	675	8202	7296	TXNRD1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.917504576573638	-0.0860977109746939	29	1	0.00148148148148148	675	8202	6196	RPS6KA2
R-HSA-1500620	Meiosis	0.92033003160786	-0.0830229432587334	115	6	0.00888888888888889	675	8202	4361,23345,545,5932,10274,27030	MRE11A,SYNE1,ATR,RBBP8,STAG1,MLH3
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.920386200234266	-0.082961914159895	49	2	0.00296296296296296	675	8202	5682,5062	PSMA1,PAK2
R-HSA-68867	Assembly of the pre-replicative complex	0.922256731664154	-0.08093164335698	67	3	0.00444444444444444	675	8202	5682,4171,1869	PSMA1,MCM2,E2F1
R-HSA-5419276	Mitochondrial translation termination	0.923536098977441	-0.079545390797182	84	4	0.00592592592592593	675	8202	56945,60488,11222,57129	MRPS22,MRPS35,MRPL3,MRPL47
R-HSA-5632684	Hedgehog 'on' state	0.923536098977441	-0.079545390797182	84	4	0.00592592592592593	675	8202	5682,2736,339745,409	PSMA1,GLI2,SPOPL,ARRB2
R-HSA-5368286	Mitochondrial translation initiation	0.923536098977441	-0.079545390797182	84	4	0.00592592592592593	675	8202	56945,60488,11222,57129	MRPS22,MRPS35,MRPL3,MRPL47
R-HSA-157858	Gap junction trafficking and regulation	0.924317792132531	-0.0786993355917573	30	1	0.00148148148148148	675	8202	1759	DNM1
R-HSA-420092	Glucagon-type ligand receptors	0.924317792132531	-0.0786993355917573	30	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-169911	Regulation of Apoptosis	0.925754008116072	-0.0771467296098079	50	2	0.00296296296296296	675	8202	5682,5062	PSMA1,PAK2
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.926881003903015	-0.0759300885351786	68	3	0.00444444444444444	675	8202	545,23225,81929	ATR,NUP210,SEH1L
R-HSA-1430728	Metabolism	0.928697706354936	-0.07397198994056	1691	125	0.185185185185185	675	8202	384,2548,349565,2180,57128,3339,91942,10165,133522,4711,56922,89874,2992,2639,6382,1352,253558,9435,7957,26230,23175,587,3705,440,23225,90161,1490,775,57834,5255,60490,3790,109,1312,8309,4129,6820,11343,81929,55454,10057,6580,7378,56261,9442,5577,857,4144,80270,23007,23097,253782,25937,406,949,9575,266722,10090,84706,5563,5207,115677,8639,79993,259230,5646,2792,30849,5297,29940,26227,5305,4724,55512,2644,783,622,348,6548,8833,215,5742,85007,776,5106,6812,5330,224,8398,9331,7296,9415,5096,217,412,29968,10243,79718,594,7003,5095,56895,5465,25830,5682,23236,5291,166785,131870,5467,57761,23576,9651,5091,8613,84649,3099,5332,1800,6907,5337,132,10331,9619,11112	ARG2,GAA,NMNAT3,ACSL1,LYRM4,HSPG2,NDUFAF2,SLC25A13,PPARGC1B,NDUFB5,MCCC1,SLC25A21,GYG1,GCDH,SDC1,COX10,LCLAT1,CHST2,EPM2A,TIAM2,LPIN1,BCAT2,ITPK1,ASNS,NUP210,HS6ST2,CTGF,CACNA1C,CYP4F11,PHKA1,PPCDC,KCNS3,ADCY3,COMT,ACOX2,MAOB,SULT2B1,MGLL,SEH1L,CSGALNACT2,ABCC5,SLC22A1,UPP1,GPCPD1,MED27,PRKAR2B,CAV1,MAT2A,HSD3B7,PLCH1,CDK19,CERS6,WWTR1,ARNTL,SCARB1,CLOCK,HS6ST3,UST,GPT2,PRKAA2,PFKFB1,NOSTRIN,AOC3,ELOVL7,SGMS1,PRSS3,GNGT1,PIK3R4,PI4KA,DSE,PHGDH,PIP4K2A,NDUFS4,SMPD3,GCHFR,CACNB2,BDH1,APOE,SLC9A1,GMPS,ABCD1,PTGS1,PHYKPL,CACNA1D,PCK2,STXBP1,PLCB2,ALDH3A2,PLA2G6,B4GALT6,TXNRD1,FADS2,PCCB,ALDH2,STS,PSAT1,GPHN,TBL1XR1,BCKDHB,TEAD1,PCCA,AGPAT4,PPARA,SULT4A1,PSMA1,PLCB1,PIK3CB,MMAA,NUDT16,PPARD,TRIB3,DDAH1,PLCH2,PC,PLPP3,DGAT2,HK2,PLCB4,DPEP1,TBL1X,PLD1,ADK,B3GNT3,ABCG1,HIBADH
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.930569075815871	-0.0719589704956715	31	1	0.00148148148148148	675	8202	857	CAV1
R-HSA-168638	NOD1/2 Signaling Pathway	0.930569075815871	-0.0719589704956715	31	1	0.00148148148148148	675	8202	329	BIRC2
R-HSA-913531	Interferon Signaling	0.932314415786267	-0.0700851651944359	194	11	0.0162962962962963	675	8202	3840,23225,1958,1974,8672,10346,9830,4734,3383,81929,3669	KPNA4,NUP210,EGR1,EIF4A2,EIF4G3,TRIM22,TRIM14,NEDD4,ICAM1,SEH1L,ISG20
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.935481630884281	-0.0666937690735149	52	2	0.00296296296296296	675	8202	256435,6480	ST6GALNAC3,ST6GAL1
R-HSA-392518	Signal amplification	0.936304710845377	-0.0658143097080974	32	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-202433	Generation of second messenger molecules	0.936304710845377	-0.0658143097080974	32	1	0.00148148148148148	675	8202	5062	PAK2
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.936304710845377	-0.0658143097080974	32	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-68875	Mitotic Prophase	0.938573872700165	-0.0633937124676404	136	7	0.0103703703703704	675	8202	23225,10783,7443,140609,81929,23175,10051	NUP210,NEK6,VRK1,NEK7,SEH1L,LPIN1,SMC4
R-HSA-73777	RNA Polymerase I Chain Elongation	0.9389319743846	-0.0630122471429562	88	4	0.00592592592592593	675	8202	4331,902,9014,728340	MNAT1,CCNH,TAF1B,GTF2H2C
R-HSA-933541	TRAF6 mediated IRF7 activation	0.941567173533443	-0.0602095860764009	33	1	0.00148148148148148	675	8202	170506	DHX36
R-HSA-72187	mRNA 3'-end processing	0.941567173533443	-0.0602095860764009	33	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.943993430838958	-0.0576360717178855	54	2	0.00296296296296296	675	8202	152503,7037	SH3D19,TFRC
R-HSA-201681	TCF dependent signaling in response to WNT	0.945557611954186	-0.0559804599486394	229	13	0.0192592592592593	675	8202	8085,8607,7015,7090,4609,6259,5682,857,26108,6659,6934,22943,59352	KMT2D,RUVBL1,TERT,TLE3,MYC,RYK,PSMA1,CAV1,PYGO1,SOX4,TCF7L2,DKK1,LGR6
R-HSA-5621481	C-type lectin receptors (CLRs)	0.946207527281266	-0.0552933605416679	123	6	0.00888888888888889	675	8202	5682,4773,5530,2534,9252,5062	PSMA1,NFATC2,PPP3CA,FYN,RPS6KA5,PAK2
R-HSA-390522	Striated Muscle Contraction	0.946395446022339	-0.0550947782247836	34	1	0.00148148148148148	675	8202	7273	TTN
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.946395446022339	-0.0550947782247836	34	1	0.00148148148148148	675	8202	2247	FGF2
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.94665883559138	-0.0548165087918373	107	5	0.00740740740740741	675	8202	58477,6747,6184,6165,29927	SRPRB,SSR3,RPN1,RPL35A,SEC61A1
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.94665883559138	-0.0548165087918373	107	5	0.00740740740740741	675	8202	4331,902,9014,1107,728340	MNAT1,CCNH,TAF1B,CHD3,GTF2H2C
R-HSA-72702	Ribosomal scanning and start codon recognition	0.94783796297928	-0.0535717164638218	55	2	0.00296296296296296	675	8202	8894,1974	EIF2S2,EIF4A2
R-HSA-72649	Translation initiation complex formation	0.94783796297928	-0.0535717164638218	55	2	0.00296296296296296	675	8202	8894,1974	EIF2S2,EIF4A2
R-HSA-1280215	Cytokine Signaling in Immune system	0.948807864122906	-0.0525489622792373	539	35	0.0518518518518519	675	8202	6712,200734,1958,5922,8835,1950,8672,9542,3606,10346,329,1847,9965,4734,3383,23225,53358,3556,9830,81929,2889,8831,2247,1974,1852,5682,283455,57731,5291,3669,8660,3840,2534,2185,409	SPTBN2,SPRED2,EGR1,RASA2,SOCS2,EGF,EIF4G3,NRG2,IL18,TRIM22,BIRC2,DUSP5,FGF19,NEDD4,ICAM1,NUP210,SHC3,IL1RAP,TRIM14,SEH1L,RAPGEF1,SYNGAP1,FGF2,EIF4A2,DUSP9,PSMA1,KSR2,SPTBN4,PIK3CB,ISG20,IRS2,KPNA4,FYN,PTK2B,ARRB2
R-HSA-432720	Lysosome Vesicle Biogenesis	0.950825303265609	-0.0504249312443924	35	1	0.00148148148148148	675	8202	1777	DNASE2
R-HSA-73864	RNA Polymerase I Transcription	0.952090101050763	-0.0490956047083429	109	5	0.00740740740740741	675	8202	4331,902,9014,1107,728340	MNAT1,CCNH,TAF1B,CHD3,GTF2H2C
R-HSA-168256	Immune System	0.952479906978274	-0.0486862672397171	1371	98	0.145185185185185	675	8202	5599,6712,200734,3798,8835,1950,9542,5027,3606,329,8411,30011,10225,23225,6196,53358,79876,109,7220,4361,717,3556,9830,81929,26259,1604,10616,7879,9140,283455,4773,5577,57731,7462,3669,8660,3108,2534,29927,644150,10533,2185,10477,409,3903,4208,9208,1958,5922,3684,5646,27161,30849,90423,8672,4842,10346,23239,1780,9252,2309,10666,9965,1847,4734,3383,5581,466,55070,5062,8398,4644,10152,1759,5530,2889,8831,25847,92369,2247,3164,1974,51295,7328,5682,1852,5291,10622,57761,3840,10000,84166,716,5337,126433,170506,340061,945	MAPK8,SPTBN2,SPRED2,KIF5A,SOCS2,EGF,NRG2,P2RX7,IL18,BIRC2,EEA1,SH3KBP1,CD96,NUP210,RPS6KA2,SHC3,UBA5,ADCY3,TRPC1,MRE11A,C2,IL1RAP,TRIM14,SEH1L,FBXW8,CD55,RBCK1,RAB7A,ATG12,KSR2,NFATC2,PRKAR2B,SPTBN4,LAT2,ISG20,IRS2,HLA-DMA,FYN,SEC61A1,WIPF3,ATG7,PTK2B,UBE2E3,ARRB2,LAIR1,MEF2C,LRRFIP1,EGR1,RASA2,ITGAM,PRSS3,AGO2,PIK3R4,ATP6V1E2,EIF4G3,NOS1,TRIM22,PHLPP1,DYNC1I1,RPS6KA5,FOXO3,CD226,FGF19,DUSP5,NEDD4,ICAM1,PRKCE,ATF1,DET1,PAK2,PLA2G6,MYO5A,ABI2,DNM1,PPP3CA,RAPGEF1,SYNGAP1,ANAPC13,SPSB4,FGF2,NR4A1,EIF4A2,ECSIT,UBE2H,PSMA1,DUSP9,PIK3CB,POLR3G,TRIB3,KPNA4,AKT3,NLRC5,C1S,PLD1,FBXO27,DHX36,TMEM173,CD33
R-HSA-69304	Regulation of DNA replication	0.952798895246251	-0.048351420422984	75	3	0.00444444444444444	675	8202	5682,4171,1869	PSMA1,MCM2,E2F1
R-HSA-1221632	Meiotic synapsis	0.952798895246251	-0.048351420422984	75	3	0.00444444444444444	675	8202	23345,545,10274	SYNE1,ATR,STAG1
R-HSA-162909	Host Interactions of HIV factors	0.956081825316083	-0.0449117782586499	127	6	0.00888888888888889	675	8202	5682,2534,23225,11168,81929,5062	PSMA1,FYN,NUP210,PSIP1,SEH1L,PAK2
R-HSA-2262752	Cellular responses to stress	0.956713494624145	-0.0442513110100752	379	23	0.0340740740740741	675	8202	7296,23135,5563,5599,57634,9821,9448,30849,9140,22955,7422,2113,6009,80012,23225,6196,1869,10533,4361,545,648,1021,81929	TXNRD1,KDM6B,PRKAA2,MAPK8,EP400,RB1CC1,MAP4K4,PIK3R4,ATG12,SCMH1,VEGFA,ETS1,RHEB,PHC3,NUP210,RPS6KA2,E2F1,ATG7,MRE11A,ATR,BMI1,CDK6,SEH1L
R-HSA-3214815	HDACs deacetylate histones	0.956792414173018	-0.0441688241480749	94	4	0.00592592592592593	675	8202	55869,6907,79718,1107	HDAC8,TBL1X,TBL1XR1,CHD3
R-HSA-5653656	Vesicle-mediated transport	0.957559398599174	-0.0433675247609111	294	17	0.0251851851851852	675	8202	5563,1759,83696,152503,1777,7037,9276,23243,149111,8773,4253,60412,348,117156,949,22820,4644	PRKAA2,DNM1,TRAPPC9,SH3D19,DNASE2,TFRC,COPB2,ANKRD28,CNIH3,SNAP23,CTAGE5,EXOC4,APOE,SCGB3A2,SCARB1,COPG1,MYO5A
R-HSA-72737	Cap-dependent Translation Initiation	0.959298852008687	-0.0415526238558265	112	5	0.00740740740740741	675	8202	6165,8893,8894,1978,1974	RPL35A,EIF2B5,EIF2S2,EIF4EBP1,EIF4A2
R-HSA-72613	Eukaryotic Translation Initiation	0.959298852008687	-0.0415526238558265	112	5	0.00740740740740741	675	8202	6165,8893,8894,1978,1974	RPL35A,EIF2B5,EIF2S2,EIF4EBP1,EIF4A2
R-HSA-2467813	Separation of Sister Chromatids	0.960435549519796	-0.0403683999933548	161	8	0.0118518518518519	675	8202	10274,23421,8379,5682,64105,55869,81929,401541	STAG1,ITGB3BP,MAD1L1,PSMA1,CENPK,HDAC8,SEH1L,CENPP
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.960843360292007	-0.0399438798716245	59	2	0.00296296296296296	675	8202	5682,2736	PSMA1,GLI2
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.961569307567151	-0.039188633797992	223	12	0.0177777777777778	675	8202	10616,92369,25847,55070,79876,10533,7328,5682,10477,126433,4734,26259	RBCK1,SPSB4,ANAPC13,DET1,UBA5,ATG7,UBE2H,PSMA1,UBE2E3,FBXO27,NEDD4,FBXW8
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.962039410034112	-0.0386998623841193	38	1	0.00148148148148148	675	8202	9197	SLC33A1
R-HSA-211859	Biological oxidations	0.963758559422693	-0.0369144727715925	194	10	0.0148148148148148	675	8202	8639,217,57834,25830,1312,5742,1800,4129,6820,4144	AOC3,ALDH2,CYP4F11,SULT4A1,COMT,PTGS1,DPEP1,MAOB,SULT2B1,MAT2A
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.96517799384941	-0.0354427450670039	39	1	0.00148148148148148	675	8202	7035	TFPI
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.965502241671387	-0.0351068553437239	115	5	0.00740740740740741	675	8202	10225,3903,10666,3383,945	CD96,LAIR1,CD226,ICAM1,CD33
R-HSA-156580	Phase II conjugation	0.965876070968076	-0.0347197439229203	98	4	0.00592592592592593	675	8202	1312,6820,4144,25830	COMT,SULT2B1,MAT2A,SULT4A1
R-HSA-199991	Membrane Trafficking	0.966052074539673	-0.0345375388316044	256	14	0.0207407407407407	675	8202	23243,5563,1759,83696,149111,152503,8773,60412,4253,1777,7037,4644,22820,9276	ANKRD28,PRKAA2,DNM1,TRAPPC9,CNIH3,SH3D19,SNAP23,EXOC4,CTAGE5,DNASE2,TFRC,MYO5A,COPG1,COPB2
R-HSA-611105	Respiratory electron transport	0.96790555499636	-0.0326207636180652	81	3	0.00444444444444444	675	8202	91942,4711,4724	NDUFAF2,NDUFB5,NDUFS4
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.96790555499636	-0.0326207636180652	81	3	0.00444444444444444	675	8202	9140,170506,84166	ATG12,DHX36,NLRC5
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.96790555499636	-0.0326207636180652	81	3	0.00444444444444444	675	8202	5682,7090,6934	PSMA1,TLE3,TCF7L2
R-HSA-5663205	Infectious disease	0.969762349993159	-0.0307042375091661	347	20	0.0296296296296296	675	8202	7296,118429,902,728340,8731,5682,6875,6857,84168,11168,4331,6165,23225,3840,2534,5062,22916,8732,7518,81929	TXNRD1,ANTXR2,CCNH,GTF2H2C,RNMT,PSMA1,TAF4B,SYT1,ANTXR1,PSIP1,MNAT1,RPL35A,NUP210,KPNA4,FYN,PAK2,NCBP2,RNGTT,XRCC4,SEH1L
R-HSA-5358346	Hedgehog ligand biogenesis	0.972770427721828	-0.0276071673669319	64	2	0.00296296296296296	675	8202	5682,55733	PSMA1,HHAT
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.972770427721828	-0.0276071673669319	64	2	0.00296296296296296	675	8202	5585,23081	PKN1,KDM4C
R-HSA-1236974	ER-Phagosome pathway	0.972770427721828	-0.0276071673669319	64	2	0.00296296296296296	675	8202	5682,29927	PSMA1,SEC61A1
R-HSA-73856	RNA Polymerase II Transcription Termination	0.973122583900089	-0.0272452192228124	42	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.973122583900089	-0.0272452192228124	42	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-912446	Meiotic recombination	0.973621838665194	-0.0267323067210341	84	3	0.00444444444444444	675	8202	4361,5932,27030	MRE11A,RBBP8,MLH3
R-HSA-427413	NoRC negatively regulates rRNA expression	0.976225870459716	-0.0240612946922501	104	4	0.00592592592592593	675	8202	4331,902,9014,728340	MNAT1,CCNH,TAF1B,GTF2H2C
R-HSA-212436	Generic Transcription Pathway	0.976423954950082	-0.0238584068129507	553	34	0.0503703703703704	675	8202	7567,9534,5563,339327,169841,54541,9668,339500,1490,4609,7068,7296,83667,79718,3164,7003,9442,5465,2100,79970,6009,6498,5467,9975,10000,25937,619279,3516,6907,7029,3172,51385,158431,7182	ZNF19,ZNF254,PRKAA2,ZNF546,ZNF169,DDIT4,ZNF432,ZNF678,CTGF,MYC,THRB,TXNRD1,SESN2,TBL1XR1,NR4A1,TEAD1,MED27,PPARA,ESR2,ZNF767P,RHEB,SKIL,PPARD,NR1D2,AKT3,WWTR1,ZNF704,RBPJ,TBL1X,TFDP2,HNF4A,ZNF589,ZNF782,NR2C2
R-HSA-3371556	Cellular response to heat stress	0.976881280390233	-0.0233901487647632	86	3	0.00444444444444444	675	8202	545,23225,81929	ATR,NUP210,SEH1L
R-HSA-446652	Interleukin-1 signaling	0.977385551218083	-0.0228740771302396	44	1	0.00148148148148148	675	8202	3556	IL1RAP
R-HSA-418594	G alpha (i) signalling events	0.977756240125932	-0.0224948832385927	236	12	0.0177777777777778	675	8202	51083,8787,58191,2781,2550,2792,2914,728,9628,109,4543,23566	GAL,RGS9,CXCL16,GNAZ,GABBR1,GNGT1,GRM4,C5AR1,RGS6,ADCY3,MTNR1A,LPAR3
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.978363760796913	-0.0218737345460512	87	3	0.00444444444444444	675	8202	5682,54464,5073	PSMA1,XRN1,PARN
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.979256690344312	-0.0209614743489285	45	1	0.00148148148148148	675	8202	5467	PPARD
R-HSA-909733	Interferon alpha/beta signaling	0.979707104279919	-0.0205016251727662	68	2	0.00296296296296296	675	8202	1958,3669	EGR1,ISG20
R-HSA-977225	Amyloid formation	0.979755470903085	-0.0204522579393335	88	3	0.00444444444444444	675	8202	3339,23062,23621	HSPG2,GGA2,BACE1
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.980217465806001	-0.0199808280508703	107	4	0.00592592592592593	675	8202	4331,902,9014,728340	MNAT1,CCNH,TAF1B,GTF2H2C
R-HSA-195258	RHO GTPase Effectors	0.980583434462457	-0.0196075431746178	285	15	0.0222222222222222	675	8202	10152,23421,644150,3798,5062,4638,8379,64105,5585,81624,5217,114793,81929,23081,401541	ABI2,ITGB3BP,WIPF3,KIF5A,PAK2,MYLK,MAD1L1,CENPK,PKN1,DIAPH3,PFN2,FMNL2,SEH1L,KDM4C,CENPP
R-HSA-68949	Orc1 removal from chromatin	0.982499778923739	-0.017655160252752	70	2	0.00296296296296296	675	8202	5682,4171	PSMA1,MCM2
R-HSA-212300	PRC2 methylates histones and DNA	0.982499778923739	-0.017655160252752	70	2	0.00296296296296296	675	8202	1788,3720	DNMT3A,JARID2
R-HSA-69052	Switching of origins to a post-replicative state	0.982499778923739	-0.017655160252752	70	2	0.00296296296296296	675	8202	5682,4171	PSMA1,MCM2
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.983992431751889	-0.0161370732685181	48	1	0.00148148148148148	675	8202	8894	EIF2S2
R-HSA-877300	Interferon gamma signaling	0.984514566166984	-0.0156065855152184	92	3	0.00444444444444444	675	8202	10346,9830,3383	TRIM22,TRIM14,ICAM1
R-HSA-69300	Removal of licensing factors from origins	0.984917963320977	-0.0151969272470681	72	2	0.00296296296296296	675	8202	5682,4171	PSMA1,MCM2
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.985317561572411	-0.014791292233524	49	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-211000	Gene Silencing by RNA	0.985375142074553	-0.0147328554188423	130	5	0.00740740740740741	675	8202	23225,29102,27161,23405,81929	NUP210,DROSHA,AGO2,DICER1,SEH1L
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.98653314431229	-0.0135583562001435	50	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.98653314431229	-0.0135583562001435	50	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-72165	mRNA Splicing - Minor Pathway	0.98653314431229	-0.0135583562001435	50	1	0.00148148148148148	675	8202	22916	NCBP2
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.98653314431229	-0.0135583562001435	50	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.98653314431229	-0.0135583562001435	50	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-1461973	Defensins	0.987648223737599	-0.0124286934832942	51	1	0.00148148148148148	675	8202	5646	PRSS3
R-HSA-180534	Vpu mediated degradation of CD4	0.987648223737599	-0.0124286934832942	51	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.987648223737599	-0.0124286934832942	51	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-68886	M Phase	0.987687535874248	-0.0123888904913596	296	15	0.0222222222222222	675	8202	23225,10783,10274,23421,140609,8379,5682,5520,55869,64105,7443,23175,81929,10051,401541	NUP210,NEK6,STAG1,ITGB3BP,NEK7,MAD1L1,PSMA1,PPP2R2A,HDAC8,CENPK,VRK1,LPIN1,SEH1L,SMC4,CENPP
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.988671098100045	-0.0113935627304068	52	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.988671098100045	-0.0113935627304068	52	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-69541	Stabilization of p53	0.988671098100045	-0.0113935627304068	52	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-69610	p53-Independent DNA Damage Response	0.988671098100045	-0.0113935627304068	52	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.988722072168111	-0.0113420058940184	267	13	0.0192592592592593	675	8202	10616,29927,92369,25847,55070,79876,10533,7328,5682,10477,126433,4734,26259	RBCK1,SEC61A1,SPSB4,ANAPC13,DET1,UBA5,ATG7,UBE2H,PSMA1,UBE2E3,FBXO27,NEDD4,FBXW8
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.989609381401105	-0.0104449779557613	53	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.989628469529	-0.0104256895939444	77	2	0.00296296296296296	675	8202	4361,57634	MRE11A,EP400
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.990382448429508	-0.00966409890763715	99	3	0.00444444444444444	675	8202	5682,4773,5530	PSMA1,NFATC2,PPP3CA
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.990470059711262	-0.00957564074989857	54	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-4641257	Degradation of AXIN	0.990470059711262	-0.00957564074989857	54	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-1280218	Adaptive Immune System	0.990768726346711	-0.00927414590756702	668	40	0.0592592592592593	675	8202	6712,3798,1950,27161,9542,23239,1780,2309,10666,9965,30011,4734,3383,10225,55070,5062,79876,7220,26259,1759,10616,25847,92369,2247,3164,7879,7328,5682,5291,8660,3108,57761,2534,29927,10000,10533,10477,126433,3903,945	SPTBN2,KIF5A,EGF,AGO2,NRG2,PHLPP1,DYNC1I1,FOXO3,CD226,FGF19,SH3KBP1,NEDD4,ICAM1,CD96,DET1,PAK2,UBA5,TRPC1,FBXW8,DNM1,RBCK1,ANAPC13,SPSB4,FGF2,NR4A1,RAB7A,UBE2H,PSMA1,PIK3CB,IRS2,HLA-DMA,TRIB3,FYN,SEC61A1,AKT3,ATG7,UBE2E3,FBXO27,LAIR1,CD33
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.99125954298673	-0.00877887885447242	55	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.99125954298673	-0.00877887885447242	55	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.99125954298673	-0.00877887885447242	55	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-5578749	Transcriptional regulation by small RNAs	0.991619487499116	-0.00841582643341629	101	3	0.00444444444444444	675	8202	23225,27161,81929	NUP210,AGO2,SEH1L
R-HSA-380108	Chemokine receptors bind chemokines	0.991983712436332	-0.00804859074704361	56	1	0.00148148148148148	675	8202	58191	CXCL16
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.991983712436332	-0.00804859074704361	56	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-4641258	Degradation of DVL	0.991983712436332	-0.00804859074704361	56	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.992178958273281	-0.00785178648249312	102	3	0.00444444444444444	675	8202	91942,4711,4724	NDUFAF2,NDUFB5,NDUFS4
R-HSA-1236975	Antigen processing-Cross presentation	0.992332610367979	-0.00769693518564686	81	2	0.00296296296296296	675	8202	5682,29927	PSMA1,SEC61A1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.992647964095378	-0.00737919532047198	57	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.992647964095378	-0.00737919532047198	57	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.99319167294524	-0.00683160944968319	104	3	0.00444444444444444	675	8202	6165,8894,1974	RPL35A,EIF2S2,EIF4A2
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.993257248855732	-0.00676558619603158	58	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.993257248855732	-0.00676558619603158	58	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.993649258885591	-0.00637099285868195	105	3	0.00444444444444444	675	8202	6165,8894,1974	RPL35A,EIF2S2,EIF4A2
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.993816108980042	-0.00620309046647853	59	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.993816108980042	-0.00620309046647853	59	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.993816108980042	-0.00620309046647853	59	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-351202	Metabolism of polyamines	0.993895372770355	-0.00612333664799672	84	2	0.00296296296296296	675	8202	5682,384	PSMA1,ARG2
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.994077015798126	-0.0059405946448164	106	3	0.00444444444444444	675	8202	5520,6165,22916	PPP2R2A,RPL35A,NCBP2
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.994077015798126	-0.0059405946448164	106	3	0.00444444444444444	675	8202	5520,6165,22916	PPP2R2A,RPL35A,NCBP2
R-HSA-69615	G1/S DNA Damage Checkpoints	0.994328712020607	-0.00568743079570437	60	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.994328712020607	-0.00568743079570437	60	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.994798881438081	-0.00521469146236437	61	1	0.00148148148148148	675	8202	57834	CYP4F11
R-HSA-5334118	DNA methylation	0.995230125139908	-0.0047812870173517	62	1	0.00148148148148148	675	8202	1788	DNMT3A
R-HSA-4608870	Asymmetric localization of PCP proteins	0.995625661451931	-0.00438393395954552	63	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.995834807486759	-0.00417389109014418	89	2	0.00296296296296296	675	8202	6165,22916	RPL35A,NCBP2
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.99598844294361	-0.00401962493513117	64	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-5625740	RHO GTPases activate PKNs	0.996142710136658	-0.00386474839186885	90	2	0.00296296296296296	675	8202	5585,23081	PKN1,KDM4C
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.996321178387176	-0.00368560511903633	65	1	0.00148148148148148	675	8202	9014	TAF1B
R-HSA-72163	mRNA Splicing - Major Pathway	0.996379748906015	-0.00362682006197766	113	3	0.00444444444444444	675	8202	6627,22916,220988	SNRPA1,NCBP2,HNRNPA3
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.996399212654378	-0.00360728578473123	153	5	0.00740740740740741	675	8202	6627,22916,23225,220988,81929	SNRPA1,NCBP2,NUP210,HNRNPA3,SEH1L
R-HSA-1169091	Activation of NF-kappaB in B cells	0.99662635284166	-0.00337935073743677	66	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-202403	TCR signaling	0.996858788008909	-0.00314615595354853	115	3	0.00444444444444444	675	8202	5682,5291,5062	PSMA1,PIK3CB,PAK2
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.997398382370048	-0.00260500771818364	69	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.997398382370048	-0.00260500771818364	69	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-202424	Downstream TCR signaling	0.99757226909053	-0.00243068262643808	96	2	0.00296296296296296	675	8202	5682,5291	PSMA1,PIK3CB
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.99757226909053	-0.00243068262643808	96	2	0.00296296296296296	675	8202	5682,329	PSMA1,BIRC2
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.997614304165509	-0.00238854614101009	70	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-72172	mRNA Splicing	0.997802219223559	-0.00220019944105758	120	3	0.00444444444444444	675	8202	6627,22916,220988	SNRPA1,NCBP2,HNRNPA3
R-HSA-2299718	Condensation of Prophase Chromosomes	0.997812329834437	-0.00219006661166641	71	1	0.00148148148148148	675	8202	10051	SMC4
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.997993940613526	-0.00200807421863776	72	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.998087278200537	-0.00191455338772283	143	4	0.00592592592592593	675	8202	5467,91942,4711,4724	PPARD,NDUFAF2,NDUFB5,NDUFS4
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.998160495369432	-0.00184119859690245	73	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-168254	Influenza Infection	0.998542673008609	-0.00145838992519127	147	4	0.00592592592592593	675	8202	6165,3840,23225,81929	RPL35A,KPNA4,NUP210,SEH1L
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.998673968795581	-0.00132691116178302	127	3	0.00444444444444444	675	8202	6165,23225,81929	RPL35A,NUP210,SEH1L
R-HSA-2871837	FCERI mediated NF-kB activation	0.998699588181067	-0.00130125808812728	77	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.998699588181067	-0.00130125808812728	77	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-74160	Gene Expression	0.998767197905983	-0.00123356261963473	1330	83	0.122962962962963	675	8202	9534,1788,728340,339327,5520,16,220988,10556,200424,58477,23225,1490,81929,7068,51520,2617,83667,902,8731,9442,4774,79970,6009,4784,6498,6165,29927,1107,1978,25937,619279,6747,54464,7029,3172,51385,7182,7567,6627,5563,833,6301,29102,169841,27161,10667,10644,5073,54541,9668,6184,8894,339500,9014,4609,8732,10302,7296,60487,8893,79718,3164,7003,1974,5465,5682,2100,6875,10622,4331,5467,9975,10000,23405,54901,57472,22916,4782,3516,6907,116461,158431,3720	ZNF254,DNMT3A,GTF2H2C,ZNF546,PPP2R2A,AARS,HNRNPA3,RPP30,TET3,SRPRB,NUP210,CTGF,SEH1L,THRB,LARS,GARS,SESN2,CCNH,RNMT,MED27,NFIA,ZNF767P,RHEB,NFIX,SKIL,RPL35A,SEC61A1,CHD3,EIF4EBP1,WWTR1,ZNF704,SSR3,XRN1,TFDP2,HNF4A,ZNF589,NR2C2,ZNF19,SNRPA1,PRKAA2,CARS,SARS,DROSHA,ZNF169,AGO2,FARS2,IGF2BP2,PARN,DDIT4,ZNF432,RPN1,EIF2S2,ZNF678,TAF1B,MYC,RNGTT,SNAPC5,TXNRD1,TRMT11,EIF2B5,TBL1XR1,NR4A1,TEAD1,EIF4A2,PPARA,PSMA1,ESR2,TAF4B,POLR3G,MNAT1,PPARD,NR1D2,AKT3,DICER1,CDKAL1,CNOT6,NCBP2,NFIC,RBPJ,TBL1X,TSEN15,ZNF782,JARID2
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.998795689598919	-0.0012050361656075	105	2	0.00296296296296296	675	8202	6196,1021	RPS6KA2,CDK6
R-HSA-375276	Peptide ligand-binding receptors	0.999030028345712	-0.000970442381212148	193	6	0.00888888888888889	675	8202	51083,728,58191,10911,257313,84634	GAL,C5AR1,CXCL16,UTS2,UTS2B,KISS1R
R-HSA-453276	Regulation of mitotic cell cycle	0.999227309372255	-0.000772989307015941	83	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.999227309372255	-0.000772989307015941	83	1	0.00148148148148148	675	8202	5682	PSMA1
R-HSA-192823	Viral mRNA Translation	0.999291549575391	-0.0007087014941983	84	1	0.00148148148148148	675	8202	6165	RPL35A
R-HSA-156902	Peptide chain elongation	0.999291549575391	-0.0007087014941983	84	1	0.00148148148148148	675	8202	6165	RPL35A
R-HSA-168255	Influenza Life Cycle	0.999313133442685	-0.000687102558222624	136	3	0.00444444444444444	675	8202	6165,23225,81929	RPL35A,NUP210,SEH1L
R-HSA-72764	Eukaryotic Translation Termination	0.999350456199057	-0.000649754845911291	85	1	0.00148148148148148	675	8202	6165	RPL35A
R-HSA-156842	Eukaryotic Translation Elongation	0.999499416846365	-0.000500708487210416	88	1	0.00148148148148148	675	8202	6165	RPL35A
R-HSA-72689	Formation of a pool of free 40S subunits	0.999702778200223	-0.000297265978930237	94	1	0.00148148148148148	675	8202	6165	RPL35A
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999857454377086	-0.000142555783507388	318	11	0.0162962962962963	675	8202	3363,51083,58191,728,2863,10911,4543,23566,257313,84634,3269	HTR7,GAL,CXCL16,C5AR1,GPR39,UTS2,MTNR1A,LPAR3,UTS2B,KISS1R,HRH1
R-HSA-500792	GPCR ligand binding	0.99988765855747	-0.000112347753302108	444	18	0.0266666666666667	675	8202	51083,30817,1604,2550,2792,728,10267,23566,257313,84634,3363,58191,2914,2863,797,10911,4543,3269	GAL,ADGRE2,CD55,GABBR1,GNGT1,C5AR1,RAMP1,LPAR3,UTS2B,KISS1R,HTR7,CXCL16,GRM4,GPR39,CALCB,UTS2,MTNR1A,HRH1
R-HSA-372790	Signaling by GPCR	0.999993115178595	-6.88484510572605e-06	1230	65	0.0962962962962963	675	8202	51083,6712,200734,1950,9542,8527,23566,26230,6196,2781,53358,109,9628,5144,9828,11343,1604,1894,728,283455,5577,57731,29,8622,3363,8660,2534,797,409,30817,2869,5922,7204,2792,2550,10267,9965,1847,5581,58191,23263,10911,5330,4543,1608,5530,8831,2247,1852,84033,5682,5151,5140,23236,5291,257313,84634,50940,8787,10000,5332,2914,2863,3269,50649	GAL,SPTBN2,SPRED2,EGF,NRG2,DGKD,LPAR3,TIAM2,RPS6KA2,GNAZ,SHC3,ADCY3,RGS6,PDE4D,ARHGEF17,MGLL,CD55,ECT2,C5AR1,KSR2,PRKAR2B,SPTBN4,ABR,PDE8B,HTR7,IRS2,FYN,CALCB,ARRB2,ADGRE2,GRK5,RASA2,TRIO,GNGT1,GABBR1,RAMP1,FGF19,DUSP5,PRKCE,CXCL16,MCF2L,UTS2,PLCB2,MTNR1A,DGKG,PPP3CA,SYNGAP1,FGF2,DUSP9,OBSCN,PSMA1,PDE8A,PDE3B,PLCB1,PIK3CB,UTS2B,KISS1R,PDE11A,RGS9,AKT3,PLCB4,GRM4,GPR39,HRH1,ARHGEF4
R-HSA-388396	GPCR downstream signaling	0.99999897896988	-1.02103064141875e-06	928	42	0.0622222222222222	675	8202	51083,2869,2550,2792,7204,8527,10267,23566,26230,5581,58191,2781,23263,109,9628,5144,10911,9828,1608,4543,5330,11343,1894,728,84033,5151,5140,23236,5291,29,257313,50940,8622,84634,3363,8787,10000,2914,5332,797,3269,50649	GAL,GRK5,GABBR1,GNGT1,TRIO,DGKD,RAMP1,LPAR3,TIAM2,PRKCE,CXCL16,GNAZ,MCF2L,ADCY3,RGS6,PDE4D,UTS2,ARHGEF17,DGKG,MTNR1A,PLCB2,MGLL,ECT2,C5AR1,OBSCN,PDE8A,PDE3B,PLCB1,PIK3CB,ABR,UTS2B,PDE11A,PDE8B,KISS1R,HTR7,RGS9,AKT3,GRM4,PLCB4,CALCB,HRH1,ARHGEF4
R-HSA-381753	Olfactory Signaling Pathway	0.999999999975734	-2.42656141848915e-11	381	1	0.00148148148148148	675	8202	2792	GNGT1
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-916853	Degradation of GABA	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-168268	Virus Assembly and Release	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-1483101	Synthesis of PS	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-192905	vRNP Assembly	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-844623	The IPAF inflammasome	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-156582	Acetylation	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-198765	Signalling to ERK5	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-70688	Proline catabolism	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-75094	Formation of the Editosome	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-1483226	Synthesis of PI	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999977778	-2.22216463979796e-11	2	0	0	675	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5653890	Lactose synthesis	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-70350	Fructose catabolism	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-111458	Formation of apoptosome	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-193681	Ceramide signalling	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-110331	Cleavage of the damaged purine	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-1296067	Potassium transport channels	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-351200	Interconversion of polyamines	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-73927	Depurination	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999979474	-2.05260090608422e-11	3	0	0	675	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-389542	NADPH regeneration	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-3248023	Regulation by TREX1	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-169131	Inhibition of PKR	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1483076	Synthesis of CL	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1300645	Acrosome Reaction	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5619084	ABC transporter disorders	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999982473	-1.7527188034272e-11	1	0	0	675	8202
R-HSA-879518	Transport of organic anions	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-71288	Creatine metabolism	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-1059683	Interleukin-6 signaling	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-211999	CYP2E1 reactions	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-193048	Androgen biosynthesis	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-71240	Tryptophan catabolism	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-5655291	Signaling by FGFR4 in disease	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999988151	-1.1848686931638e-11	11	0	0	675	8202
R-HSA-190861	Gap junction assembly	0.999999999988385	-1.16152862005987e-11	19	0	0	675	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999988385	-1.16152862005987e-11	19	0	0	675	8202
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.999999999988385	-1.16152862005987e-11	19	0	0	675	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-71262	Carnitine synthesis	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-173736	Alternative complement activation	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-1296061	HCN channels	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-75072	mRNA Editing	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-6783984	Glycine degradation	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-888593	Reuptake of GABA	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-209563	Axonal growth stimulation	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-428776	Class II GLUTs	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-442745	Activation of CaMK IV	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999989828	-1.01722051734556e-11	4	0	0	675	8202
R-HSA-74259	Purine catabolism	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-419771	Opsins	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999989863	-1.01373659229852e-11	10	0	0	675	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-3371568	Attenuation phase	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-2024101	CS/DS degradation	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-877312	Regulation of IFNG signaling	0.999999999990602	-9.39792470267574e-12	14	0	0	675	8202
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.99999999999143	-8.56991823767914e-12	24	0	0	675	8202
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.99999999999143	-8.56991823767914e-12	24	0	0	675	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.99999999999143	-8.56991823767914e-12	24	0	0	675	8202
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.99999999999143	-8.56991823767914e-12	24	0	0	675	8202
R-HSA-5260271	Diseases of Immune System	0.99999999999143	-8.56991823767914e-12	24	0	0	675	8202
R-HSA-933542	TRAF6 mediated NF-kB activation	0.99999999999143	-8.56991823767914e-12	24	0	0	675	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-156587	Amino Acid conjugation	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-425381	Bicarbonate transporters	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-390696	Adrenoceptors	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999993335	-6.66547981837323e-12	9	0	0	675	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-392517	Rap1 signalling	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-5625900	RHO GTPases activate CIT	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999993667	-6.33314361521958e-12	16	0	0	675	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-209776	Amine-derived hormones	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999994696	-5.30417106260435e-12	18	0	0	675	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-75157	FasL/ CD95L signaling	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-5652084	Fructose metabolism	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-2161541	Abacavir metabolism	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-446205	Synthesis of GDP-mannose	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-167827	The proton buffering model	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-444209	Free fatty acid receptors	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-70370	Galactose catabolism	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-197264	Nicotinamide salvaging	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-114516	Disinhibition of SNARE formation	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-390651	Dopamine receptors	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-157881	Cyclin B2 mediated events	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-111463	SMAC binds to IAPs	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-561048	Organic anion transport	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-391906	Leukotriene receptors	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-1169092	Activation of RAS in B cells	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-167826	The fatty acid cycling model	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999995139	-4.86103011726667e-12	5	0	0	675	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-70921	Histidine catabolism	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-500753	Pyrimidine biosynthesis	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-176417	Phosphorylation of Emi1	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-1237112	Methionine salvage pathway	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-1566977	Fibronectin matrix formation	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-174362	Transport and synthesis of PAPS	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-205025	NADE modulates death signalling	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-211916	Vitamins	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-189483	Heme degradation	0.999999999995784	-4.21546903776157e-12	6	0	0	675	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-159418	Recycling of bile acids and salts	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999996238	-3.76188164637149e-12	15	0	0	675	8202
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.999999999996542	-3.45819775710933e-12	36	0	0	675	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999997109	-2.89107925339305e-12	22	0	0	675	8202
R-HSA-3371571	HSF1-dependent transactivation	0.999999999997109	-2.89107925339305e-12	22	0	0	675	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999997109	-2.89107925339305e-12	22	0	0	675	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-428643	Organic anion transporters	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-804914	Transport of fatty acids	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-444821	Relaxin receptors	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-192456	Digestion of dietary lipid	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999998373	-1.62711122785726e-12	8	0	0	675	8202
R-HSA-354192	Integrin alphaIIb beta3 signaling	1.00000000000132	1.32476043962402e-12	27	0	0	675	8202
R-HSA-389948	PD-1 signaling	1.00000000000246	2.4626835335909e-12	23	0	0	675	8202
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1.00000000000246	2.4626835335909e-12	23	0	0	675	8202
R-HSA-211976	Endogenous sterols	1.00000000000246	2.4626835335909e-12	23	0	0	675	8202
R-HSA-191273	Cholesterol biosynthesis	1.00000000000246	2.4626835335909e-12	23	0	0	675	8202
R-HSA-201451	Signaling by BMP	1.00000000000246	2.4626835335909e-12	23	0	0	675	8202
R-HSA-167287	HIV elongation arrest and recovery	1.00000000000401	4.00852233352749e-12	31	0	0	675	8202
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000000401	4.00852233352749e-12	31	0	0	675	8202
R-HSA-418990	Adherens junctions interactions	1.00000000000401	4.00852233352749e-12	31	0	0	675	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-3371511	HSF1 activation	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-2022857	Keratan sulfate degradation	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-417957	P2Y receptors	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-202670	ERKs are inactivated	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000000582	5.82173396236476e-12	12	0	0	675	8202
R-HSA-1502540	Signaling by Activin	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-209560	NF-kB is activated and signals survival	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-211227	Activation of DNA fragmentation factor	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-174403	Glutathione synthesis and recycling	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-977441	GABA A receptor activation	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-171007	p38MAPK events	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-140342	Apoptosis induced DNA fragmentation	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-209822	Glycoprotein hormones	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-5626467	RHO GTPases activate IQGAPs	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-175474	Assembly Of The HIV Virion	1.00000000000625	6.25022817048378e-12	13	0	0	675	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-111471	Apoptotic factor-mediated response	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-75158	TRAIL  signaling	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000726	7.25790304600243e-12	7	0	0	675	8202
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1.00000000000863	8.62906941624418e-12	26	0	0	675	8202
R-HSA-912694	Regulation of IFNA signaling	1.00000000000863	8.62906941624418e-12	26	0	0	675	8202
R-HSA-975298	Ligand-gated ion channel transport	1.00000000000863	8.62906941624418e-12	26	0	0	675	8202
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.00000000000863	8.62906941624418e-12	26	0	0	675	8202
R-HSA-5673000	RAF activation	1.00000000000994	9.94450276619166e-12	25	0	0	675	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000000994	9.94450276619166e-12	25	0	0	675	8202
R-HSA-162588	Budding and maturation of HIV virion	1.00000000000994	9.94450276619166e-12	25	0	0	675	8202
R-HSA-1461957	Beta defensins	1.00000000000998	9.97675174601235e-12	42	0	0	675	8202
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-176412	Phosphorylation of the APC/C	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-1482801	Acyl chain remodelling of PS	1.00000000001094	1.09403228134519e-11	17	0	0	675	8202
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000001185	1.18475249201652e-11	30	0	0	675	8202
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000001185	1.18475249201652e-11	30	0	0	675	8202
R-HSA-5683826	Surfactant metabolism	1.00000000001185	1.18475249201652e-11	30	0	0	675	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.0000000000134	1.33999965072195e-11	28	0	0	675	8202
R-HSA-171306	Packaging Of Telomere Ends	1.00000000001385	1.38463801304195e-11	49	0	0	675	8202
R-HSA-76009	Platelet Aggregation (Plug Formation)	1.00000000001517	1.51678980543507e-11	37	0	0	675	8202
R-HSA-156590	Glutathione conjugation	1.00000000001517	1.51678980543507e-11	37	0	0	675	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000001685	1.68452561538059e-11	60	0	0	675	8202
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000002036	2.03566716237928e-11	21	0	0	675	8202
R-HSA-211981	Xenobiotics	1.00000000002036	2.03566716237928e-11	21	0	0	675	8202
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1.00000000002036	2.03566716237928e-11	21	0	0	675	8202
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000002036	2.03566716237928e-11	21	0	0	675	8202
R-HSA-156588	Glucuronidation	1.00000000002036	2.03566716237928e-11	21	0	0	675	8202
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1.00000000002036	2.03566716237928e-11	21	0	0	675	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000002099	2.0985456338333e-11	29	0	0	675	8202
